BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1280868 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccccc1 |THB:4:6:8:10,(-7.3,-.22,;-5.81,-.61,;-4.78,.53,;-3.37,-.1,;-2.04,.67,;-.7,-.1,;-2.04,2.21,;-3.37,2.98,;-3.37,4.52,;-2.04,5.29,;-2.04,3.75,;-.7,4.52,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-3.53,-1.63,;-5.04,-1.95,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 603922 US11660293, Example 1 Orexin/Hypocretin receptor type 1 Homo sapiens 7.24 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603922 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603922&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526658 482596656 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280869 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccccc1 |THB:4:6:8:10,(-7.3,-.22,;-5.81,-.61,;-4.78,.53,;-3.37,-.1,;-2.04,.67,;-.7,-.1,;-2.04,2.21,;-3.37,2.98,;-3.37,4.52,;-2.04,5.29,;-2.04,3.75,;-.7,4.52,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-3.53,-1.63,;-5.04,-1.95,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 603922 US11660293, Example 1 Orexin receptor type 2 Homo sapiens 107 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603922 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603922&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526658 482596656 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280870 Cc1nc(C(=O)N2C3CC(C3)CC2COc2cc3ccccc3cn2)c(s1)-c1ccccc1 |(-7.96,-.22,;-6.48,-.61,;-5.45,.53,;-4.04,-.1,;-2.71,.67,;-1.37,-.1,;-2.71,2.21,;-4.04,2.98,;-4.04,4.52,;-2.71,5.29,;-2.71,3.75,;-1.37,4.52,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-4.2,-1.63,;-5.71,-1.95,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C27H25N3O2S/c1-17-29-25(26(33-17)19-7-3-2-4-8-19)27(31)30-22-11-18(12-22)13-23(30)16-32-24-14-20-9-5-6-10-21(20)15-28-24/h2-10,14-15,18,22-23H,11-13,16H2,1H3 MRYWAOSAXXOEPY-UHFFFAOYSA-N 603923 US11660293, Example 38 Orexin/Hypocretin receptor type 1 Homo sapiens 24.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603923 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603923&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526752 482596657 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280871 Cc1nc(C(=O)N2C3CC(C3)CC2COc2cc3ccccc3cn2)c(s1)-c1ccccc1 |(-7.96,-.22,;-6.48,-.61,;-5.45,.53,;-4.04,-.1,;-2.71,.67,;-1.37,-.1,;-2.71,2.21,;-4.04,2.98,;-4.04,4.52,;-2.71,5.29,;-2.71,3.75,;-1.37,4.52,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-4.2,-1.63,;-5.71,-1.95,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C27H25N3O2S/c1-17-29-25(26(33-17)19-7-3-2-4-8-19)27(31)30-22-11-18(12-22)13-23(30)16-32-24-14-20-9-5-6-10-21(20)15-28-24/h2-10,14-15,18,22-23H,11-13,16H2,1H3 MRYWAOSAXXOEPY-UHFFFAOYSA-N 603923 US11660293, Example 38 Orexin receptor type 2 Homo sapiens 126 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603923 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603923&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526752 482596657 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280872 Cc1ccc(c(n1)C(=O)N1C2CC(C2)CC1COc1ccc(F)cc1)-n1nccn1 |(-7.34,.24,;-6,-.53,;-6,-2.07,;-4.67,-2.84,;-3.33,-2.07,;-3.33,-.53,;-4.67,.24,;-2,.24,;-.67,-.53,;-2,1.78,;-3.33,2.55,;-3.33,4.09,;-2,4.86,;-2,3.32,;-.67,4.09,;-.67,2.55,;.67,1.78,;2,2.55,;3.33,1.78,;4.67,2.55,;6,1.78,;6,.24,;7.34,-.53,;4.67,-.53,;3.33,.24,;-2,-2.84,;-2,-4.38,;-.54,-4.86,;.37,-3.61,;-.54,-2.37,)| InChI=1S/C22H22FN5O2/c1-14-2-7-20(28-24-8-9-25-28)21(26-14)22(29)27-17-10-15(11-17)12-18(27)13-30-19-5-3-16(23)4-6-19/h2-9,15,17-18H,10-13H2,1H3 PRZYCTZBFOOVLD-UHFFFAOYSA-N 603968 US11660293, Example 39 Orexin/Hypocretin receptor type 1 Homo sapiens 22.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603968 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603968&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137527124 482596700 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280873 Cc1ccc(c(n1)C(=O)N1C2CC(C2)CC1COc1ccc(F)cc1)-n1nccn1 |(-7.34,.24,;-6,-.53,;-6,-2.07,;-4.67,-2.84,;-3.33,-2.07,;-3.33,-.53,;-4.67,.24,;-2,.24,;-.67,-.53,;-2,1.78,;-3.33,2.55,;-3.33,4.09,;-2,4.86,;-2,3.32,;-.67,4.09,;-.67,2.55,;.67,1.78,;2,2.55,;3.33,1.78,;4.67,2.55,;6,1.78,;6,.24,;7.34,-.53,;4.67,-.53,;3.33,.24,;-2,-2.84,;-2,-4.38,;-.54,-4.86,;.37,-3.61,;-.54,-2.37,)| InChI=1S/C22H22FN5O2/c1-14-2-7-20(28-24-8-9-25-28)21(26-14)22(29)27-17-10-15(11-17)12-18(27)13-30-19-5-3-16(23)4-6-19/h2-9,15,17-18H,10-13H2,1H3 PRZYCTZBFOOVLD-UHFFFAOYSA-N 603968 US11660293, Example 39 Orexin receptor type 2 Homo sapiens 646 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603968 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603968&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137527124 482596700 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280874 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccccc1F |THB:4:6:8:10,(-7.3,-.22,;-5.81,-.61,;-4.78,.53,;-3.37,-.1,;-2.04,.67,;-.7,-.1,;-2.04,2.21,;-3.37,2.98,;-3.37,4.52,;-2.04,5.29,;-2.04,3.75,;-.7,4.52,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-3.53,-1.63,;-5.04,-1.95,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,;-4.33,-4.6,)| 603969 US11660293, Example 40 Orexin/Hypocretin receptor type 1 Homo sapiens 46.8 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603969&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526494 482596701 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280875 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccccc1F |THB:4:6:8:10,(-7.3,-.22,;-5.81,-.61,;-4.78,.53,;-3.37,-.1,;-2.04,.67,;-.7,-.1,;-2.04,2.21,;-3.37,2.98,;-3.37,4.52,;-2.04,5.29,;-2.04,3.75,;-.7,4.52,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-3.53,-1.63,;-5.04,-1.95,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,;-4.33,-4.6,)| 603969 US11660293, Example 40 Orexin receptor type 2 Homo sapiens 646 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603969&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526494 482596701 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280876 Cc1nc(C(=O)N2C3CC(C3)CC2COc2cccc(F)c2)c(s1)-c1ccccc1 |THB:4:6:8:10,(-7.3,-.22,;-5.81,-.61,;-4.78,.53,;-3.37,-.1,;-2.04,.67,;-.7,-.1,;-2.04,2.21,;-3.37,2.98,;-3.37,4.52,;-2.04,5.29,;-2.04,3.75,;-.7,4.52,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;5.96,2.21,;7.3,2.98,;4.63,2.98,;-3.53,-1.63,;-5.04,-1.95,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 603970 US11660293, Example 44 Orexin/Hypocretin receptor type 1 Homo sapiens 70.8 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603970 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603970&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137527014 482596702 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280877 Cc1nc(C(=O)N2C3CC(C3)CC2COc2cccc(F)c2)c(s1)-c1ccccc1 |THB:4:6:8:10,(-7.3,-.22,;-5.81,-.61,;-4.78,.53,;-3.37,-.1,;-2.04,.67,;-.7,-.1,;-2.04,2.21,;-3.37,2.98,;-3.37,4.52,;-2.04,5.29,;-2.04,3.75,;-.7,4.52,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;5.96,2.21,;7.3,2.98,;4.63,2.98,;-3.53,-1.63,;-5.04,-1.95,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 603970 US11660293, Example 44 Orexin receptor type 2 Homo sapiens 417 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603970 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603970&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137527014 482596702 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280878 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccccc2F)c(s1)-c1ccccc1 |(-6.63,-.22,;-5.14,-.61,;-4.11,.53,;-2.71,-.1,;-1.37,.67,;-.04,-.1,;-1.37,2.21,;-2.71,2.98,;-2.71,4.52,;-1.37,5.29,;-1.37,3.75,;-.04,4.52,;-.04,2.98,;1.3,2.21,;2.63,2.98,;3.96,2.21,;3.96,.67,;5.3,-.1,;6.63,.67,;6.63,2.21,;5.3,2.98,;5.3,4.52,;-2.87,-1.63,;-4.37,-1.95,;-1.78,-2.72,;-.29,-2.32,;.8,-3.41,;.4,-4.89,;-1.09,-5.29,;-2.18,-4.2,)| InChI=1S/C24H23FN2O2S/c1-15-26-22(23(30-15)17-7-3-2-4-8-17)24(28)27-18-11-16(12-18)13-19(27)14-29-21-10-6-5-9-20(21)25/h2-10,16,18-19H,11-14H2,1H3 IYICDAKCJSTFCY-UHFFFAOYSA-N 603971 US11660293, Example 45 Orexin/Hypocretin receptor type 1 Homo sapiens 60.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603971 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603971&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526386 482596703 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280879 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccccc2F)c(s1)-c1ccccc1 |(-6.63,-.22,;-5.14,-.61,;-4.11,.53,;-2.71,-.1,;-1.37,.67,;-.04,-.1,;-1.37,2.21,;-2.71,2.98,;-2.71,4.52,;-1.37,5.29,;-1.37,3.75,;-.04,4.52,;-.04,2.98,;1.3,2.21,;2.63,2.98,;3.96,2.21,;3.96,.67,;5.3,-.1,;6.63,.67,;6.63,2.21,;5.3,2.98,;5.3,4.52,;-2.87,-1.63,;-4.37,-1.95,;-1.78,-2.72,;-.29,-2.32,;.8,-3.41,;.4,-4.89,;-1.09,-5.29,;-2.18,-4.2,)| InChI=1S/C24H23FN2O2S/c1-15-26-22(23(30-15)17-7-3-2-4-8-17)24(28)27-18-11-16(12-18)13-19(27)14-29-21-10-6-5-9-20(21)25/h2-10,16,18-19H,11-14H2,1H3 IYICDAKCJSTFCY-UHFFFAOYSA-N 603971 US11660293, Example 45 Orexin receptor type 2 Homo sapiens 75.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603971 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603971&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526386 482596703 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280880 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(Br)cc2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H23BrN2O2S/c1-15-26-22(23(30-15)17-5-3-2-4-6-17)24(28)27-19-11-16(12-19)13-20(27)14-29-21-9-7-18(25)8-10-21/h2-10,16,19-20H,11-14H2,1H3 DNWVBLXOPBJJKA-UHFFFAOYSA-N 603972 US11660293, Example 46 Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603972&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526681 482596704 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280881 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(Br)cc2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H23BrN2O2S/c1-15-26-22(23(30-15)17-5-3-2-4-6-17)24(28)27-19-11-16(12-19)13-20(27)14-29-21-9-7-18(25)8-10-21/h2-10,16,19-20H,11-14H2,1H3 DNWVBLXOPBJJKA-UHFFFAOYSA-N 603972 US11660293, Example 46 Orexin receptor type 2 Homo sapiens 309 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603972&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526681 482596704 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280882 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)c(F)c2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;3.32,.67,;4.66,-.1,;5.99,.67,;7.32,-.1,;5.99,2.21,;7.32,2.98,;4.66,2.98,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H22F2N2O2S/c1-14-27-22(23(31-14)16-5-3-2-4-6-16)24(29)28-17-9-15(10-17)11-18(28)13-30-19-7-8-20(25)21(26)12-19/h2-8,12,15,17-18H,9-11,13H2,1H3 JQCMZSCMFLYRDP-UHFFFAOYSA-N 603973 US11660293, Example 47 Orexin/Hypocretin receptor type 1 Homo sapiens 24.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603973 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603973&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526372 482596705 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280883 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)c(F)c2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;3.32,.67,;4.66,-.1,;5.99,.67,;7.32,-.1,;5.99,2.21,;7.32,2.98,;4.66,2.98,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H22F2N2O2S/c1-14-27-22(23(31-14)16-5-3-2-4-6-16)24(29)28-17-9-15(10-17)11-18(28)13-30-19-7-8-20(25)21(26)12-19/h2-8,12,15,17-18H,9-11,13H2,1H3 JQCMZSCMFLYRDP-UHFFFAOYSA-N 603973 US11660293, Example 47 Orexin receptor type 2 Homo sapiens 123 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603973 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603973&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526372 482596705 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280884 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(C)cc2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C25H26N2O2S/c1-16-8-10-22(11-9-16)29-15-21-14-18-12-20(13-18)27(21)25(28)23-24(30-17(2)26-23)19-6-4-3-5-7-19/h3-11,18,20-21H,12-15H2,1-2H3 VJJQDNUYAYPZEY-UHFFFAOYSA-N 603974 US11660293, Example 48 Orexin/Hypocretin receptor type 1 Homo sapiens 35.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603974 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603974&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526565 482596706 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280885 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(C)cc2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C25H26N2O2S/c1-16-8-10-22(11-9-16)29-15-21-14-18-12-20(13-18)27(21)25(28)23-24(30-17(2)26-23)19-6-4-3-5-7-19/h3-11,18,20-21H,12-15H2,1-2H3 VJJQDNUYAYPZEY-UHFFFAOYSA-N 603974 US11660293, Example 48 Orexin receptor type 2 Homo sapiens 295 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603974 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603974&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526565 482596706 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280886 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(Cl)cc2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H23ClN2O2S/c1-15-26-22(23(30-15)17-5-3-2-4-6-17)24(28)27-19-11-16(12-19)13-20(27)14-29-21-9-7-18(25)8-10-21/h2-10,16,19-20H,11-14H2,1H3 OHOFFEZANHFCPS-UHFFFAOYSA-N 603975 US11660293, Example 49 Orexin/Hypocretin receptor type 1 Homo sapiens 13.2 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603975 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603975&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137527164 482596707 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280887 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(Cl)cc2)c(s1)-c1ccccc1 |(-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H23ClN2O2S/c1-15-26-22(23(30-15)17-5-3-2-4-6-17)24(28)27-19-11-16(12-19)13-20(27)14-29-21-9-7-18(25)8-10-21/h2-10,16,19-20H,11-14H2,1H3 OHOFFEZANHFCPS-UHFFFAOYSA-N 603975 US11660293, Example 49 Orexin receptor type 2 Homo sapiens 155 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603975 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603975&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137527164 482596707 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280888 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccc(F)cc1 |(-7.32,-.27,;-5.78,-.27,;-4.75,.88,;-3.35,.25,;-2.01,1.02,;-.68,.25,;-2.01,2.56,;-3.35,3.33,;-3.35,4.87,;-2.01,5.64,;-2.01,4.1,;-.68,4.87,;-.68,3.33,;.66,2.56,;1.99,3.33,;3.32,2.56,;4.66,3.33,;5.99,2.56,;5.99,1.02,;7.32,.25,;4.66,.25,;3.32,1.02,;-3.51,-1.28,;-5.01,-1.6,;-2.42,-2.37,;-.93,-1.97,;.16,-3.06,;-.24,-4.55,;.85,-5.64,;-1.73,-4.95,;-2.82,-3.86,)| InChI=1S/C24H22F2N2O2S/c1-14-27-22(23(31-14)16-2-4-17(25)5-3-16)24(29)28-19-10-15(11-19)12-20(28)13-30-21-8-6-18(26)7-9-21/h2-9,15,19-20H,10-13H2,1H3 WQHFPPCQMCKIGR-UHFFFAOYSA-N 603976 US11660293, Example 50 Orexin/Hypocretin receptor type 1 Homo sapiens 21.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603976&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526975 482596708 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280889 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccc(F)cc1 |(-7.32,-.27,;-5.78,-.27,;-4.75,.88,;-3.35,.25,;-2.01,1.02,;-.68,.25,;-2.01,2.56,;-3.35,3.33,;-3.35,4.87,;-2.01,5.64,;-2.01,4.1,;-.68,4.87,;-.68,3.33,;.66,2.56,;1.99,3.33,;3.32,2.56,;4.66,3.33,;5.99,2.56,;5.99,1.02,;7.32,.25,;4.66,.25,;3.32,1.02,;-3.51,-1.28,;-5.01,-1.6,;-2.42,-2.37,;-.93,-1.97,;.16,-3.06,;-.24,-4.55,;.85,-5.64,;-1.73,-4.95,;-2.82,-3.86,)| InChI=1S/C24H22F2N2O2S/c1-14-27-22(23(31-14)16-2-4-17(25)5-3-16)24(29)28-19-10-15(11-19)12-20(28)13-30-21-8-6-18(26)7-9-21/h2-9,15,19-20H,10-13H2,1H3 WQHFPPCQMCKIGR-UHFFFAOYSA-N 603976 US11660293, Example 50 Orexin receptor type 2 Homo sapiens 302 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603976&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526975 482596708 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280890 Fc1ccc(OCC2CC3CC(C3)N2C(=O)c2nc(Cl)sc2-c2ccccc2)cc1 |(7.32,-.1,;5.99,.67,;5.99,2.21,;4.66,2.98,;3.32,2.21,;1.99,2.98,;.66,2.21,;-.68,2.98,;-.68,4.52,;-2.01,5.29,;-3.35,4.52,;-3.35,2.98,;-2.01,3.75,;-2.01,2.21,;-2.01,.67,;-.68,-.1,;-3.35,-.1,;-4.75,.53,;-5.78,-.61,;-7.32,-.61,;-5.01,-1.95,;-3.51,-1.63,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,;3.32,.67,;4.66,-.1,)| InChI=1S/C23H20ClFN2O2S/c24-23-26-20(21(30-23)15-4-2-1-3-5-15)22(28)27-17-10-14(11-17)12-18(27)13-29-19-8-6-16(25)7-9-19/h1-9,14,17-18H,10-13H2 WLVNADLKEBRGCF-UHFFFAOYSA-N 603977 US11660293, Example 51 Orexin/Hypocretin receptor type 1 Homo sapiens 60.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603977 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603977&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526631 482596709 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280891 COc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccccc1 |(-7.85,.83,;-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H23FN2O3S/c1-29-24-26-21(22(31-24)16-5-3-2-4-6-16)23(28)27-18-11-15(12-18)13-19(27)14-30-20-9-7-17(25)8-10-20/h2-10,15,18-19H,11-14H2,1H3 LLLXLPXEDAIXMF-UHFFFAOYSA-N 603978 US11660293, Example 52 Orexin/Hypocretin receptor type 1 Homo sapiens 19.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603978 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603978&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526477 482596710 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280892 COc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(F)cc2)c(s1)-c1ccccc1 |(-7.85,.83,;-7.32,-.61,;-5.78,-.61,;-4.75,.53,;-3.35,-.1,;-2.01,.67,;-.68,-.1,;-2.01,2.21,;-3.35,2.98,;-3.35,4.52,;-2.01,5.29,;-2.01,3.75,;-.68,4.52,;-.68,2.98,;.66,2.21,;1.99,2.98,;3.32,2.21,;4.66,2.98,;5.99,2.21,;5.99,.67,;7.32,-.1,;4.66,-.1,;3.32,.67,;-3.51,-1.63,;-5.01,-1.95,;-2.42,-2.72,;-.93,-2.32,;.16,-3.41,;-.24,-4.89,;-1.73,-5.29,;-2.82,-4.2,)| InChI=1S/C24H23FN2O3S/c1-29-24-26-21(22(31-24)16-5-3-2-4-6-16)23(28)27-18-11-15(12-18)13-19(27)14-30-20-9-7-17(25)8-10-20/h2-10,15,18-19H,11-14H2,1H3 LLLXLPXEDAIXMF-UHFFFAOYSA-N 603978 US11660293, Example 52 Orexin receptor type 2 Homo sapiens 162 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603978 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603978&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526477 482596710 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280893 Fc1ccc(OCC2CC3CC(C3)N2C(=O)c2nc(sc2-c2ccccc2)C2CC2)cc1 |(8.04,-.1,;6.71,.67,;6.71,2.21,;5.37,2.98,;4.04,2.21,;2.71,2.98,;1.37,2.21,;.04,2.98,;.04,4.52,;-1.29,5.29,;-2.63,4.52,;-2.63,2.98,;-1.29,3.75,;-1.29,2.21,;-1.29,.67,;.04,-.1,;-2.63,-.1,;-4.04,.53,;-5.07,-.61,;-4.3,-1.95,;-2.79,-1.63,;-1.7,-2.72,;-.21,-2.32,;.88,-3.41,;.48,-4.89,;-1.01,-5.29,;-2.1,-4.2,;-6.55,-.22,;-7.64,.87,;-8.04,-.61,;4.04,.67,;5.37,-.1,)| InChI=1S/C26H25FN2O2S/c27-19-8-10-22(11-9-19)31-15-21-14-16-12-20(13-16)29(21)26(30)23-24(17-4-2-1-3-5-17)32-25(28-23)18-6-7-18/h1-5,8-11,16,18,20-21H,6-7,12-15H2 AKHRABRQQITMOA-UHFFFAOYSA-N 603979 US11660293, Example 53 Orexin/Hypocretin receptor type 1 Homo sapiens 26.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603979 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603979&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137527113 482596711 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280894 Fc1ccc(OCC2CC3CC(C3)N2C(=O)c2nc(sc2-c2ccccc2)C2CC2)cc1 |(8.04,-.1,;6.71,.67,;6.71,2.21,;5.37,2.98,;4.04,2.21,;2.71,2.98,;1.37,2.21,;.04,2.98,;.04,4.52,;-1.29,5.29,;-2.63,4.52,;-2.63,2.98,;-1.29,3.75,;-1.29,2.21,;-1.29,.67,;.04,-.1,;-2.63,-.1,;-4.04,.53,;-5.07,-.61,;-4.3,-1.95,;-2.79,-1.63,;-1.7,-2.72,;-.21,-2.32,;.88,-3.41,;.48,-4.89,;-1.01,-5.29,;-2.1,-4.2,;-6.55,-.22,;-7.64,.87,;-8.04,-.61,;4.04,.67,;5.37,-.1,)| InChI=1S/C26H25FN2O2S/c27-19-8-10-22(11-9-19)31-15-21-14-16-12-20(13-16)29(21)26(30)23-24(17-4-2-1-3-5-17)32-25(28-23)18-6-7-18/h1-5,8-11,16,18,20-21H,6-7,12-15H2 AKHRABRQQITMOA-UHFFFAOYSA-N 603979 US11660293, Example 53 Orexin receptor type 2 Homo sapiens 74.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603979 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603979&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137527113 482596711 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280895 Cc1nc(C(=O)N2C3CC(C3)CC2COc2nc3ccc(F)cc3s2)c(s1)-c1ccccc1 |(-8.47,-.61,;-6.93,-.61,;-5.9,.53,;-4.49,-.1,;-3.16,.67,;-1.82,-.1,;-3.16,2.21,;-4.49,2.98,;-4.49,4.52,;-3.16,5.29,;-3.16,3.75,;-1.82,4.52,;-1.82,2.98,;-.49,2.21,;.85,2.98,;2.18,2.21,;2.34,.68,;3.85,.36,;4.62,-.97,;6.16,-.97,;6.93,.36,;8.47,.36,;6.16,1.7,;4.62,1.7,;3.59,2.84,;-4.65,-1.63,;-6.16,-1.95,;-3.56,-2.72,;-3.96,-4.2,;-2.87,-5.29,;-1.38,-4.89,;-.98,-3.41,;-2.07,-2.32,)| InChI=1S/C25H22FN3O2S2/c1-14-27-22(23(32-14)16-5-3-2-4-6-16)24(30)29-18-9-15(10-18)11-19(29)13-31-25-28-20-8-7-17(26)12-21(20)33-25/h2-8,12,15,18-19H,9-11,13H2,1H3 UBANQRFBWRPAOS-UHFFFAOYSA-N 603980 US11660293, Example 54 Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603980 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603980&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137527001 482596712 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280896 Cc1nc(C(=O)N2C3CC(C3)CC2COc2nc3ccc(F)cc3s2)c(s1)-c1ccccc1 |(-8.47,-.61,;-6.93,-.61,;-5.9,.53,;-4.49,-.1,;-3.16,.67,;-1.82,-.1,;-3.16,2.21,;-4.49,2.98,;-4.49,4.52,;-3.16,5.29,;-3.16,3.75,;-1.82,4.52,;-1.82,2.98,;-.49,2.21,;.85,2.98,;2.18,2.21,;2.34,.68,;3.85,.36,;4.62,-.97,;6.16,-.97,;6.93,.36,;8.47,.36,;6.16,1.7,;4.62,1.7,;3.59,2.84,;-4.65,-1.63,;-6.16,-1.95,;-3.56,-2.72,;-3.96,-4.2,;-2.87,-5.29,;-1.38,-4.89,;-.98,-3.41,;-2.07,-2.32,)| InChI=1S/C25H22FN3O2S2/c1-14-27-22(23(32-14)16-5-3-2-4-6-16)24(30)29-18-9-15(10-18)11-19(29)13-31-25-28-20-8-7-17(26)12-21(20)33-25/h2-8,12,15,18-19H,9-11,13H2,1H3 UBANQRFBWRPAOS-UHFFFAOYSA-N 603980 US11660293, Example 54 Orexin receptor type 2 Homo sapiens 93.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603980 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603980&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137527001 482596712 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280897 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(cn2)C(F)(F)F)c(s1)-c1ccccc1 |(-7.99,-.61,;-6.45,-.61,;-5.42,.53,;-4.01,-.1,;-2.68,.67,;-1.35,-.1,;-2.68,2.21,;-4.01,2.98,;-4.01,4.52,;-2.68,5.29,;-2.68,3.75,;-1.35,4.52,;-1.35,2.98,;-.01,2.21,;1.32,2.98,;2.66,2.21,;3.99,2.98,;5.32,2.21,;5.37,.65,;3.99,-.1,;2.66,.67,;6.7,-.12,;8.04,-.89,;5.93,-1.46,;7.47,1.21,;-4.17,-1.63,;-5.68,-1.95,;-3.08,-2.72,;-3.48,-4.2,;-2.39,-5.29,;-.91,-4.89,;-.51,-3.41,;-1.6,-2.32,)| InChI=1S/C24H22F3N3O2S/c1-14-29-21(22(33-14)16-5-3-2-4-6-16)23(31)30-18-9-15(10-18)11-19(30)13-32-20-8-7-17(12-28-20)24(25,26)27/h2-8,12,15,18-19H,9-11,13H2,1H3 MTEAPXFIFCSKLO-UHFFFAOYSA-N 603981 US11660293, Example 55 Orexin/Hypocretin receptor type 1 Homo sapiens 41.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603981 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603981&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526698 482596713 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280898 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc(cn2)C(F)(F)F)c(s1)-c1ccccc1 |(-7.99,-.61,;-6.45,-.61,;-5.42,.53,;-4.01,-.1,;-2.68,.67,;-1.35,-.1,;-2.68,2.21,;-4.01,2.98,;-4.01,4.52,;-2.68,5.29,;-2.68,3.75,;-1.35,4.52,;-1.35,2.98,;-.01,2.21,;1.32,2.98,;2.66,2.21,;3.99,2.98,;5.32,2.21,;5.37,.65,;3.99,-.1,;2.66,.67,;6.7,-.12,;8.04,-.89,;5.93,-1.46,;7.47,1.21,;-4.17,-1.63,;-5.68,-1.95,;-3.08,-2.72,;-3.48,-4.2,;-2.39,-5.29,;-.91,-4.89,;-.51,-3.41,;-1.6,-2.32,)| InChI=1S/C24H22F3N3O2S/c1-14-29-21(22(33-14)16-5-3-2-4-6-16)23(31)30-18-9-15(10-18)11-19(30)13-32-20-8-7-17(12-28-20)24(25,26)27/h2-8,12,15,18-19H,9-11,13H2,1H3 MTEAPXFIFCSKLO-UHFFFAOYSA-N 603981 US11660293, Example 55 Orexin receptor type 2 Homo sapiens 324 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603981 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603981&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526698 482596713 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280899 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc3ccccc3n2)c(s1)-c1ccccc1 |(-7.99,-.61,;-6.45,-.61,;-5.42,.53,;-4.01,-.1,;-2.68,.67,;-1.35,-.1,;-2.68,2.21,;-4.01,2.98,;-4.01,4.52,;-2.68,5.29,;-2.68,3.75,;-1.35,4.52,;-1.35,2.98,;-.01,2.21,;1.32,2.98,;2.66,2.21,;2.66,.67,;3.99,-.1,;5.32,.67,;6.66,-.1,;7.99,.67,;7.99,2.21,;6.66,2.98,;5.32,2.21,;3.99,2.98,;-4.17,-1.63,;-5.68,-1.95,;-3.08,-2.72,;-3.48,-4.2,;-2.39,-5.29,;-.91,-4.89,;-.51,-3.41,;-1.6,-2.32,)| InChI=1S/C27H25N3O2S/c1-17-28-25(26(33-17)20-8-3-2-4-9-20)27(31)30-21-13-18(14-21)15-22(30)16-32-24-12-11-19-7-5-6-10-23(19)29-24/h2-12,18,21-22H,13-16H2,1H3 YMSYZOCTMYHHTM-UHFFFAOYSA-N 603982 US11660293, Example 56 Orexin/Hypocretin receptor type 1 Homo sapiens 10.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603982 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603982&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526731 482596714 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280900 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ccc3ccccc3n2)c(s1)-c1ccccc1 |(-7.99,-.61,;-6.45,-.61,;-5.42,.53,;-4.01,-.1,;-2.68,.67,;-1.35,-.1,;-2.68,2.21,;-4.01,2.98,;-4.01,4.52,;-2.68,5.29,;-2.68,3.75,;-1.35,4.52,;-1.35,2.98,;-.01,2.21,;1.32,2.98,;2.66,2.21,;2.66,.67,;3.99,-.1,;5.32,.67,;6.66,-.1,;7.99,.67,;7.99,2.21,;6.66,2.98,;5.32,2.21,;3.99,2.98,;-4.17,-1.63,;-5.68,-1.95,;-3.08,-2.72,;-3.48,-4.2,;-2.39,-5.29,;-.91,-4.89,;-.51,-3.41,;-1.6,-2.32,)| InChI=1S/C27H25N3O2S/c1-17-28-25(26(33-17)20-8-3-2-4-9-20)27(31)30-21-13-18(14-21)15-22(30)16-32-24-12-11-19-7-5-6-10-23(19)29-24/h2-12,18,21-22H,13-16H2,1H3 YMSYZOCTMYHHTM-UHFFFAOYSA-N 603982 US11660293, Example 56 Orexin receptor type 2 Homo sapiens 75.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603982 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603982&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526731 482596714 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280901 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ncc3ccn(C)c3n2)c(s1)-c1ccccc1 |(-7.84,-.61,;-6.3,-.61,;-5.27,.53,;-3.86,-.1,;-2.53,.67,;-1.2,-.1,;-2.53,2.21,;-3.86,2.98,;-3.86,4.52,;-2.53,5.29,;-2.53,3.75,;-1.2,4.52,;-1.2,2.98,;.14,2.21,;1.47,2.98,;2.8,2.21,;2.8,.67,;4.14,-.1,;5.47,.67,;6.94,.2,;7.84,1.44,;6.94,2.69,;7.33,4.18,;5.47,2.21,;4.14,2.98,;-4.03,-1.63,;-5.53,-1.95,;-2.94,-2.72,;-3.33,-4.2,;-2.25,-5.29,;-.76,-4.89,;-.36,-3.41,;-1.45,-2.32,)| InChI=1S/C25H25N5O2S/c1-15-27-21(22(33-15)17-6-4-3-5-7-17)24(31)30-19-10-16(11-19)12-20(30)14-32-25-26-13-18-8-9-29(2)23(18)28-25/h3-9,13,16,19-20H,10-12,14H2,1-2H3 YFOHCPKPHHSXFB-UHFFFAOYSA-N 603983 US11660293, Example 57 Orexin/Hypocretin receptor type 1 Homo sapiens 44.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603983 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603983&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535538 482596715 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280902 Cc1nc(C(=O)N2C3CC(C3)CC2COc2ncc3ccn(C)c3n2)c(s1)-c1ccccc1 |(-7.84,-.61,;-6.3,-.61,;-5.27,.53,;-3.86,-.1,;-2.53,.67,;-1.2,-.1,;-2.53,2.21,;-3.86,2.98,;-3.86,4.52,;-2.53,5.29,;-2.53,3.75,;-1.2,4.52,;-1.2,2.98,;.14,2.21,;1.47,2.98,;2.8,2.21,;2.8,.67,;4.14,-.1,;5.47,.67,;6.94,.2,;7.84,1.44,;6.94,2.69,;7.33,4.18,;5.47,2.21,;4.14,2.98,;-4.03,-1.63,;-5.53,-1.95,;-2.94,-2.72,;-3.33,-4.2,;-2.25,-5.29,;-.76,-4.89,;-.36,-3.41,;-1.45,-2.32,)| InChI=1S/C25H25N5O2S/c1-15-27-21(22(33-15)17-6-4-3-5-7-17)24(31)30-19-10-16(11-19)12-20(30)14-32-25-26-13-18-8-9-29(2)23(18)28-25/h3-9,13,16,19-20H,10-12,14H2,1-2H3 YFOHCPKPHHSXFB-UHFFFAOYSA-N 603983 US11660293, Example 57 Orexin receptor type 2 Homo sapiens 138 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603983 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603983&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535538 482596715 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280903 Cc1nc(C(=O)N2C3CC(C3)CC2COc2cnc3ccccc3n2)c(s1)-c1ccccc1 |(-7.99,-.61,;-6.45,-.61,;-5.42,.53,;-4.01,-.1,;-2.68,.67,;-1.35,-.1,;-2.68,2.21,;-4.01,2.98,;-4.01,4.52,;-2.68,5.29,;-2.68,3.75,;-1.35,4.52,;-1.35,2.98,;-.01,2.21,;1.32,2.98,;2.66,2.21,;2.66,.67,;3.99,-.1,;5.32,.67,;6.66,-.1,;7.99,.67,;7.99,2.21,;6.66,2.98,;5.32,2.21,;3.99,2.98,;-4.17,-1.63,;-5.68,-1.95,;-3.08,-2.72,;-3.48,-4.2,;-2.39,-5.29,;-.91,-4.89,;-.51,-3.41,;-1.6,-2.32,)| InChI=1S/C26H24N4O2S/c1-16-28-24(25(33-16)18-7-3-2-4-8-18)26(31)30-19-11-17(12-19)13-20(30)15-32-23-14-27-21-9-5-6-10-22(21)29-23/h2-10,14,17,19-20H,11-13,15H2,1H3 FTOVZWOCQNGDCB-UHFFFAOYSA-N 603984 US11660293, Example 58 Orexin/Hypocretin receptor type 1 Homo sapiens 39.8 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603984 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603984&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526978 482596716 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280904 Cc1nc(C(=O)N2C3CC(C3)CC2COc2cnc3ccccc3n2)c(s1)-c1ccccc1 |(-7.99,-.61,;-6.45,-.61,;-5.42,.53,;-4.01,-.1,;-2.68,.67,;-1.35,-.1,;-2.68,2.21,;-4.01,2.98,;-4.01,4.52,;-2.68,5.29,;-2.68,3.75,;-1.35,4.52,;-1.35,2.98,;-.01,2.21,;1.32,2.98,;2.66,2.21,;2.66,.67,;3.99,-.1,;5.32,.67,;6.66,-.1,;7.99,.67,;7.99,2.21,;6.66,2.98,;5.32,2.21,;3.99,2.98,;-4.17,-1.63,;-5.68,-1.95,;-3.08,-2.72,;-3.48,-4.2,;-2.39,-5.29,;-.91,-4.89,;-.51,-3.41,;-1.6,-2.32,)| InChI=1S/C26H24N4O2S/c1-16-28-24(25(33-16)18-7-3-2-4-8-18)26(31)30-19-11-17(12-19)13-20(30)15-32-23-14-27-21-9-5-6-10-22(21)29-23/h2-10,14,17,19-20H,11-13,15H2,1H3 FTOVZWOCQNGDCB-UHFFFAOYSA-N 603984 US11660293, Example 58 Orexin receptor type 2 Homo sapiens 174 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603984 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603984&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526978 482596716 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280905 Cc1nc(C(=O)N2C3CC(C3)CC2CNc2cc3ccccc3cn2)c(s1)-c1ccccc1 |(-7.96,-.22,;-6.48,-.61,;-5.45,.53,;-4.04,-.1,;-2.71,.67,;-1.37,-.1,;-2.71,2.21,;-4.04,2.98,;-4.04,4.52,;-2.71,5.29,;-2.71,3.75,;-1.37,4.52,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-4.2,-1.63,;-5.71,-1.95,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C27H26N4OS/c1-17-30-25(26(33-17)19-7-3-2-4-8-19)27(32)31-22-11-18(12-22)13-23(31)16-29-24-14-20-9-5-6-10-21(20)15-28-24/h2-10,14-15,18,22-23H,11-13,16H2,1H3,(H,28,29) VRXWOXAZZHJCFZ-UHFFFAOYSA-N 603985 US11660293, Example 59 Orexin/Hypocretin receptor type 1 Homo sapiens 7.94 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603985 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603985&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526404 482596717 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280906 Cc1nc(C(=O)N2C3CC(C3)CC2CNc2cc3ccccc3cn2)c(s1)-c1ccccc1 |(-7.96,-.22,;-6.48,-.61,;-5.45,.53,;-4.04,-.1,;-2.71,.67,;-1.37,-.1,;-2.71,2.21,;-4.04,2.98,;-4.04,4.52,;-2.71,5.29,;-2.71,3.75,;-1.37,4.52,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-4.2,-1.63,;-5.71,-1.95,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C27H26N4OS/c1-17-30-25(26(33-17)19-7-3-2-4-8-19)27(32)31-22-11-18(12-22)13-23(31)16-29-24-14-20-9-5-6-10-21(20)15-28-24/h2-10,14-15,18,22-23H,11-13,16H2,1H3,(H,28,29) VRXWOXAZZHJCFZ-UHFFFAOYSA-N 603985 US11660293, Example 59 Orexin receptor type 2 Homo sapiens 34.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603985 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603985&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526404 482596717 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280907 Cc1nc(C(=O)N2C3CC(C3)CC2CNc2ccc3ccccc3n2)c(s1)-c1ccccc1 |(-7.96,-.22,;-6.48,-.61,;-5.45,.53,;-4.04,-.1,;-2.71,.67,;-1.37,-.1,;-2.71,2.21,;-4.04,2.98,;-4.04,4.52,;-2.71,5.29,;-2.71,3.75,;-1.37,4.52,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;2.63,.67,;3.96,-.1,;5.3,.67,;6.63,-.1,;7.96,.67,;7.96,2.21,;6.63,2.98,;5.3,2.21,;3.96,2.98,;-4.2,-1.63,;-5.71,-1.95,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C27H26N4OS/c1-17-29-25(26(33-17)20-8-3-2-4-9-20)27(32)31-21-13-18(14-21)15-22(31)16-28-24-12-11-19-7-5-6-10-23(19)30-24/h2-12,18,21-22H,13-16H2,1H3,(H,28,30) QBCXVWKRNKNMIO-UHFFFAOYSA-N 603986 US11660293, Example 60 Orexin/Hypocretin receptor type 1 Homo sapiens 5.37 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603986&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526761 482596718 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280908 Cc1nc(C(=O)N2C3CC(C3)CC2CNc2ccc3ccccc3n2)c(s1)-c1ccccc1 |(-7.96,-.22,;-6.48,-.61,;-5.45,.53,;-4.04,-.1,;-2.71,.67,;-1.37,-.1,;-2.71,2.21,;-4.04,2.98,;-4.04,4.52,;-2.71,5.29,;-2.71,3.75,;-1.37,4.52,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;2.63,.67,;3.96,-.1,;5.3,.67,;6.63,-.1,;7.96,.67,;7.96,2.21,;6.63,2.98,;5.3,2.21,;3.96,2.98,;-4.2,-1.63,;-5.71,-1.95,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C27H26N4OS/c1-17-29-25(26(33-17)20-8-3-2-4-9-20)27(32)31-21-13-18(14-21)15-22(31)16-28-24-12-11-19-7-5-6-10-23(19)30-24/h2-12,18,21-22H,13-16H2,1H3,(H,28,30) QBCXVWKRNKNMIO-UHFFFAOYSA-N 603986 US11660293, Example 60 Orexin receptor type 2 Homo sapiens 40.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603986&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526761 482596718 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280909 Cc1nc(C(=O)N2C3CC(C3)CC2CNc2nc3ccc(F)cc3s2)c(s1)-c1ccccc1 |(-8.47,-.61,;-6.93,-.61,;-5.9,.53,;-4.49,-.1,;-3.16,.67,;-1.82,-.1,;-3.16,2.21,;-4.49,2.98,;-4.49,4.52,;-3.16,5.29,;-3.16,3.75,;-1.82,4.52,;-1.82,2.98,;-.49,2.21,;.85,2.98,;2.18,2.21,;2.34,.68,;3.85,.36,;4.62,-.97,;6.16,-.97,;6.93,.36,;8.47,.36,;6.16,1.7,;4.62,1.7,;3.59,2.84,;-4.65,-1.63,;-6.16,-1.95,;-3.56,-2.72,;-3.96,-4.2,;-2.87,-5.29,;-1.38,-4.89,;-.98,-3.41,;-2.07,-2.32,)| InChI=1S/C25H23FN4OS2/c1-14-28-22(23(32-14)16-5-3-2-4-6-16)24(31)30-18-9-15(10-18)11-19(30)13-27-25-29-20-8-7-17(26)12-21(20)33-25/h2-8,12,15,18-19H,9-11,13H2,1H3,(H,27,29) JNJHLMLNEZQKOC-UHFFFAOYSA-N 603987 US11660293, Example 61 Orexin/Hypocretin receptor type 1 Homo sapiens 0.759 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603987 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603987&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137527030 482596719 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280910 Cc1nc(C(=O)N2C3CC(C3)CC2CNc2nc3ccc(F)cc3s2)c(s1)-c1ccccc1 |(-8.47,-.61,;-6.93,-.61,;-5.9,.53,;-4.49,-.1,;-3.16,.67,;-1.82,-.1,;-3.16,2.21,;-4.49,2.98,;-4.49,4.52,;-3.16,5.29,;-3.16,3.75,;-1.82,4.52,;-1.82,2.98,;-.49,2.21,;.85,2.98,;2.18,2.21,;2.34,.68,;3.85,.36,;4.62,-.97,;6.16,-.97,;6.93,.36,;8.47,.36,;6.16,1.7,;4.62,1.7,;3.59,2.84,;-4.65,-1.63,;-6.16,-1.95,;-3.56,-2.72,;-3.96,-4.2,;-2.87,-5.29,;-1.38,-4.89,;-.98,-3.41,;-2.07,-2.32,)| InChI=1S/C25H23FN4OS2/c1-14-28-22(23(32-14)16-5-3-2-4-6-16)24(31)30-18-9-15(10-18)11-19(30)13-27-25-29-20-8-7-17(26)12-21(20)33-25/h2-8,12,15,18-19H,9-11,13H2,1H3,(H,27,29) JNJHLMLNEZQKOC-UHFFFAOYSA-N 603987 US11660293, Example 61 Orexin receptor type 2 Homo sapiens 9.33 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603987 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603987&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137527030 482596719 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280911 Cc1nc(C(=O)N2C3CC(C3)[C@@H](F)[C@@H]2COc2ccc(F)cn2)c(s1)-c1ccccc1 |r,wU:11.12,wD:13.15,(-7.32,6.59,;-5.79,6.43,;-4.76,7.58,;-3.35,6.95,;-2.02,7.72,;-.68,6.95,;-2.02,9.26,;-3.35,10.03,;-3.35,11.57,;-2.02,12.34,;-2.02,10.8,;-.68,11.57,;.65,12.34,;-.68,10.03,;.65,9.26,;1.98,10.03,;3.32,9.26,;3.32,7.72,;4.65,6.95,;5.99,7.72,;7.32,6.95,;5.99,9.26,;4.65,10.03,;-3.51,5.42,;-5.02,5.1,;-2.37,4.39,;-2.69,2.88,;-1.54,1.85,;-.08,2.33,;.24,3.83,;-.9,4.87,)| InChI=1S/C23H21F2N3O2S/c1-13-27-21(22(31-13)14-5-3-2-4-6-14)23(29)28-17-9-15(10-17)20(25)18(28)12-30-19-8-7-16(24)11-26-19/h2-8,11,15,17-18,20H,9-10,12H2,1H3 GWSVRMGUOLRNCG-UHFFFAOYSA-N 603988 US11660293, Example 63::(3S,4R or 3R,4S)-4-fluoro-3-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-(2-methyl-5-phenyl-1,3-thiazole-4-carbonyl)-2-azabicyclo[3.1.1]heptane (E62) and (3R,4S or 3S,4R)-4-fluoro-3-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-(2-methyl-5-phenyl-1,3-thiazole-4-carbonyl)-2-azabicyclo[3.1.1]heptane (E63) Orexin/Hypocretin receptor type 1 Homo sapiens 8.71 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603988 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603988&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526450 482596720 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280912 Cc1nc(C(=O)N2C3CC(C3)[C@@H](F)[C@@H]2COc2ccc(F)cn2)c(s1)-c1ccccc1 |r,wU:11.12,wD:13.15,(-7.32,6.59,;-5.79,6.43,;-4.76,7.58,;-3.35,6.95,;-2.02,7.72,;-.68,6.95,;-2.02,9.26,;-3.35,10.03,;-3.35,11.57,;-2.02,12.34,;-2.02,10.8,;-.68,11.57,;.65,12.34,;-.68,10.03,;.65,9.26,;1.98,10.03,;3.32,9.26,;3.32,7.72,;4.65,6.95,;5.99,7.72,;7.32,6.95,;5.99,9.26,;4.65,10.03,;-3.51,5.42,;-5.02,5.1,;-2.37,4.39,;-2.69,2.88,;-1.54,1.85,;-.08,2.33,;.24,3.83,;-.9,4.87,)| InChI=1S/C23H21F2N3O2S/c1-13-27-21(22(31-13)14-5-3-2-4-6-14)23(29)28-17-9-15(10-17)20(25)18(28)12-30-19-8-7-16(24)11-26-19/h2-8,11,15,17-18,20H,9-10,12H2,1H3 GWSVRMGUOLRNCG-UHFFFAOYSA-N 603988 US11660293, Example 63::(3S,4R or 3R,4S)-4-fluoro-3-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-(2-methyl-5-phenyl-1,3-thiazole-4-carbonyl)-2-azabicyclo[3.1.1]heptane (E62) and (3R,4S or 3S,4R)-4-fluoro-3-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-(2-methyl-5-phenyl-1,3-thiazole-4-carbonyl)-2-azabicyclo[3.1.1]heptane (E63) Orexin receptor type 2 Homo sapiens 427 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603988 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603988&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526450 482596720 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280913 C[C@@H]1C2CC(C2)N([C@H]1COc1cc2ccccc2cn1)C(=O)c1nc(C)sc1-c1ccccc1 |r,wU:1.0,wD:7.9,(-.04,5.29,;-1.37,4.52,;-2.71,5.29,;-4.04,4.52,;-4.04,2.98,;-2.71,3.75,;-2.71,2.21,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-2.71,.67,;-1.37,-.1,;-4.04,-.1,;-5.45,.53,;-6.48,-.61,;-7.96,-.22,;-5.71,-1.95,;-4.2,-1.63,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C28H27N3O2S/c1-17-22-12-23(13-22)31(24(17)16-33-25-14-20-10-6-7-11-21(20)15-29-25)28(32)26-27(34-18(2)30-26)19-8-4-3-5-9-19/h3-11,14-15,17,22-24H,12-13,16H2,1-2H3 DSGAQPGARLXAPN-UHFFFAOYSA-N 603989 US11660293, Example 86::US11660293, Example 88 Orexin/Hypocretin receptor type 1 Homo sapiens 89.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603989&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526676 482596721 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280914 C[C@@H]1C2CC(C2)N([C@H]1COc1cc2ccccc2cn1)C(=O)c1nc(C)sc1-c1ccccc1 |r,wU:1.0,wD:7.9,(-.04,5.29,;-1.37,4.52,;-2.71,5.29,;-4.04,4.52,;-4.04,2.98,;-2.71,3.75,;-2.71,2.21,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-2.71,.67,;-1.37,-.1,;-4.04,-.1,;-5.45,.53,;-6.48,-.61,;-7.96,-.22,;-5.71,-1.95,;-4.2,-1.63,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C28H27N3O2S/c1-17-22-12-23(13-22)31(24(17)16-33-25-14-20-10-6-7-11-21(20)15-29-25)28(32)26-27(34-18(2)30-26)19-8-4-3-5-9-19/h3-11,14-15,17,22-24H,12-13,16H2,1-2H3 DSGAQPGARLXAPN-UHFFFAOYSA-N 603989 US11660293, Example 86::US11660293, Example 88 Orexin receptor type 2 Homo sapiens 1288 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603989&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526676 482596721 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280915 C[C@@H]1C2CC(C2)N([C@H]1COc1cc2ccccc2cn1)C(=O)c1nc(C)sc1-c1ccccc1 |r,wU:1.0,wD:7.9,(-.04,5.29,;-1.37,4.52,;-2.71,5.29,;-4.04,4.52,;-4.04,2.98,;-2.71,3.75,;-2.71,2.21,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-2.71,.67,;-1.37,-.1,;-4.04,-.1,;-5.45,.53,;-6.48,-.61,;-7.96,-.22,;-5.71,-1.95,;-4.2,-1.63,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C28H27N3O2S/c1-17-22-12-23(13-22)31(24(17)16-33-25-14-20-10-6-7-11-21(20)15-29-25)28(32)26-27(34-18(2)30-26)19-8-4-3-5-9-19/h3-11,14-15,17,22-24H,12-13,16H2,1-2H3 DSGAQPGARLXAPN-UHFFFAOYSA-N 603989 US11660293, Example 86::US11660293, Example 88 Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603989&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137526676 482596721 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280916 C[C@@H]1C2CC(C2)N([C@H]1COc1cc2ccccc2cn1)C(=O)c1nc(C)sc1-c1ccccc1 |r,wU:1.0,wD:7.9,(-.04,5.29,;-1.37,4.52,;-2.71,5.29,;-4.04,4.52,;-4.04,2.98,;-2.71,3.75,;-2.71,2.21,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-2.71,.67,;-1.37,-.1,;-4.04,-.1,;-5.45,.53,;-6.48,-.61,;-7.96,-.22,;-5.71,-1.95,;-4.2,-1.63,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C28H27N3O2S/c1-17-22-12-23(13-22)31(24(17)16-33-25-14-20-10-6-7-11-21(20)15-29-25)28(32)26-27(34-18(2)30-26)19-8-4-3-5-9-19/h3-11,14-15,17,22-24H,12-13,16H2,1-2H3 DSGAQPGARLXAPN-UHFFFAOYSA-N 603989 US11660293, Example 86::US11660293, Example 88 Orexin receptor type 2 Homo sapiens 275 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603989&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137526676 482596721 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280917 C[C@H]1C2CC(C2)N([C@H]1COc1cc2ccccc2cn1)C(=O)c1nc(C)sc1-c1ccccc1 |r,wD:7.9,1.0,(-.04,5.29,;-1.37,4.52,;-2.71,5.29,;-4.04,4.52,;-4.04,2.98,;-2.71,3.75,;-2.71,2.21,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-2.71,.67,;-1.37,-.1,;-4.04,-.1,;-5.45,.53,;-6.48,-.61,;-7.96,-.22,;-5.71,-1.95,;-4.2,-1.63,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C28H27N3O2S/c1-17-22-12-23(13-22)31(24(17)16-33-25-14-20-10-6-7-11-21(20)15-29-25)28(32)26-27(34-18(2)30-26)19-8-4-3-5-9-19/h3-11,14-15,17,22-24H,12-13,16H2,1-2H3 DSGAQPGARLXAPN-UHFFFAOYSA-N 603991 US11660293, Example 89 Orexin/Hypocretin receptor type 1 Homo sapiens 1.38 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603991 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603991&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137527172 482596722 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280918 C[C@H]1C2CC(C2)N([C@H]1COc1cc2ccccc2cn1)C(=O)c1nc(C)sc1-c1ccccc1 |r,wD:7.9,1.0,(-.04,5.29,;-1.37,4.52,;-2.71,5.29,;-4.04,4.52,;-4.04,2.98,;-2.71,3.75,;-2.71,2.21,;-1.37,2.98,;-.04,2.21,;1.3,2.98,;2.63,2.21,;3.96,2.98,;5.3,2.21,;6.63,2.98,;7.96,2.21,;7.96,.67,;6.63,-.1,;5.3,.67,;3.96,-.1,;2.63,.67,;-2.71,.67,;-1.37,-.1,;-4.04,-.1,;-5.45,.53,;-6.48,-.61,;-7.96,-.22,;-5.71,-1.95,;-4.2,-1.63,;-3.11,-2.72,;-1.62,-2.32,;-.53,-3.41,;-.93,-4.89,;-2.42,-5.29,;-3.51,-4.2,)| InChI=1S/C28H27N3O2S/c1-17-22-12-23(13-22)31(24(17)16-33-25-14-20-10-6-7-11-21(20)15-29-25)28(32)26-27(34-18(2)30-26)19-8-4-3-5-9-19/h3-11,14-15,17,22-24H,12-13,16H2,1-2H3 DSGAQPGARLXAPN-UHFFFAOYSA-N 603991 US11660293, Example 89 Orexin receptor type 2 Homo sapiens 1000 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603991 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603991&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137527172 482596722 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280919 C[C@H]1C2CC(C2)N([C@H]1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wD:7.9,1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.47,;-2,1.93,;-.67,2.69,;.67,1.93,;2,2.69,;3.33,1.93,;4.67,2.69,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.38,;-3.33,-.38,;-4.67,.38,;-6,-.38,;-7.34,.38,;-6,-1.93,;-4.67,-2.69,;-3.33,-1.93,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;-.67,-5,;-2,-4.23,)| InChI=1S/C25H25FN4O2/c1-15-4-9-21(24-27-10-3-11-28-24)23(29-15)25(31)30-19-12-17(13-19)16(2)22(30)14-32-20-7-5-18(26)6-8-20/h3-11,16-17,19,22H,12-14H2,1-2H3 MPIPRURYZBEAQW-UHFFFAOYSA-N 603992 US11660293, Example 91 Orexin/Hypocretin receptor type 1 Homo sapiens 3.47 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603992 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603992&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 142536147 482596723 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280920 C[C@H]1C2CC(C2)N([C@H]1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wD:7.9,1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.47,;-2,1.93,;-.67,2.69,;.67,1.93,;2,2.69,;3.33,1.93,;4.67,2.69,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.38,;-3.33,-.38,;-4.67,.38,;-6,-.38,;-7.34,.38,;-6,-1.93,;-4.67,-2.69,;-3.33,-1.93,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;-.67,-5,;-2,-4.23,)| InChI=1S/C25H25FN4O2/c1-15-4-9-21(24-27-10-3-11-28-24)23(29-15)25(31)30-19-12-17(13-19)16(2)22(30)14-32-20-7-5-18(26)6-8-20/h3-11,16-17,19,22H,12-14H2,1-2H3 MPIPRURYZBEAQW-UHFFFAOYSA-N 603992 US11660293, Example 91 Orexin receptor type 2 Homo sapiens 35.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603992 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603992&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 142536147 482596723 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280921 C[C@@H]1C2CC(C2)N([C@H]1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,wD:7.9,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.47,;-2,1.93,;-.67,2.69,;.67,1.93,;2,2.69,;3.33,1.93,;4.67,2.69,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.38,;-3.33,-.38,;-4.67,.38,;-6,-.38,;-7.34,.38,;-6,-1.93,;-4.67,-2.69,;-3.33,-1.93,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;-.67,-5,;-2,-4.23,)| InChI=1S/C25H25FN4O2/c1-15-4-9-21(24-27-10-3-11-28-24)23(29-15)25(31)30-19-12-17(13-19)16(2)22(30)14-32-20-7-5-18(26)6-8-20/h3-11,16-17,19,22H,12-14H2,1-2H3 MPIPRURYZBEAQW-UHFFFAOYSA-N 603993 US11660293, Example 93 Orexin/Hypocretin receptor type 1 Homo sapiens 1.95 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603993 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603993&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 151107163 482596724 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280922 C[C@@H]1C2CC(C2)N([C@H]1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,wD:7.9,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.47,;-2,1.93,;-.67,2.69,;.67,1.93,;2,2.69,;3.33,1.93,;4.67,2.69,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.38,;-3.33,-.38,;-4.67,.38,;-6,-.38,;-7.34,.38,;-6,-1.93,;-4.67,-2.69,;-3.33,-1.93,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;-.67,-5,;-2,-4.23,)| InChI=1S/C25H25FN4O2/c1-15-4-9-21(24-27-10-3-11-28-24)23(29-15)25(31)30-19-12-17(13-19)16(2)22(30)14-32-20-7-5-18(26)6-8-20/h3-11,16-17,19,22H,12-14H2,1-2H3 MPIPRURYZBEAQW-UHFFFAOYSA-N 603993 US11660293, Example 93 Orexin receptor type 2 Homo sapiens 407 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603993 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603993&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 151107163 482596724 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280923 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 603994 US11660293, Example 94 Orexin/Hypocretin receptor type 1 Homo sapiens 9.12 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603994 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603994&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535432 482596725 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280924 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 603994 US11660293, Example 94 Orexin receptor type 2 Homo sapiens 447 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603994 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603994&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535432 482596725 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280925 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24FN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 BMWCLKVQSHSQLB-UHFFFAOYSA-N 603995 US11660293, Example 95 Orexin/Hypocretin receptor type 1 Homo sapiens 8.13 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603995 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603995&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003522 482596726 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280926 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24FN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 BMWCLKVQSHSQLB-UHFFFAOYSA-N 603995 US11660293, Example 95 Orexin receptor type 2 Homo sapiens 251 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603995 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603995&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003522 482596726 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280927 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1nccs1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H24FN3O2S/c1-14-3-8-20(23-26-9-10-31-23)22(27-14)24(29)28-18-11-16(12-18)15(2)21(28)13-30-19-6-4-17(25)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 QPARLCSIRSPDKM-UHFFFAOYSA-N 603996 US11660293, Example 96 Orexin/Hypocretin receptor type 1 Homo sapiens 6.61 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603996 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603996&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535433 482596727 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280928 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1nccs1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H24FN3O2S/c1-14-3-8-20(23-26-9-10-31-23)22(27-14)24(29)28-18-11-16(12-18)15(2)21(28)13-30-19-6-4-17(25)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 QPARLCSIRSPDKM-UHFFFAOYSA-N 603996 US11660293, Example 96 Orexin receptor type 2 Homo sapiens 132 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603996 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603996&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535433 482596727 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280929 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C24H25FN4O2/c1-15-3-8-22(29-26-9-10-27-29)21(11-15)24(30)28-19-12-17(13-19)16(2)23(28)14-31-20-6-4-18(25)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 HKSXHTBOSLOINF-UHFFFAOYSA-N 603997 US11660293, Example 97 Orexin/Hypocretin receptor type 1 Homo sapiens 18.2 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603997 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603997&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535431 482596728 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280930 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C24H25FN4O2/c1-15-3-8-22(29-26-9-10-27-29)21(11-15)24(30)28-19-12-17(13-19)16(2)23(28)14-31-20-6-4-18(25)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 HKSXHTBOSLOINF-UHFFFAOYSA-N 603997 US11660293, Example 97 Orexin receptor type 2 Homo sapiens 309 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603997 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603997&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535431 482596728 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280931 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-c1nccs1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C25H25FN2O2S/c1-15-3-8-21(24-27-9-10-31-24)22(11-15)25(29)28-19-12-17(13-19)16(2)23(28)14-30-20-6-4-18(26)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 MMLUBEJJBUFIMQ-UHFFFAOYSA-N 603998 US11660293, Example 98 Orexin/Hypocretin receptor type 1 Homo sapiens 13.8 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603998 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603998&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003566 482596729 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280932 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-c1nccs1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C25H25FN2O2S/c1-15-3-8-21(24-27-9-10-31-24)22(11-15)25(29)28-19-12-17(13-19)16(2)23(28)14-30-20-6-4-18(26)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 MMLUBEJJBUFIMQ-UHFFFAOYSA-N 603998 US11660293, Example 98 Orexin receptor type 2 Homo sapiens 178 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603998 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603998&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003566 482596729 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280933 C[C@@H]1C2CC(C2)N(C1COc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23ClN6O2/c1-13-3-5-18(29-25-7-8-26-29)21(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 RINUSVQKQZFOBX-UHFFFAOYSA-N 603999 US11660293, Example 99 Orexin/Hypocretin receptor type 1 Homo sapiens 42.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603999 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603999&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003550 482596730 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280934 C[C@@H]1C2CC(C2)N(C1COc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23ClN6O2/c1-13-3-5-18(29-25-7-8-26-29)21(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 RINUSVQKQZFOBX-UHFFFAOYSA-N 603999 US11660293, Example 99 Orexin receptor type 2 Homo sapiens 661 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=603999 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=603999&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003550 482596730 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280935 C[C@@H]1C2CC(C2)N(C1COc1ccc(C)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H26N6O2/c1-14-4-7-21(24-12-14)31-13-20-16(3)17-10-18(11-17)28(20)23(30)22-19(6-5-15(2)27-22)29-25-8-9-26-29/h4-9,12,16-18,20H,10-11,13H2,1-3H3 SRMCHGYEDGQWNE-UHFFFAOYSA-N 604000 US11660293, Example 100 Orexin/Hypocretin receptor type 1 Homo sapiens 93.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604000 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604000&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003534 482596731 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280936 C[C@@H]1C2CC(C2)N(C1COc1ccc(C)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H26N6O2/c1-14-4-7-21(24-12-14)31-13-20-16(3)17-10-18(11-17)28(20)23(30)22-19(6-5-15(2)27-22)29-25-8-9-26-29/h4-9,12,16-18,20H,10-11,13H2,1-3H3 SRMCHGYEDGQWNE-UHFFFAOYSA-N 604000 US11660293, Example 100 Orexin receptor type 2 Homo sapiens 1096 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604000 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604000&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003534 482596731 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280937 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-c1nccs1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C25H25FN2O2S/c1-15-3-8-21(24-27-9-10-31-24)22(11-15)25(29)28-19-12-17(13-19)16(2)23(28)14-30-20-6-4-18(26)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 MMLUBEJJBUFIMQ-UHFFFAOYSA-N 604001 US11660293, Example 101 Orexin/Hypocretin receptor type 1 Homo sapiens 9.55 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604001 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604001&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003561 482596732 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280938 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-c1nccs1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C25H25FN2O2S/c1-15-3-8-21(24-27-9-10-31-24)22(11-15)25(29)28-19-12-17(13-19)16(2)23(28)14-30-20-6-4-18(26)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 MMLUBEJJBUFIMQ-UHFFFAOYSA-N 604001 US11660293, Example 101 Orexin receptor type 2 Homo sapiens 708 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604001 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604001&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003561 482596732 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280939 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23ClN6O2/c1-13-3-5-18(29-25-7-8-26-29)21(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 RINUSVQKQZFOBX-UHFFFAOYSA-N 604002 US11660293, Example 102 Orexin/Hypocretin receptor type 1 Homo sapiens 58.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604002 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604002&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535543 482596733 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280940 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23ClN6O2/c1-13-3-5-18(29-25-7-8-26-29)21(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 RINUSVQKQZFOBX-UHFFFAOYSA-N 604002 US11660293, Example 102 Orexin receptor type 2 Homo sapiens 1950 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604002 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604002&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535543 482596733 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280941 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24FN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 BMWCLKVQSHSQLB-UHFFFAOYSA-N 604003 US11660293, Example 103::US11660293, Example 105 Orexin/Hypocretin receptor type 1 Homo sapiens 10.0 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604003&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535542 482596734 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280942 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24FN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 BMWCLKVQSHSQLB-UHFFFAOYSA-N 604003 US11660293, Example 103::US11660293, Example 105 Orexin receptor type 2 Homo sapiens 2512 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604003&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535542 482596734 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280943 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24FN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 BMWCLKVQSHSQLB-UHFFFAOYSA-N 604003 US11660293, Example 103::US11660293, Example 105 Orexin/Hypocretin receptor type 1 Homo sapiens 6.31 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604003&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535542 482596734 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280944 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24FN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 BMWCLKVQSHSQLB-UHFFFAOYSA-N 604003 US11660293, Example 103::US11660293, Example 105 Orexin receptor type 2 Homo sapiens 1318 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604003 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604003&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535542 482596734 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280945 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1nccs1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H24FN3O2S/c1-14-3-8-20(23-26-9-10-31-23)22(27-14)24(29)28-18-11-16(12-18)15(2)21(28)13-30-19-6-4-17(25)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 QPARLCSIRSPDKM-UHFFFAOYSA-N 604005 US11660293, Example 106::US11660293, Example 108 Orexin/Hypocretin receptor type 1 Homo sapiens 6.92 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604005&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535627 482596735 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280946 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1nccs1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H24FN3O2S/c1-14-3-8-20(23-26-9-10-31-23)22(27-14)24(29)28-18-11-16(12-18)15(2)21(28)13-30-19-6-4-17(25)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 QPARLCSIRSPDKM-UHFFFAOYSA-N 604005 US11660293, Example 106::US11660293, Example 108 Orexin receptor type 2 Homo sapiens 759 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604005&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535627 482596735 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280947 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1nccs1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H24FN3O2S/c1-14-3-8-20(23-26-9-10-31-23)22(27-14)24(29)28-18-11-16(12-18)15(2)21(28)13-30-19-6-4-17(25)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 QPARLCSIRSPDKM-UHFFFAOYSA-N 604005 US11660293, Example 106::US11660293, Example 108 Orexin/Hypocretin receptor type 1 Homo sapiens 3.24 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604005&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535627 482596735 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280948 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1nccs1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H24FN3O2S/c1-14-3-8-20(23-26-9-10-31-23)22(27-14)24(29)28-18-11-16(12-18)15(2)21(28)13-30-19-6-4-17(25)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 QPARLCSIRSPDKM-UHFFFAOYSA-N 604005 US11660293, Example 106::US11660293, Example 108 Orexin receptor type 2 Homo sapiens 407 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604005 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604005&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535627 482596735 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280949 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C24H25FN4O2/c1-15-3-8-22(29-26-9-10-27-29)21(11-15)24(30)28-19-12-17(13-19)16(2)23(28)14-31-20-6-4-18(25)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 HKSXHTBOSLOINF-UHFFFAOYSA-N 604007 US11660293, Example 109 Orexin/Hypocretin receptor type 1 Homo sapiens 30.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604007 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604007&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003568 482596736 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280950 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C24H25FN4O2/c1-15-3-8-22(29-26-9-10-27-29)21(11-15)24(30)28-19-12-17(13-19)16(2)23(28)14-31-20-6-4-18(25)5-7-20/h3-11,16-17,19,23H,12-14H2,1-2H3 HKSXHTBOSLOINF-UHFFFAOYSA-N 604007 US11660293, Example 109 Orexin receptor type 2 Homo sapiens 1288 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604007 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604007&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003568 482596736 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280951 C[C@H]1C2CC(C2)N(C1COc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H23FN6O2S/c1-13-3-6-19(31-26-7-8-27-31)22(28-13)23(32)30-17-9-15(10-17)14(2)20(30)12-33-24-29-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3 HDEGHOXJEMJYTM-UHFFFAOYSA-N 604008 US11660293, Example 110 Orexin/Hypocretin receptor type 1 Homo sapiens 100 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604008 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604008&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 142536159 482596737 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280952 C[C@H]1C2CC(C2)N(C1COc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H23FN6O2S/c1-13-3-6-19(31-26-7-8-27-31)22(28-13)23(32)30-17-9-15(10-17)14(2)20(30)12-33-24-29-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3 HDEGHOXJEMJYTM-UHFFFAOYSA-N 604008 US11660293, Example 110 Orexin receptor type 2 Homo sapiens 871 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604008 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604008&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 142536159 482596737 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280953 C[C@H]1C2CC(C2)N(C1COc1ccc(F)c(F)c1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;7.34,2.47,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H23F2N5O2/c1-13-3-6-20(30-26-7-8-27-30)22(28-13)23(31)29-16-9-15(10-16)14(2)21(29)12-32-17-4-5-18(24)19(25)11-17/h3-8,11,14-16,21H,9-10,12H2,1-2H3 RABQMBPICHVYLI-UHFFFAOYSA-N 604009 US11660293, Example 111 Orexin/Hypocretin receptor type 1 Homo sapiens 29.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604009 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604009&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535563 482596738 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280954 C[C@H]1C2CC(C2)N(C1COc1ccc(F)c(F)c1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;7.34,2.47,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H23F2N5O2/c1-13-3-6-20(30-26-7-8-27-30)22(28-13)23(31)29-16-9-15(10-16)14(2)21(29)12-32-17-4-5-18(24)19(25)11-17/h3-8,11,14-16,21H,9-10,12H2,1-2H3 RABQMBPICHVYLI-UHFFFAOYSA-N 604009 US11660293, Example 111 Orexin receptor type 2 Homo sapiens 1023 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604009 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604009&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535563 482596738 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280955 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24ClN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 DCNHWCVUWVDUDQ-UHFFFAOYSA-N 604010 US11660293, Example 112::US11660293, Example 120::US11660293, Example 119 Orexin/Hypocretin receptor type 1 Homo sapiens 14.8 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604010&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535564 482596739 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280956 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24ClN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 DCNHWCVUWVDUDQ-UHFFFAOYSA-N 604010 US11660293, Example 112::US11660293, Example 120::US11660293, Example 119 Orexin receptor type 2 Homo sapiens 1202 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604010&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535564 482596739 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280957 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604011 US11660293, Example 113::US11660293, Example 115 Orexin/Hypocretin receptor type 1 Homo sapiens 6.17 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604011&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535441 482596740 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280958 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604011 US11660293, Example 113::US11660293, Example 115 Orexin receptor type 2 Homo sapiens 1905 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604011&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535441 482596740 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280959 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604011 US11660293, Example 113::US11660293, Example 115 Orexin/Hypocretin receptor type 1 Homo sapiens 3.16 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604011&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535441 482596740 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280960 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604011 US11660293, Example 113::US11660293, Example 115 Orexin receptor type 2 Homo sapiens 1175 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604011&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535441 482596740 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280961 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604013 US11660293, Example 116 Orexin/Hypocretin receptor type 1 Homo sapiens 47.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604013 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604013&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535444 482596741 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280962 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604013 US11660293, Example 116 Orexin receptor type 2 Homo sapiens 5495 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604013 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604013&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535444 482596741 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280963 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)sc1-c1ccccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604014 US11660293, Example 117 Orexin/Hypocretin receptor type 1 Homo sapiens 74.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604014 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604014&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535442 482596742 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280964 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)sc1-c1ccccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604014 US11660293, Example 117 Orexin receptor type 2 Homo sapiens 3388 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604014 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604014&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535442 482596742 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280965 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wD:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;3.33,.39,;4.67,-.38,;6,.39,;7.34,-.38,;6,1.92,;4.67,2.7,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.24,;-.67,-5,;-2,-4.23,)| InChI=1S/C24H24ClN5O2/c1-14-4-6-19(23-26-8-3-9-27-23)22(29-14)24(31)30-18-10-16(11-18)15(2)20(30)13-32-21-7-5-17(25)12-28-21/h3-9,12,15-16,18,20H,10-11,13H2,1-2H3 ULXCRCBIBXKVAB-UHFFFAOYSA-N 604015 US11660293, Example 118 Orexin/Hypocretin receptor type 1 Homo sapiens 40.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604015 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604015&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535552 482596743 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280966 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wD:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;3.33,.39,;4.67,-.38,;6,.39,;7.34,-.38,;6,1.92,;4.67,2.7,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.24,;-.67,-5,;-2,-4.23,)| InChI=1S/C24H24ClN5O2/c1-14-4-6-19(23-26-8-3-9-27-23)22(29-14)24(31)30-18-10-16(11-18)15(2)20(30)13-32-21-7-5-17(25)12-28-21/h3-9,12,15-16,18,20H,10-11,13H2,1-2H3 ULXCRCBIBXKVAB-UHFFFAOYSA-N 604015 US11660293, Example 118 Orexin receptor type 2 Homo sapiens 1778 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604015 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604015&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535552 482596743 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280967 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24ClN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 DCNHWCVUWVDUDQ-UHFFFAOYSA-N 604010 US11660293, Example 112::US11660293, Example 120::US11660293, Example 119 Orexin/Hypocretin receptor type 1 Homo sapiens 83.2 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604010&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535564 482596739 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280968 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24ClN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 DCNHWCVUWVDUDQ-UHFFFAOYSA-N 604010 US11660293, Example 112::US11660293, Example 120::US11660293, Example 119 Orexin receptor type 2 Homo sapiens 1698 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604010&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535564 482596739 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280969 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24ClN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 DCNHWCVUWVDUDQ-UHFFFAOYSA-N 604010 US11660293, Example 112::US11660293, Example 120::US11660293, Example 119 Orexin/Hypocretin receptor type 1 Homo sapiens 10.0 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604010&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535564 482596739 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280970 C[C@H]1C2CC(C2)N(C1COc1ccc(Cl)cc1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H24ClN5O2/c1-14-3-8-20(29-25-9-10-26-29)22(27-14)23(30)28-18-11-16(12-18)15(2)21(28)13-31-19-6-4-17(24)5-7-19/h3-10,15-16,18,21H,11-13H2,1-2H3 DCNHWCVUWVDUDQ-UHFFFAOYSA-N 604010 US11660293, Example 112::US11660293, Example 120::US11660293, Example 119 Orexin receptor type 2 Homo sapiens 1047 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604010 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604010&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535564 482596739 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280971 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cnccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604018 US11660293, Example 121 Orexin/Hypocretin receptor type 1 Homo sapiens 43.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604018&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535383 482596744 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280972 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cnccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604018 US11660293, Example 121 Orexin receptor type 2 Homo sapiens 2884 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604018&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535383 482596744 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280973 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1cccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H25FN4O2/c1-15-4-9-21(28-11-3-10-26-28)23(27-15)24(30)29-19-12-17(13-19)16(2)22(29)14-31-20-7-5-18(25)6-8-20/h3-11,16-17,19,22H,12-14H2,1-2H3 KVJFQIQLAXWGIH-UHFFFAOYSA-N 604019 US11660293, Example 122 Orexin/Hypocretin receptor type 1 Homo sapiens 60.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604019&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535384 482596745 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280974 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1cccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C24H25FN4O2/c1-15-4-9-21(28-11-3-10-26-28)23(27-15)24(30)29-19-12-17(13-19)16(2)22(29)14-31-20-7-5-18(25)6-8-20/h3-11,16-17,19,22H,12-14H2,1-2H3 KVJFQIQLAXWGIH-UHFFFAOYSA-N 604019 US11660293, Example 122 Orexin receptor type 2 Homo sapiens 3981 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604019&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535384 482596745 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280975 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ccccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604020 US11660293, Example 123::US11660293, Example 124 Orexin/Hypocretin receptor type 1 Homo sapiens 9.55 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604020&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535546 482596746 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280976 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ccccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604020 US11660293, Example 123::US11660293, Example 124 Orexin receptor type 2 Homo sapiens 759 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604020&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535546 482596746 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280977 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ccccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604020 US11660293, Example 123::US11660293, Example 124 Orexin/Hypocretin receptor type 1 Homo sapiens 3.72 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604020&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535546 482596746 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280978 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ccccn1 |r,wD:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;3.3,.67,;4.63,-.1,;5.96,.67,;7.3,-.1,;5.96,2.21,;4.63,2.98,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604020 US11660293, Example 123::US11660293, Example 124 Orexin receptor type 2 Homo sapiens 501 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604020&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535546 482596746 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280979 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-n1nccn1 |r,wD:1.0,(.63,5.12,;-.7,4.35,;-2.04,5.12,;-3.37,4.35,;-3.37,2.81,;-2.04,3.58,;-2.04,2.04,;-.7,2.81,;.63,2.04,;1.96,2.81,;3.3,2.04,;3.3,.5,;4.63,-.27,;5.96,.5,;7.3,-.27,;5.96,2.04,;4.63,2.81,;-2.04,.5,;-.7,-.27,;-3.37,-.27,;-4.78,.35,;-5.81,-.79,;-7.3,-.39,;-5.04,-2.13,;-3.53,-1.81,;-2.44,-2.9,;-2.69,-4.42,;-1.31,-5.12,;-.22,-4.03,;-.92,-2.65,)| InChI=1S/C21H22FN5O2S/c1-12-14-9-16(10-14)26(18(12)11-29-17-5-3-15(22)4-6-17)20(28)19-21(30-13(2)25-19)27-23-7-8-24-27/h3-8,12,14,16,18H,9-11H2,1-2H3 OULOYMJFWCSJQZ-UHFFFAOYSA-N 604022 US11660293, Example 126 Orexin/Hypocretin receptor type 1 Homo sapiens 40.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604022&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535568 482596747 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280980 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-n1nccn1 |r,wD:1.0,(.63,5.12,;-.7,4.35,;-2.04,5.12,;-3.37,4.35,;-3.37,2.81,;-2.04,3.58,;-2.04,2.04,;-.7,2.81,;.63,2.04,;1.96,2.81,;3.3,2.04,;3.3,.5,;4.63,-.27,;5.96,.5,;7.3,-.27,;5.96,2.04,;4.63,2.81,;-2.04,.5,;-.7,-.27,;-3.37,-.27,;-4.78,.35,;-5.81,-.79,;-7.3,-.39,;-5.04,-2.13,;-3.53,-1.81,;-2.44,-2.9,;-2.69,-4.42,;-1.31,-5.12,;-.22,-4.03,;-.92,-2.65,)| InChI=1S/C21H22FN5O2S/c1-12-14-9-16(10-14)26(18(12)11-29-17-5-3-15(22)4-6-17)20(28)19-21(30-13(2)25-19)27-23-7-8-24-27/h3-8,12,14,16,18H,9-11H2,1-2H3 OULOYMJFWCSJQZ-UHFFFAOYSA-N 604022 US11660293, Example 126 Orexin receptor type 2 Homo sapiens 1995 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604022 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604022&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535568 482596747 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280981 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1ncc(C)n1 |r,wD:1.0,(.67,5.44,;-.67,4.67,;-2,5.44,;-3.33,4.67,;-3.33,3.13,;-2,3.9,;-2,2.36,;-.67,3.13,;.67,2.36,;2,3.13,;3.33,2.36,;4.67,3.13,;6,2.36,;6,.82,;7.34,.05,;4.67,.05,;3.33,.82,;-2,.82,;-.67,.05,;-3.33,.05,;-4.67,.82,;-6,.05,;-7.34,.82,;-6,-1.49,;-4.67,-2.26,;-3.33,-1.49,;-2,-2.26,;-.59,-1.63,;.44,-2.78,;-.33,-4.11,;.44,-5.44,;-1.84,-3.79,)| InChI=1S/C24H26FN5O2/c1-14-4-9-21(30-26-12-15(2)28-30)23(27-14)24(31)29-19-10-17(11-19)16(3)22(29)13-32-20-7-5-18(25)6-8-20/h4-9,12,16-17,19,22H,10-11,13H2,1-3H3 VIRNLKBWGGBTIE-UHFFFAOYSA-N 604023 US11660293, Example 127 Orexin/Hypocretin receptor type 1 Homo sapiens 12.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604023&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003565 482596748 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280982 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1ncc(C)n1 |r,wD:1.0,(.67,5.44,;-.67,4.67,;-2,5.44,;-3.33,4.67,;-3.33,3.13,;-2,3.9,;-2,2.36,;-.67,3.13,;.67,2.36,;2,3.13,;3.33,2.36,;4.67,3.13,;6,2.36,;6,.82,;7.34,.05,;4.67,.05,;3.33,.82,;-2,.82,;-.67,.05,;-3.33,.05,;-4.67,.82,;-6,.05,;-7.34,.82,;-6,-1.49,;-4.67,-2.26,;-3.33,-1.49,;-2,-2.26,;-.59,-1.63,;.44,-2.78,;-.33,-4.11,;.44,-5.44,;-1.84,-3.79,)| InChI=1S/C24H26FN5O2/c1-14-4-9-21(30-26-12-15(2)28-30)23(27-14)24(31)29-19-10-17(11-19)16(3)22(29)13-32-20-7-5-18(25)6-8-20/h4-9,12,16-17,19,22H,10-11,13H2,1-3H3 VIRNLKBWGGBTIE-UHFFFAOYSA-N 604023 US11660293, Example 127 Orexin receptor type 2 Homo sapiens 794 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604023 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604023&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003565 482596748 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280983 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H22F2N4O2/c1-14-15-10-18(11-15)28(22(14)13-31-19-5-2-16(24)3-6-19)23(30)20-12-17(25)4-7-21(20)29-26-8-9-27-29/h2-9,12,14-15,18,22H,10-11,13H2,1H3 SIMNKYRUHGKGKM-UHFFFAOYSA-N 604024 US11660293, Example 128 Orexin/Hypocretin receptor type 1 Homo sapiens 141 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604024&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535414 482596749 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280984 C[C@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H22F2N4O2/c1-14-15-10-18(11-15)28(22(14)13-31-19-5-2-16(24)3-6-19)23(30)20-12-17(25)4-7-21(20)29-26-8-9-27-29/h2-9,12,14-15,18,22H,10-11,13H2,1H3 SIMNKYRUHGKGKM-UHFFFAOYSA-N 604024 US11660293, Example 128 Orexin receptor type 2 Homo sapiens 2455 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604024&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535414 482596749 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280985 C[C@@H]1C2CC(C2)N(C1COc1ccc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H23F3N6O2/c1-13-3-5-18(32-28-7-8-29-32)21(30-13)22(33)31-17-9-15(10-17)14(2)19(31)12-34-20-6-4-16(11-27-20)23(24,25)26/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 SKKMKBIISMRNNK-UHFFFAOYSA-N 604025 US11660293, Example 129 Orexin/Hypocretin receptor type 1 Homo sapiens 155 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604025&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003524 482596750 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280986 C[C@@H]1C2CC(C2)N(C1COc1ccc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H23F3N6O2/c1-13-3-5-18(32-28-7-8-29-32)21(30-13)22(33)31-17-9-15(10-17)14(2)19(31)12-34-20-6-4-16(11-27-20)23(24,25)26/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 SKKMKBIISMRNNK-UHFFFAOYSA-N 604025 US11660293, Example 129 Orexin receptor type 2 Homo sapiens 7244 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604025&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003524 482596750 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280987 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23FN6O2/c1-13-3-5-18(29-25-7-8-26-29)21(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 OQRNDFXKJNJUCQ-UHFFFAOYSA-N 604026 US11660293, Example 130 Orexin/Hypocretin receptor type 1 Homo sapiens 126 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604026&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003547 482596751 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280988 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23FN6O2/c1-13-3-5-18(29-25-7-8-26-29)21(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 OQRNDFXKJNJUCQ-UHFFFAOYSA-N 604026 US11660293, Example 130 Orexin receptor type 2 Homo sapiens 832 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604026 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604026&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003547 482596751 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280989 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)ccc1-c1ccccn1 |r,wU:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;3.33,.38,;4.67,-.38,;6,.39,;7.34,-.38,;6,1.93,;4.67,2.7,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-2,-4.23,;-.67,-5,;.67,-4.23,;.67,-2.69,;-.67,-1.92,)| InChI=1S/C25H25FN4O2/c1-15-6-8-20(21-5-3-4-10-27-21)24(29-15)25(31)30-19-11-17(12-19)16(2)22(30)14-32-23-9-7-18(26)13-28-23/h3-10,13,16-17,19,22H,11-12,14H2,1-2H3 JKGAEAXAUVDWSQ-UHFFFAOYSA-N 604027 US11660293, Example 131 Orexin/Hypocretin receptor type 1 Homo sapiens 95.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604027&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003558 482596752 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280990 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cn1)C(=O)c1nc(C)ccc1-c1ccccn1 |r,wU:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;3.33,.38,;4.67,-.38,;6,.39,;7.34,-.38,;6,1.93,;4.67,2.7,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-2,-4.23,;-.67,-5,;.67,-4.23,;.67,-2.69,;-.67,-1.92,)| InChI=1S/C25H25FN4O2/c1-15-6-8-20(21-5-3-4-10-27-21)24(29-15)25(31)30-19-11-17(12-19)16(2)22(30)14-32-23-9-7-18(26)13-28-23/h3-10,13,16-17,19,22H,11-12,14H2,1-2H3 JKGAEAXAUVDWSQ-UHFFFAOYSA-N 604027 US11660293, Example 131 Orexin receptor type 2 Homo sapiens 794 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604027&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003558 482596752 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280991 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cccnc1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604028 US11660293, Example 132 Orexin/Hypocretin receptor type 1 Homo sapiens 10.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604028&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003536 482596753 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280992 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cccnc1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;-.96,-2.32,)| 604028 US11660293, Example 132 Orexin receptor type 2 Homo sapiens 191 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604028 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604028&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003536 482596753 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280993 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncc(cn1)C(F)(F)F |r,wU:1.0,(.67,5.67,;-.67,4.9,;-2,5.67,;-3.33,4.9,;-3.33,3.36,;-2,4.13,;-2,2.59,;-.67,3.36,;.67,2.59,;2,3.36,;3.33,2.59,;4.67,3.36,;6,2.59,;6,1.05,;7.34,.28,;4.67,.28,;3.33,1.05,;-2,1.05,;-.67,.28,;-3.33,.28,;-4.67,1.05,;-6,.28,;-7.34,1.05,;-6,-1.26,;-4.67,-2.03,;-3.33,-1.26,;-2,-2.03,;-.67,-1.26,;.67,-2.03,;.74,-3.65,;-.67,-4.34,;-2,-3.57,;2.06,-4.44,;3.39,-5.23,;1.28,-5.76,;2.85,-3.12,)| InChI=1S/C26H24F4N4O2/c1-14-3-8-21(24-31-11-17(12-32-24)26(28,29)30)23(33-14)25(35)34-19-9-16(10-19)15(2)22(34)13-36-20-6-4-18(27)5-7-20/h3-8,11-12,15-16,19,22H,9-10,13H2,1-2H3 XYMJJKWCOTZKLI-UHFFFAOYSA-N 604029 US11660293, Example 133 Orexin/Hypocretin receptor type 1 Homo sapiens 56.2 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604029&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003539 482596754 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280994 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncc(cn1)C(F)(F)F |r,wU:1.0,(.67,5.67,;-.67,4.9,;-2,5.67,;-3.33,4.9,;-3.33,3.36,;-2,4.13,;-2,2.59,;-.67,3.36,;.67,2.59,;2,3.36,;3.33,2.59,;4.67,3.36,;6,2.59,;6,1.05,;7.34,.28,;4.67,.28,;3.33,1.05,;-2,1.05,;-.67,.28,;-3.33,.28,;-4.67,1.05,;-6,.28,;-7.34,1.05,;-6,-1.26,;-4.67,-2.03,;-3.33,-1.26,;-2,-2.03,;-.67,-1.26,;.67,-2.03,;.74,-3.65,;-.67,-4.34,;-2,-3.57,;2.06,-4.44,;3.39,-5.23,;1.28,-5.76,;2.85,-3.12,)| InChI=1S/C26H24F4N4O2/c1-14-3-8-21(24-31-11-17(12-32-24)26(28,29)30)23(33-14)25(35)34-19-9-16(10-19)15(2)22(34)13-36-20-6-4-18(27)5-7-20/h3-8,11-12,15-16,19,22H,9-10,13H2,1-2H3 XYMJJKWCOTZKLI-UHFFFAOYSA-N 604029 US11660293, Example 133 Orexin receptor type 2 Homo sapiens 162 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604029 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604029&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003539 482596754 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280995 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncc(F)cn1 |r,wU:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;4.67,2.7,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;2,-5,;-.67,-5,;-2,-4.23,)| InChI=1S/C25H24F2N4O2/c1-14-3-8-21(24-28-11-18(27)12-29-24)23(30-14)25(32)31-19-9-16(10-19)15(2)22(31)13-33-20-6-4-17(26)5-7-20/h3-8,11-12,15-16,19,22H,9-10,13H2,1-2H3 FCQSDMDDTZVLII-UHFFFAOYSA-N 604030 US11660293, Example 134 Orexin/Hypocretin receptor type 1 Homo sapiens 14.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604030&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003562 482596755 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280996 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncc(F)cn1 |r,wU:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;4.67,2.7,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;2,-5,;-.67,-5,;-2,-4.23,)| InChI=1S/C25H24F2N4O2/c1-14-3-8-21(24-28-11-18(27)12-29-24)23(30-14)25(32)31-19-9-16(10-19)15(2)22(31)13-33-20-6-4-17(26)5-7-20/h3-8,11-12,15-16,19,22H,9-10,13H2,1-2H3 FCQSDMDDTZVLII-UHFFFAOYSA-N 604030 US11660293, Example 134 Orexin receptor type 2 Homo sapiens 93.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604030&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003562 482596755 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280997 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1cc(C)cn1 |r,wU:1.0,(.67,5.44,;-.67,4.67,;-2,5.44,;-3.33,4.67,;-3.33,3.13,;-2,3.9,;-2,2.36,;-.67,3.13,;.67,2.36,;2,3.13,;3.33,2.36,;4.67,3.13,;6,2.36,;6,.82,;7.34,.05,;4.67,.05,;3.33,.82,;-2,.82,;-.67,.05,;-3.33,.05,;-4.67,.82,;-6,.05,;-7.34,.82,;-6,-1.49,;-4.67,-2.26,;-3.33,-1.49,;-2,-2.26,;-1.84,-3.79,;-.33,-4.11,;.44,-5.44,;.44,-2.78,;-.59,-1.63,)| InChI=1S/C25H27FN4O2/c1-15-12-27-29(13-15)22-9-4-16(2)28-24(22)25(31)30-20-10-18(11-20)17(3)23(30)14-32-21-7-5-19(26)6-8-21/h4-9,12-13,17-18,20,23H,10-11,14H2,1-3H3 OSODIIFVJQHLCR-UHFFFAOYSA-N 604031 US11660293, Example 135 Orexin/Hypocretin receptor type 1 Homo sapiens 16.6 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604031&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535629 482596756 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1280998 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1cc(C)cn1 |r,wU:1.0,(.67,5.44,;-.67,4.67,;-2,5.44,;-3.33,4.67,;-3.33,3.13,;-2,3.9,;-2,2.36,;-.67,3.13,;.67,2.36,;2,3.13,;3.33,2.36,;4.67,3.13,;6,2.36,;6,.82,;7.34,.05,;4.67,.05,;3.33,.82,;-2,.82,;-.67,.05,;-3.33,.05,;-4.67,.82,;-6,.05,;-7.34,.82,;-6,-1.49,;-4.67,-2.26,;-3.33,-1.49,;-2,-2.26,;-1.84,-3.79,;-.33,-4.11,;.44,-5.44,;.44,-2.78,;-.59,-1.63,)| InChI=1S/C25H27FN4O2/c1-15-12-27-29(13-15)22-9-4-16(2)28-24(22)25(31)30-20-10-18(11-20)17(3)23(30)14-32-21-7-5-19(26)6-8-21/h4-9,12-13,17-18,20,23H,10-11,14H2,1-3H3 OSODIIFVJQHLCR-UHFFFAOYSA-N 604031 US11660293, Example 135 Orexin receptor type 2 Homo sapiens 407 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604031&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535629 482596756 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1280999 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cnccn1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604032 US11660293, Example 136 Orexin/Hypocretin receptor type 1 Homo sapiens 55.0 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604032&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003548 482596757 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281000 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cnccn1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-.96,-2.32,;.13,-3.41,;-.27,-4.89,;-1.75,-5.29,;-2.84,-4.2,)| 604032 US11660293, Example 136 Orexin receptor type 2 Homo sapiens 1202 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604032&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003548 482596757 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281001 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cccc(C)n1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,6.04,;-.7,5.27,;-2.04,6.04,;-3.37,5.27,;-3.37,3.73,;-2.04,4.5,;-2.04,2.96,;-.7,3.73,;.63,2.96,;1.96,3.73,;3.3,2.96,;4.63,3.73,;5.96,2.96,;5.96,1.42,;7.3,.65,;4.63,.65,;3.3,1.42,;-2.04,1.42,;-.7,.65,;-3.37,.65,;-4.78,1.27,;-5.81,.13,;-7.3,.53,;-5.04,-1.2,;-3.53,-.88,;-2.44,-1.97,;-.96,-1.57,;.13,-2.66,;-.27,-4.15,;-1.75,-4.55,;-2.15,-6.04,;-2.84,-3.46,)| 604033 US11660293, Example 137 Orexin/Hypocretin receptor type 1 Homo sapiens 10.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604033&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003527 482596758 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281002 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cccc(C)n1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,6.04,;-.7,5.27,;-2.04,6.04,;-3.37,5.27,;-3.37,3.73,;-2.04,4.5,;-2.04,2.96,;-.7,3.73,;.63,2.96,;1.96,3.73,;3.3,2.96,;4.63,3.73,;5.96,2.96,;5.96,1.42,;7.3,.65,;4.63,.65,;3.3,1.42,;-2.04,1.42,;-.7,.65,;-3.37,.65,;-4.78,1.27,;-5.81,.13,;-7.3,.53,;-5.04,-1.2,;-3.53,-.88,;-2.44,-1.97,;-.96,-1.57,;.13,-2.66,;-.27,-4.15,;-1.75,-4.55,;-2.15,-6.04,;-2.84,-3.46,)| 604033 US11660293, Example 137 Orexin receptor type 2 Homo sapiens 457 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604033&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003527 482596758 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281003 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncc(C)cn1 |r,wU:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;4.67,2.7,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;2,-5,;-.67,-5,;-2,-4.23,)| InChI=1S/C26H27FN4O2/c1-15-12-28-25(29-13-15)22-9-4-16(2)30-24(22)26(32)31-20-10-18(11-20)17(3)23(31)14-33-21-7-5-19(27)6-8-21/h4-9,12-13,17-18,20,23H,10-11,14H2,1-3H3 YPHXSPAVMMEFRO-UHFFFAOYSA-N 604034 US11660293, Example 138 Orexin/Hypocretin receptor type 1 Homo sapiens 8.32 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604034&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003531 482596759 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281004 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-c1ncc(C)cn1 |r,wU:1.0,(.67,5,;-.67,4.23,;-2,5,;-3.33,4.23,;-3.33,2.69,;-2,3.46,;-2,1.92,;-.67,2.69,;.67,1.92,;2,2.69,;3.33,1.92,;4.67,2.7,;6,1.93,;6,.39,;7.34,-.38,;4.67,-.38,;3.33,.38,;-2,.38,;-.67,-.39,;-3.33,-.39,;-4.67,.39,;-6,-.39,;-7.34,.38,;-6,-1.92,;-4.67,-2.7,;-3.33,-1.92,;-2,-2.69,;-.67,-1.92,;.67,-2.69,;.67,-4.23,;2,-5,;-.67,-5,;-2,-4.23,)| InChI=1S/C26H27FN4O2/c1-15-12-28-25(29-13-15)22-9-4-16(2)30-24(22)26(32)31-20-10-18(11-20)17(3)23(31)14-33-21-7-5-19(27)6-8-21/h4-9,12-13,17-18,20,23H,10-11,14H2,1-3H3 YPHXSPAVMMEFRO-UHFFFAOYSA-N 604034 US11660293, Example 138 Orexin receptor type 2 Homo sapiens 89.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604034 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604034&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003531 482596759 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281005 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cncc(Cl)c1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;1.62,-3.01,;-.96,-2.32,)| 604035 US11660293, Example 139 Orexin/Hypocretin receptor type 1 Homo sapiens 14.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604035&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003557 482596760 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281006 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1cncc(Cl)c1 |r,wU:1.0,TLB:0:1:3:5,THB:17:6:3:5,(.63,5.29,;-.7,4.52,;-2.04,5.29,;-3.37,4.52,;-3.37,2.98,;-2.04,3.75,;-2.04,2.21,;-.7,2.98,;.63,2.21,;1.96,2.98,;3.3,2.21,;4.63,2.98,;5.96,2.21,;5.96,.67,;7.3,-.1,;4.63,-.1,;3.3,.67,;-2.04,.67,;-.7,-.1,;-3.37,-.1,;-4.78,.53,;-5.81,-.61,;-7.3,-.22,;-5.04,-1.95,;-3.53,-1.63,;-2.44,-2.72,;-2.84,-4.2,;-1.75,-5.29,;-.27,-4.89,;.13,-3.41,;1.62,-3.01,;-.96,-2.32,)| 604035 US11660293, Example 139 Orexin receptor type 2 Homo sapiens 661 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604035&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003557 482596760 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281007 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-n1nccn1 |r,wU:1.0,(.63,5.12,;-.7,4.35,;-2.04,5.12,;-3.37,4.35,;-3.37,2.81,;-2.04,3.58,;-2.04,2.04,;-.7,2.81,;.63,2.04,;1.96,2.81,;3.3,2.04,;4.63,2.81,;5.96,2.04,;5.96,.5,;7.3,-.27,;4.63,-.27,;3.3,.5,;-2.04,.5,;-.7,-.27,;-3.37,-.27,;-4.78,.35,;-5.81,-.79,;-7.3,-.39,;-5.04,-2.13,;-3.53,-1.81,;-2.44,-2.9,;-2.69,-4.42,;-1.31,-5.12,;-.22,-4.03,;-.92,-2.65,)| InChI=1S/C21H22FN5O2S/c1-12-14-9-16(10-14)26(18(12)11-29-17-5-3-15(22)4-6-17)20(28)19-21(30-13(2)25-19)27-23-7-8-24-27/h3-8,12,14,16,18H,9-11H2,1-2H3 OULOYMJFWCSJQZ-UHFFFAOYSA-N 604036 US11660293, Example 140 Orexin/Hypocretin receptor type 1 Homo sapiens 32.4 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604036&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535450 482596761 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281008 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-n1nccn1 |r,wU:1.0,(.63,5.12,;-.7,4.35,;-2.04,5.12,;-3.37,4.35,;-3.37,2.81,;-2.04,3.58,;-2.04,2.04,;-.7,2.81,;.63,2.04,;1.96,2.81,;3.3,2.04,;4.63,2.81,;5.96,2.04,;5.96,.5,;7.3,-.27,;4.63,-.27,;3.3,.5,;-2.04,.5,;-.7,-.27,;-3.37,-.27,;-4.78,.35,;-5.81,-.79,;-7.3,-.39,;-5.04,-2.13,;-3.53,-1.81,;-2.44,-2.9,;-2.69,-4.42,;-1.31,-5.12,;-.22,-4.03,;-.92,-2.65,)| InChI=1S/C21H22FN5O2S/c1-12-14-9-16(10-14)26(18(12)11-29-17-5-3-15(22)4-6-17)20(28)19-21(30-13(2)25-19)27-23-7-8-24-27/h3-8,12,14,16,18H,9-11H2,1-2H3 OULOYMJFWCSJQZ-UHFFFAOYSA-N 604036 US11660293, Example 140 Orexin receptor type 2 Homo sapiens 603 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604036 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604036&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535450 482596761 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281009 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-n1cccn1 |r,wU:1.0,(.63,5.12,;-.7,4.35,;-2.04,5.12,;-3.37,4.35,;-3.37,2.81,;-2.04,3.58,;-2.04,2.04,;-.7,2.81,;.63,2.04,;1.96,2.81,;3.3,2.04,;4.63,2.81,;5.96,2.04,;5.96,.5,;7.3,-.27,;4.63,-.27,;3.3,.5,;-2.04,.5,;-.7,-.27,;-3.37,-.27,;-4.78,.35,;-5.81,-.79,;-7.3,-.39,;-5.04,-2.13,;-3.53,-1.81,;-2.44,-2.9,;-.92,-2.65,;-.22,-4.03,;-1.31,-5.12,;-2.69,-4.42,)| InChI=1S/C22H23FN4O2S/c1-13-15-10-17(11-15)27(19(13)12-29-18-6-4-16(23)5-7-18)21(28)20-22(30-14(2)25-20)26-9-3-8-24-26/h3-9,13,15,17,19H,10-12H2,1-2H3 FXMWAHHBGPAEQY-UHFFFAOYSA-N 604037 US11660293, Example 141 Orexin/Hypocretin receptor type 1 Homo sapiens 123 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604037&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535451 482596762 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281010 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-n1cccn1 |r,wU:1.0,(.63,5.12,;-.7,4.35,;-2.04,5.12,;-3.37,4.35,;-3.37,2.81,;-2.04,3.58,;-2.04,2.04,;-.7,2.81,;.63,2.04,;1.96,2.81,;3.3,2.04,;4.63,2.81,;5.96,2.04,;5.96,.5,;7.3,-.27,;4.63,-.27,;3.3,.5,;-2.04,.5,;-.7,-.27,;-3.37,-.27,;-4.78,.35,;-5.81,-.79,;-7.3,-.39,;-5.04,-2.13,;-3.53,-1.81,;-2.44,-2.9,;-.92,-2.65,;-.22,-4.03,;-1.31,-5.12,;-2.69,-4.42,)| InChI=1S/C22H23FN4O2S/c1-13-15-10-17(11-15)27(19(13)12-29-18-6-4-16(23)5-7-18)21(28)20-22(30-14(2)25-20)26-9-3-8-24-26/h3-9,13,15,17,19H,10-12H2,1-2H3 FXMWAHHBGPAEQY-UHFFFAOYSA-N 604037 US11660293, Example 141 Orexin receptor type 2 Homo sapiens 355 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604037&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535451 482596762 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281011 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(1.33,4.78,;,4.01,;-1.33,4.78,;-2.67,4.01,;-2.67,2.47,;-1.33,3.24,;-1.33,1.7,;,2.47,;1.33,1.7,;2.67,2.47,;4,1.7,;5.33,2.47,;6.67,1.7,;6.67,.16,;8,-.61,;5.33,-.61,;4,.16,;-1.33,.16,;,-.61,;-2.67,-.61,;-4,.16,;-5.33,-.61,;-5.33,-2.15,;-4,-2.92,;-2.67,-2.15,;-1.33,-2.92,;-1.17,-4.46,;.33,-4.78,;1.1,-3.44,;.07,-2.3,;-6.67,.16,;-8,.93,)| InChI=1S/C24H22FN5O2/c1-15-17-11-19(12-17)29(23(15)14-32-20-5-3-18(25)4-6-20)24(31)21-10-16(13-26)2-7-22(21)30-27-8-9-28-30/h2-10,15,17,19,23H,11-12,14H2,1H3 QFSRAZBOABSZSR-UHFFFAOYSA-N 604038 US11660293, Example 142 Orexin/Hypocretin receptor type 1 Homo sapiens 100 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604038&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535449 482596763 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281012 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(1.33,4.78,;,4.01,;-1.33,4.78,;-2.67,4.01,;-2.67,2.47,;-1.33,3.24,;-1.33,1.7,;,2.47,;1.33,1.7,;2.67,2.47,;4,1.7,;5.33,2.47,;6.67,1.7,;6.67,.16,;8,-.61,;5.33,-.61,;4,.16,;-1.33,.16,;,-.61,;-2.67,-.61,;-4,.16,;-5.33,-.61,;-5.33,-2.15,;-4,-2.92,;-2.67,-2.15,;-1.33,-2.92,;-1.17,-4.46,;.33,-4.78,;1.1,-3.44,;.07,-2.3,;-6.67,.16,;-8,.93,)| InChI=1S/C24H22FN5O2/c1-15-17-11-19(12-17)29(23(15)14-32-20-5-3-18(25)4-6-20)24(31)21-10-16(13-26)2-7-22(21)30-27-8-9-28-30/h2-10,15,17,19,23H,11-12,14H2,1H3 QFSRAZBOABSZSR-UHFFFAOYSA-N 604038 US11660293, Example 142 Orexin receptor type 2 Homo sapiens 468 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604038&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535449 482596763 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281013 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ccc(C)nc1 |r,wU:1.0,(.63,5.64,;-.7,4.87,;-2.04,5.64,;-3.37,4.87,;-3.37,3.33,;-2.04,4.1,;-2.04,2.56,;-.7,3.33,;.63,2.56,;1.96,3.33,;3.3,2.56,;4.63,3.33,;5.96,2.56,;5.96,1.02,;7.3,.25,;4.63,.25,;3.3,1.02,;-2.04,1.02,;-.7,.25,;-3.37,.25,;-4.78,.88,;-5.81,-.27,;-7.3,.13,;-5.04,-1.6,;-3.53,-1.28,;-2.44,-2.37,;-.96,-1.97,;.13,-3.06,;-.27,-4.55,;.82,-5.64,;-1.75,-4.95,;-2.84,-3.86,)| InChI=1S/C25H26FN3O2S/c1-14-4-5-17(12-27-14)24-23(28-16(3)32-24)25(30)29-20-10-18(11-20)15(2)22(29)13-31-21-8-6-19(26)7-9-21/h4-9,12,15,18,20,22H,10-11,13H2,1-3H3 YPAPVZLOVCSFNE-UHFFFAOYSA-N 604039 US11660293, Example 143 Orexin/Hypocretin receptor type 1 Homo sapiens 72.4 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604039&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003559 482596764 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281014 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)sc1-c1ccc(C)nc1 |r,wU:1.0,(.63,5.64,;-.7,4.87,;-2.04,5.64,;-3.37,4.87,;-3.37,3.33,;-2.04,4.1,;-2.04,2.56,;-.7,3.33,;.63,2.56,;1.96,3.33,;3.3,2.56,;4.63,3.33,;5.96,2.56,;5.96,1.02,;7.3,.25,;4.63,.25,;3.3,1.02,;-2.04,1.02,;-.7,.25,;-3.37,.25,;-4.78,.88,;-5.81,-.27,;-7.3,.13,;-5.04,-1.6,;-3.53,-1.28,;-2.44,-2.37,;-.96,-1.97,;.13,-3.06,;-.27,-4.55,;.82,-5.64,;-1.75,-4.95,;-2.84,-3.86,)| InChI=1S/C25H26FN3O2S/c1-14-4-5-17(12-27-14)24-23(28-16(3)32-24)25(30)29-20-10-18(11-20)15(2)22(29)13-31-21-8-6-19(26)7-9-21/h4-9,12,15,18,20,22H,10-11,13H2,1-3H3 YPAPVZLOVCSFNE-UHFFFAOYSA-N 604039 US11660293, Example 143 Orexin receptor type 2 Homo sapiens 1175 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604039&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003559 482596764 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281015 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1ncc(C)n1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;1.92,-3.04,;-.59,-2.3,)| InChI=1S/C24H26FN5O2/c1-14-4-9-21(30-26-12-15(2)28-30)23(27-14)24(31)29-19-10-17(11-19)16(3)22(29)13-32-20-7-5-18(25)6-8-20/h4-9,12,16-17,19,22H,10-11,13H2,1-3H3 VIRNLKBWGGBTIE-UHFFFAOYSA-N 604040 US11660293, Example 144 Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604040&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535567 482596765 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281016 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1ncc(C)n1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;1.92,-3.04,;-.59,-2.3,)| InChI=1S/C24H26FN5O2/c1-14-4-9-21(30-26-12-15(2)28-30)23(27-14)24(31)29-19-10-17(11-19)16(3)22(29)13-32-20-7-5-18(25)6-8-20/h4-9,12,16-17,19,22H,10-11,13H2,1-3H3 VIRNLKBWGGBTIE-UHFFFAOYSA-N 604040 US11660293, Example 144 Orexin receptor type 2 Homo sapiens 148 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604040&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535567 482596765 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281017 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)cnc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23FN6O2/c1-13-11-24-21(29-25-7-8-26-29)20(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-18-5-3-16(23)4-6-18/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 MIWHQQORBARCGE-UHFFFAOYSA-N 604041 US11660293, Example 145 Orexin/Hypocretin receptor type 1 Homo sapiens 93.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604041&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003532 482596766 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281018 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)cnc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H23FN6O2/c1-13-11-24-21(29-25-7-8-26-29)20(27-13)22(30)28-17-9-15(10-17)14(2)19(28)12-31-18-5-3-16(23)4-6-18/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3 MIWHQQORBARCGE-UHFFFAOYSA-N 604041 US11660293, Example 145 Orexin receptor type 2 Homo sapiens 2399 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604041&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003532 482596766 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281019 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1cc(C)nn1 |r,wU:1.0,(.67,4.58,;-.67,3.81,;-2,4.58,;-3.33,3.81,;-3.33,2.27,;-2,3.04,;-2,1.5,;-.67,2.27,;.67,1.5,;2,2.27,;3.33,1.5,;4.67,2.27,;6,1.5,;6,-.04,;7.34,-.81,;4.67,-.81,;3.33,-.04,;-2,-.04,;-.67,-.81,;-3.33,-.81,;-4.67,-.04,;-6,-.81,;-7.34,-.04,;-6,-2.35,;-4.67,-3.12,;-3.33,-2.35,;-2,-3.12,;-.75,-2.21,;.49,-3.12,;1.98,-2.72,;.02,-4.58,;-1.52,-4.58,)| InChI=1S/C24H26FN5O2/c1-14-4-9-21(29-12-15(2)27-28-29)23(26-14)24(31)30-19-10-17(11-19)16(3)22(30)13-32-20-7-5-18(25)6-8-20/h4-9,12,16-17,19,22H,10-11,13H2,1-3H3 JDKCZRYGWUZSRE-UHFFFAOYSA-N 604042 US11660293, Example 146 Orexin/Hypocretin receptor type 1 Homo sapiens 132 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604042&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535549 482596767 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281020 C[C@@H]1C2CC(C2)N(C1COc1ccc(F)cc1)C(=O)c1nc(C)ccc1-n1cc(C)nn1 |r,wU:1.0,(.67,4.58,;-.67,3.81,;-2,4.58,;-3.33,3.81,;-3.33,2.27,;-2,3.04,;-2,1.5,;-.67,2.27,;.67,1.5,;2,2.27,;3.33,1.5,;4.67,2.27,;6,1.5,;6,-.04,;7.34,-.81,;4.67,-.81,;3.33,-.04,;-2,-.04,;-.67,-.81,;-3.33,-.81,;-4.67,-.04,;-6,-.81,;-7.34,-.04,;-6,-2.35,;-4.67,-3.12,;-3.33,-2.35,;-2,-3.12,;-.75,-2.21,;.49,-3.12,;1.98,-2.72,;.02,-4.58,;-1.52,-4.58,)| InChI=1S/C24H26FN5O2/c1-14-4-9-21(29-12-15(2)27-28-29)23(26-14)24(31)30-19-10-17(11-19)16(3)22(30)13-32-20-7-5-18(25)6-8-20/h4-9,12,16-17,19,22H,10-11,13H2,1-3H3 JDKCZRYGWUZSRE-UHFFFAOYSA-N 604042 US11660293, Example 146 Orexin receptor type 2 Homo sapiens 2951 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604042&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535549 482596767 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281021 C[C@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(-.45,4.78,;-1.78,4.01,;-3.12,4.78,;-4.45,4.01,;-4.45,2.47,;-3.12,3.24,;-3.12,1.7,;-1.78,2.47,;-.45,1.7,;.88,2.47,;2.22,1.7,;2.38,.16,;3.88,-.16,;4.65,-1.49,;6.19,-1.49,;6.96,-.16,;8.45,-.55,;6.19,1.18,;4.65,1.18,;3.62,2.32,;-3.12,.16,;-1.78,-.61,;-4.45,-.61,;-5.78,.16,;-7.12,-.61,;-8.45,.16,;-7.12,-2.15,;-5.78,-2.92,;-4.45,-2.15,;-3.12,-2.92,;-2.96,-4.46,;-1.45,-4.78,;-.68,-3.44,;-1.71,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) UJGSPBJSTPPWNS-UHFFFAOYSA-N 604043 US11660293, Example 147 Orexin/Hypocretin receptor type 1 Homo sapiens 26.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604043&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535550 482596768 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281022 C[C@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(-.45,4.78,;-1.78,4.01,;-3.12,4.78,;-4.45,4.01,;-4.45,2.47,;-3.12,3.24,;-3.12,1.7,;-1.78,2.47,;-.45,1.7,;.88,2.47,;2.22,1.7,;2.38,.16,;3.88,-.16,;4.65,-1.49,;6.19,-1.49,;6.96,-.16,;8.45,-.55,;6.19,1.18,;4.65,1.18,;3.62,2.32,;-3.12,.16,;-1.78,-.61,;-4.45,-.61,;-5.78,.16,;-7.12,-.61,;-8.45,.16,;-7.12,-2.15,;-5.78,-2.92,;-4.45,-2.15,;-3.12,-2.92,;-2.96,-4.46,;-1.45,-4.78,;-.68,-3.44,;-1.71,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) UJGSPBJSTPPWNS-UHFFFAOYSA-N 604043 US11660293, Example 147 Orexin receptor type 2 Homo sapiens 219 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604043&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535550 482596768 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281023 C[C@H]1C2CC(C2)N(C1CNc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H24ClN7O/c1-13-3-5-18(30-26-7-8-27-30)21(28-13)22(31)29-17-9-15(10-17)14(2)19(29)12-25-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,24,25) JULCYAHUYCKBPG-UHFFFAOYSA-N 604044 US11660293, Example 148 Orexin/Hypocretin receptor type 1 Homo sapiens 141 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604044&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535551 482596769 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281024 C[C@H]1C2CC(C2)N(C1CNc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H24ClN7O/c1-13-3-5-18(30-26-7-8-27-30)21(28-13)22(31)29-17-9-15(10-17)14(2)19(29)12-25-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,24,25) JULCYAHUYCKBPG-UHFFFAOYSA-N 604044 US11660293, Example 148 Orexin receptor type 2 Homo sapiens 2399 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604044&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535551 482596769 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281025 C[C@H]1C2CC(C2)N(C1CNc1ncc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)23(30-15)24(34)32-19-11-18(12-19)16(2)22(32)14-27-25-26-13-17-5-3-4-6-20(17)31-25/h3-10,13,16,18-19,22H,11-12,14H2,1-2H3,(H,26,27,31) WYIQCOVRKHTUCK-UHFFFAOYSA-N 604045 US11660293, Example 149 Orexin/Hypocretin receptor type 1 Homo sapiens 151 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604045&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430313 482596770 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281026 C[C@H]1C2CC(C2)N(C1CNc1ncc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)23(30-15)24(34)32-19-11-18(12-19)16(2)22(32)14-27-25-26-13-17-5-3-4-6-20(17)31-25/h3-10,13,16,18-19,22H,11-12,14H2,1-2H3,(H,26,27,31) WYIQCOVRKHTUCK-UHFFFAOYSA-N 604045 US11660293, Example 149 Orexin receptor type 2 Homo sapiens 1905 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604045 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604045&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430313 482596770 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281027 C[C@H]1C2CC(C2)N(C1CNc1nc2ccccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;3.12,.16,;4.63,-.16,;5.4,-1.49,;6.94,-1.49,;7.71,-.16,;6.94,1.18,;5.4,1.18,;4.37,2.32,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7OS/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) BXYGKHMCWKCMQG-UHFFFAOYSA-N 604046 US11660293, Example 150 Orexin/Hypocretin receptor type 1 Homo sapiens 31.6 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604046&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535425 482596771 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281028 C[C@H]1C2CC(C2)N(C1CNc1nc2ccccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wD:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;3.12,.16,;4.63,-.16,;5.4,-1.49,;6.94,-1.49,;7.71,-.16,;6.94,1.18,;5.4,1.18,;4.37,2.32,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7OS/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) BXYGKHMCWKCMQG-UHFFFAOYSA-N 604046 US11660293, Example 150 Orexin receptor type 2 Homo sapiens 724 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604046 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604046&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535425 482596771 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281029 C[C@@H]1C2CC(C2)N(C1CNc1cc2ccccc2cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;4,2.47,;5.33,1.7,;6.67,2.47,;8,1.7,;8,.16,;6.67,-.61,;5.33,.16,;4,-.61,;2.67,.16,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C26H27N7O/c1-16-7-8-22(33-29-9-10-30-33)25(31-16)26(34)32-21-11-20(12-21)17(2)23(32)15-28-24-13-18-5-3-4-6-19(18)14-27-24/h3-10,13-14,17,20-21,23H,11-12,15H2,1-2H3,(H,27,28) JJJXBYIQNATBQW-UHFFFAOYSA-N 604047 US11660293, Example 151 Orexin/Hypocretin receptor type 1 Homo sapiens 25.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604047&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430314 482596772 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281030 C[C@@H]1C2CC(C2)N(C1CNc1cc2ccccc2cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;4,2.47,;5.33,1.7,;6.67,2.47,;8,1.7,;8,.16,;6.67,-.61,;5.33,.16,;4,-.61,;2.67,.16,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C26H27N7O/c1-16-7-8-22(33-29-9-10-30-33)25(31-16)26(34)32-21-11-20(12-21)17(2)23(32)15-28-24-13-18-5-3-4-6-19(18)14-27-24/h3-10,13-14,17,20-21,23H,11-12,15H2,1-2H3,(H,27,28) JJJXBYIQNATBQW-UHFFFAOYSA-N 604047 US11660293, Example 151 Orexin receptor type 2 Homo sapiens 3802 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604047 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604047&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430314 482596772 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281031 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.48,4.78,;-1.81,4.01,;-3.14,4.78,;-4.48,4.01,;-4.48,2.47,;-3.14,3.24,;-3.14,1.7,;-1.81,2.47,;-.48,1.7,;.86,2.47,;2.19,1.7,;2.35,.16,;3.86,-.16,;4.63,-1.49,;6.17,-1.49,;6.94,-.16,;8.48,-.16,;6.17,1.18,;4.63,1.18,;3.6,2.32,;-3.14,.16,;-1.81,-.61,;-4.48,-.61,;-5.81,.16,;-7.14,-.61,;-8.48,.16,;-7.14,-2.15,;-5.81,-2.92,;-4.48,-2.15,;-3.14,-2.92,;-2.98,-4.46,;-1.48,-4.78,;-.71,-3.44,;-1.74,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) UJGSPBJSTPPWNS-UHFFFAOYSA-N 604048 US11660293, Example 152::US11660293, Example 154 Orexin/Hypocretin receptor type 1 Homo sapiens 2.09 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604048&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430315 482596773 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281032 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.48,4.78,;-1.81,4.01,;-3.14,4.78,;-4.48,4.01,;-4.48,2.47,;-3.14,3.24,;-3.14,1.7,;-1.81,2.47,;-.48,1.7,;.86,2.47,;2.19,1.7,;2.35,.16,;3.86,-.16,;4.63,-1.49,;6.17,-1.49,;6.94,-.16,;8.48,-.16,;6.17,1.18,;4.63,1.18,;3.6,2.32,;-3.14,.16,;-1.81,-.61,;-4.48,-.61,;-5.81,.16,;-7.14,-.61,;-8.48,.16,;-7.14,-2.15,;-5.81,-2.92,;-4.48,-2.15,;-3.14,-2.92,;-2.98,-4.46,;-1.48,-4.78,;-.71,-3.44,;-1.74,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) UJGSPBJSTPPWNS-UHFFFAOYSA-N 604048 US11660293, Example 152::US11660293, Example 154 Orexin receptor type 2 Homo sapiens 794 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604048&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430315 482596773 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281033 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.48,4.78,;-1.81,4.01,;-3.14,4.78,;-4.48,4.01,;-4.48,2.47,;-3.14,3.24,;-3.14,1.7,;-1.81,2.47,;-.48,1.7,;.86,2.47,;2.19,1.7,;2.35,.16,;3.86,-.16,;4.63,-1.49,;6.17,-1.49,;6.94,-.16,;8.48,-.16,;6.17,1.18,;4.63,1.18,;3.6,2.32,;-3.14,.16,;-1.81,-.61,;-4.48,-.61,;-5.81,.16,;-7.14,-.61,;-8.48,.16,;-7.14,-2.15,;-5.81,-2.92,;-4.48,-2.15,;-3.14,-2.92,;-2.98,-4.46,;-1.48,-4.78,;-.71,-3.44,;-1.74,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) UJGSPBJSTPPWNS-UHFFFAOYSA-N 604048 US11660293, Example 152::US11660293, Example 154 Orexin/Hypocretin receptor type 1 Homo sapiens 0.871 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604048&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430315 482596773 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281034 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.48,4.78,;-1.81,4.01,;-3.14,4.78,;-4.48,4.01,;-4.48,2.47,;-3.14,3.24,;-3.14,1.7,;-1.81,2.47,;-.48,1.7,;.86,2.47,;2.19,1.7,;2.35,.16,;3.86,-.16,;4.63,-1.49,;6.17,-1.49,;6.94,-.16,;8.48,-.16,;6.17,1.18,;4.63,1.18,;3.6,2.32,;-3.14,.16,;-1.81,-.61,;-4.48,-.61,;-5.81,.16,;-7.14,-.61,;-8.48,.16,;-7.14,-2.15,;-5.81,-2.92,;-4.48,-2.15,;-3.14,-2.92,;-2.98,-4.46,;-1.48,-4.78,;-.71,-3.44,;-1.74,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) UJGSPBJSTPPWNS-UHFFFAOYSA-N 604048 US11660293, Example 152::US11660293, Example 154 Orexin receptor type 2 Homo sapiens 589 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604048 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604048&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430315 482596773 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281035 C[C@@H]1C2CC(C2)N(C1CNc1ncc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)23(30-15)24(34)32-19-11-18(12-19)16(2)22(32)14-27-25-26-13-17-5-3-4-6-20(17)31-25/h3-10,13,16,18-19,22H,11-12,14H2,1-2H3,(H,26,27,31) WYIQCOVRKHTUCK-UHFFFAOYSA-N 604050 US11660293, Example 155 Orexin/Hypocretin receptor type 1 Homo sapiens 19.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604050&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535557 482596774 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281036 C[C@@H]1C2CC(C2)N(C1CNc1ncc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)23(30-15)24(34)32-19-11-18(12-19)16(2)22(32)14-27-25-26-13-17-5-3-4-6-20(17)31-25/h3-10,13,16,18-19,22H,11-12,14H2,1-2H3,(H,26,27,31) WYIQCOVRKHTUCK-UHFFFAOYSA-N 604050 US11660293, Example 155 Orexin receptor type 2 Homo sapiens 3236 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604050&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535557 482596774 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281037 C[C@@H]1C2CC(C2)N(C1CNc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H24ClN7O/c1-13-3-5-18(30-26-7-8-27-30)21(28-13)22(31)29-17-9-15(10-17)14(2)19(29)12-25-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,24,25) JULCYAHUYCKBPG-UHFFFAOYSA-N 604051 US11660293, Example 156 Orexin/Hypocretin receptor type 1 Homo sapiens 29.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604051&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535559 482596775 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281038 C[C@@H]1C2CC(C2)N(C1CNc1ccc(Cl)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H24ClN7O/c1-13-3-5-18(30-26-7-8-27-30)21(28-13)22(31)29-17-9-15(10-17)14(2)19(29)12-25-20-6-4-16(23)11-24-20/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,24,25) JULCYAHUYCKBPG-UHFFFAOYSA-N 604051 US11660293, Example 156 Orexin receptor type 2 Homo sapiens 4467 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604051&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535559 482596775 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281039 C[C@@H]1C2CC(C2)N(C1CNc1nc2cc(F)ccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;3.12,.16,;4.63,-.16,;5.4,-1.49,;6.94,-1.49,;7.71,-2.82,;7.71,-.16,;6.94,1.18,;5.4,1.18,;4.37,2.32,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-5-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-11-16(25)4-6-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) MMECXESNOXCLAZ-UHFFFAOYSA-N 604052 US11660293, Example 157 Orexin/Hypocretin receptor type 1 Homo sapiens 14.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604052&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430316 482596776 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281040 C[C@@H]1C2CC(C2)N(C1CNc1nc2cc(F)ccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;3.12,.16,;4.63,-.16,;5.4,-1.49,;6.94,-1.49,;7.71,-2.82,;7.71,-.16,;6.94,1.18,;5.4,1.18,;4.37,2.32,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H24FN7OS/c1-13-3-5-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-11-16(25)4-6-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) MMECXESNOXCLAZ-UHFFFAOYSA-N 604052 US11660293, Example 157 Orexin receptor type 2 Homo sapiens 2344 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604052 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604052&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430316 482596776 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281041 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)24(30-15)25(34)32-18-11-17(12-18)16(2)22(32)13-27-23-14-26-19-5-3-4-6-20(19)31-23/h3-10,14,16-18,22H,11-13H2,1-2H3,(H,27,31) UZPPFCJPRSHSQF-UHFFFAOYSA-N 604053 US11660293, Example 158::US11660293, Example 159::US11660293, Example 160 Orexin/Hypocretin receptor type 1 Homo sapiens 3.98 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604053&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430317 482596777 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281042 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)24(30-15)25(34)32-18-11-17(12-18)16(2)22(32)13-27-23-14-26-19-5-3-4-6-20(19)31-23/h3-10,14,16-18,22H,11-13H2,1-2H3,(H,27,31) UZPPFCJPRSHSQF-UHFFFAOYSA-N 604053 US11660293, Example 158::US11660293, Example 159::US11660293, Example 160 Orexin receptor type 2 Homo sapiens 1820 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604053&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430317 482596777 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281043 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)24(30-15)25(34)32-18-11-17(12-18)16(2)22(32)13-27-23-14-26-19-5-3-4-6-20(19)31-23/h3-10,14,16-18,22H,11-13H2,1-2H3,(H,27,31) UZPPFCJPRSHSQF-UHFFFAOYSA-N 604053 US11660293, Example 158::US11660293, Example 159::US11660293, Example 160 Orexin/Hypocretin receptor type 1 Homo sapiens 145 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604053&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430317 482596777 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281044 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)24(30-15)25(34)32-18-11-17(12-18)16(2)22(32)13-27-23-14-26-19-5-3-4-6-20(19)31-23/h3-10,14,16-18,22H,11-13H2,1-2H3,(H,27,31) UZPPFCJPRSHSQF-UHFFFAOYSA-N 604053 US11660293, Example 158::US11660293, Example 159::US11660293, Example 160 Orexin receptor type 2 Homo sapiens 25704 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604053&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430317 482596777 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281045 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)24(30-15)25(34)32-18-11-17(12-18)16(2)22(32)13-27-23-14-26-19-5-3-4-6-20(19)31-23/h3-10,14,16-18,22H,11-13H2,1-2H3,(H,27,31) UZPPFCJPRSHSQF-UHFFFAOYSA-N 604053 US11660293, Example 158::US11660293, Example 159::US11660293, Example 160 Orexin/Hypocretin receptor type 1 Homo sapiens 2.09 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604053&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430317 482596777 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281046 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C25H26N8O/c1-15-7-8-21(33-28-9-10-29-33)24(30-15)25(34)32-18-11-17(12-18)16(2)22(32)13-27-23-14-26-19-5-3-4-6-20(19)31-23/h3-10,14,16-18,22H,11-13H2,1-2H3,(H,27,31) UZPPFCJPRSHSQF-UHFFFAOYSA-N 604053 US11660293, Example 158::US11660293, Example 159::US11660293, Example 160 Orexin receptor type 2 Homo sapiens 1047 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604053&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430317 482596777 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281047 C[C@@H]1C2CC(C2)N(C1CNc1ccc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C26H27N7O/c1-16-7-9-22(33-28-11-12-29-33)25(30-16)26(34)32-20-13-19(14-20)17(2)23(32)15-27-24-10-8-18-5-3-4-6-21(18)31-24/h3-12,17,19-20,23H,13-15H2,1-2H3,(H,27,31) HHRNIXBJAYHRIZ-UHFFFAOYSA-N 604056 US11660293, Example 161 Orexin/Hypocretin receptor type 1 Homo sapiens 47.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604056&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430318 482596778 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281048 C[C@@H]1C2CC(C2)N(C1CNc1ccc2ccccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C26H27N7O/c1-16-7-9-22(33-28-11-12-29-33)25(30-16)26(34)32-20-13-19(14-20)17(2)23(32)15-27-24-10-8-18-5-3-4-6-21(18)31-24/h3-12,17,19-20,23H,13-15H2,1-2H3,(H,27,31) HHRNIXBJAYHRIZ-UHFFFAOYSA-N 604056 US11660293, Example 161 Orexin receptor type 2 Homo sapiens 6310 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604056 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604056&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430318 482596778 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281049 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wU:1.0,(.26,5.29,;-1.08,4.52,;-2.41,5.29,;-3.75,4.52,;-3.75,2.98,;-2.41,3.75,;-2.41,2.21,;-1.08,2.98,;.26,2.21,;1.59,2.98,;2.92,2.21,;4.33,2.84,;5.36,1.7,;6.9,1.7,;7.67,.36,;6.9,-.97,;7.67,-2.31,;5.36,-.97,;4.59,.36,;3.08,.68,;-2.41,.67,;-1.08,-.1,;-3.75,-.1,;-5.15,.53,;-6.18,-.61,;-7.67,-.22,;-5.41,-1.95,;-3.91,-1.63,;-2.82,-2.72,;-3.22,-4.2,;-2.13,-5.29,;-.64,-4.89,;-.24,-3.41,;-1.33,-2.32,)| InChI=1S/C24H23FN6OS2/c1-12-14-8-16(9-14)31(18(12)11-28-24-30-17-5-4-15(25)10-19(17)34-24)23(32)20-21(33-13(2)29-20)22-26-6-3-7-27-22/h3-7,10,12,14,16,18H,8-9,11H2,1-2H3,(H,28,30) XDXYXPLVHKKDNY-UHFFFAOYSA-N 604057 US11660293, Example 162::US11660293, Example 164 Orexin/Hypocretin receptor type 1 Homo sapiens 1.48 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604057&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535461 482596779 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281050 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wU:1.0,(.26,5.29,;-1.08,4.52,;-2.41,5.29,;-3.75,4.52,;-3.75,2.98,;-2.41,3.75,;-2.41,2.21,;-1.08,2.98,;.26,2.21,;1.59,2.98,;2.92,2.21,;4.33,2.84,;5.36,1.7,;6.9,1.7,;7.67,.36,;6.9,-.97,;7.67,-2.31,;5.36,-.97,;4.59,.36,;3.08,.68,;-2.41,.67,;-1.08,-.1,;-3.75,-.1,;-5.15,.53,;-6.18,-.61,;-7.67,-.22,;-5.41,-1.95,;-3.91,-1.63,;-2.82,-2.72,;-3.22,-4.2,;-2.13,-5.29,;-.64,-4.89,;-.24,-3.41,;-1.33,-2.32,)| InChI=1S/C24H23FN6OS2/c1-12-14-8-16(9-14)31(18(12)11-28-24-30-17-5-4-15(25)10-19(17)34-24)23(32)20-21(33-13(2)29-20)22-26-6-3-7-27-22/h3-7,10,12,14,16,18H,8-9,11H2,1-2H3,(H,28,30) XDXYXPLVHKKDNY-UHFFFAOYSA-N 604057 US11660293, Example 162::US11660293, Example 164 Orexin receptor type 2 Homo sapiens 2570 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604057&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535461 482596779 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281051 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wU:1.0,(.26,5.29,;-1.08,4.52,;-2.41,5.29,;-3.75,4.52,;-3.75,2.98,;-2.41,3.75,;-2.41,2.21,;-1.08,2.98,;.26,2.21,;1.59,2.98,;2.92,2.21,;4.33,2.84,;5.36,1.7,;6.9,1.7,;7.67,.36,;6.9,-.97,;7.67,-2.31,;5.36,-.97,;4.59,.36,;3.08,.68,;-2.41,.67,;-1.08,-.1,;-3.75,-.1,;-5.15,.53,;-6.18,-.61,;-7.67,-.22,;-5.41,-1.95,;-3.91,-1.63,;-2.82,-2.72,;-3.22,-4.2,;-2.13,-5.29,;-.64,-4.89,;-.24,-3.41,;-1.33,-2.32,)| InChI=1S/C24H23FN6OS2/c1-12-14-8-16(9-14)31(18(12)11-28-24-30-17-5-4-15(25)10-19(17)34-24)23(32)20-21(33-13(2)29-20)22-26-6-3-7-27-22/h3-7,10,12,14,16,18H,8-9,11H2,1-2H3,(H,28,30) XDXYXPLVHKKDNY-UHFFFAOYSA-N 604057 US11660293, Example 162::US11660293, Example 164 Orexin/Hypocretin receptor type 1 Homo sapiens 1.17 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604057&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535461 482596779 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281052 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1nc(C)sc1-c1ncccn1 |r,wU:1.0,(.26,5.29,;-1.08,4.52,;-2.41,5.29,;-3.75,4.52,;-3.75,2.98,;-2.41,3.75,;-2.41,2.21,;-1.08,2.98,;.26,2.21,;1.59,2.98,;2.92,2.21,;4.33,2.84,;5.36,1.7,;6.9,1.7,;7.67,.36,;6.9,-.97,;7.67,-2.31,;5.36,-.97,;4.59,.36,;3.08,.68,;-2.41,.67,;-1.08,-.1,;-3.75,-.1,;-5.15,.53,;-6.18,-.61,;-7.67,-.22,;-5.41,-1.95,;-3.91,-1.63,;-2.82,-2.72,;-3.22,-4.2,;-2.13,-5.29,;-.64,-4.89,;-.24,-3.41,;-1.33,-2.32,)| InChI=1S/C24H23FN6OS2/c1-12-14-8-16(9-14)31(18(12)11-28-24-30-17-5-4-15(25)10-19(17)34-24)23(32)20-21(33-13(2)29-20)22-26-6-3-7-27-22/h3-7,10,12,14,16,18H,8-9,11H2,1-2H3,(H,28,30) XDXYXPLVHKKDNY-UHFFFAOYSA-N 604057 US11660293, Example 162::US11660293, Example 164 Orexin receptor type 2 Homo sapiens 2089 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604057&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535461 482596779 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281053 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-29-5-6-30-33)20(31-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-18(10-28-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,28) USKPBEMLQZDOJI-UHFFFAOYSA-N 604059 US11660293, Example 165::US11660293, Example 166::US11660293, Example 167 Orexin/Hypocretin receptor type 1 Homo sapiens 23.4 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604059&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430319 482596780 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281054 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-29-5-6-30-33)20(31-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-18(10-28-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,28) USKPBEMLQZDOJI-UHFFFAOYSA-N 604059 US11660293, Example 165::US11660293, Example 166::US11660293, Example 167 Orexin receptor type 2 Homo sapiens 14791 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604059&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430319 482596780 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281055 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-29-5-6-30-33)20(31-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-18(10-28-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,28) USKPBEMLQZDOJI-UHFFFAOYSA-N 604059 US11660293, Example 165::US11660293, Example 166::US11660293, Example 167 Orexin/Hypocretin receptor type 1 Homo sapiens 102 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604059&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430319 482596780 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281056 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-29-5-6-30-33)20(31-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-18(10-28-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,28) USKPBEMLQZDOJI-UHFFFAOYSA-N 604059 US11660293, Example 165::US11660293, Example 166::US11660293, Example 167 Orexin receptor type 2 Homo sapiens 51286 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604059&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430319 482596780 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281057 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-29-5-6-30-33)20(31-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-18(10-28-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,28) USKPBEMLQZDOJI-UHFFFAOYSA-N 604059 US11660293, Example 165::US11660293, Example 166::US11660293, Example 167 Orexin/Hypocretin receptor type 1 Homo sapiens 7.59 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604059&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430319 482596780 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281058 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-29-5-6-30-33)20(31-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-18(10-28-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,28) USKPBEMLQZDOJI-UHFFFAOYSA-N 604059 US11660293, Example 165::US11660293, Example 166::US11660293, Example 167 Orexin receptor type 2 Homo sapiens 7413 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604059&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430319 482596780 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281059 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22F2N6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-2-16(26)11-22(19)34-24)23(33)18-10-15(25)3-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) QTDGTVJGEPWMKX-UHFFFAOYSA-N 604062 US11660293, Example 168::US11660293, Example 170 Orexin/Hypocretin receptor type 1 Homo sapiens 3.47 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604062&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430320 482596781 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281060 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22F2N6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-2-16(26)11-22(19)34-24)23(33)18-10-15(25)3-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) QTDGTVJGEPWMKX-UHFFFAOYSA-N 604062 US11660293, Example 168::US11660293, Example 170 Orexin receptor type 2 Homo sapiens 1318 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604062&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430320 482596781 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281061 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22F2N6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-2-16(26)11-22(19)34-24)23(33)18-10-15(25)3-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) QTDGTVJGEPWMKX-UHFFFAOYSA-N 604062 US11660293, Example 168::US11660293, Example 170 Orexin/Hypocretin receptor type 1 Homo sapiens 1.38 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604062&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430320 482596781 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281062 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22F2N6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-2-16(26)11-22(19)34-24)23(33)18-10-15(25)3-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) QTDGTVJGEPWMKX-UHFFFAOYSA-N 604062 US11660293, Example 168::US11660293, Example 170 Orexin receptor type 2 Homo sapiens 1023 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604062&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430320 482596781 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281063 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22ClFN6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-3-16(26)11-22(19)34-24)23(33)18-10-15(25)2-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) HKMZXBJJLIWIFY-UHFFFAOYSA-N 604064 US11660293, Example 171::US11660293, Example 173 Orexin/Hypocretin receptor type 1 Homo sapiens 1.26 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604064&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535510 482596782 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281064 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22ClFN6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-3-16(26)11-22(19)34-24)23(33)18-10-15(25)2-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) HKMZXBJJLIWIFY-UHFFFAOYSA-N 604064 US11660293, Example 171::US11660293, Example 173 Orexin receptor type 2 Homo sapiens 479 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604064&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535510 482596782 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281065 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22ClFN6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-3-16(26)11-22(19)34-24)23(33)18-10-15(25)2-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) HKMZXBJJLIWIFY-UHFFFAOYSA-N 604064 US11660293, Example 171::US11660293, Example 173 Orexin/Hypocretin receptor type 1 Homo sapiens 0.437 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604064&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535510 482596782 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281066 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H22ClFN6OS/c1-13-14-8-17(9-14)31(21(13)12-27-24-30-19-4-3-16(26)11-22(19)34-24)23(33)18-10-15(25)2-5-20(18)32-28-6-7-29-32/h2-7,10-11,13-14,17,21H,8-9,12H2,1H3,(H,27,30) HKMZXBJJLIWIFY-UHFFFAOYSA-N 604064 US11660293, Example 171::US11660293, Example 173 Orexin receptor type 2 Homo sapiens 295 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604064 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604064&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535510 482596782 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281067 CCOc1ccc(C)nc1C(=O)N1C2CC(C2)[C@@H](C)C1CNc1nc2ccc(F)cc2s1 |r,wU:17.19,(-1.04,-5,;-2.37,-4.23,;-2.37,-2.69,;-3.71,-1.93,;-5.04,-2.69,;-6.37,-1.93,;-6.37,-.38,;-7.71,.38,;-5.04,.38,;-3.71,-.38,;-2.37,.38,;-1.04,-.38,;-2.37,1.93,;-3.71,2.69,;-3.71,4.23,;-2.37,5,;-2.37,3.47,;-1.04,4.23,;.29,5,;-1.04,2.69,;.29,1.93,;1.63,2.69,;2.96,1.93,;4.37,2.55,;5.4,1.41,;6.94,1.41,;7.71,.07,;6.94,-1.26,;7.71,-2.59,;5.4,-1.26,;4.63,.07,;3.12,.39,)| InChI=1S/C24H27FN4O2S/c1-4-31-20-8-5-13(2)27-22(20)23(30)29-17-9-15(10-17)14(3)19(29)12-26-24-28-18-7-6-16(25)11-21(18)32-24/h5-8,11,14-15,17,19H,4,9-10,12H2,1-3H3,(H,26,28) PETFZHTTWWEOOY-UHFFFAOYSA-N 604066 US11660293, Example 174 Orexin/Hypocretin receptor type 1 Homo sapiens 1.51 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604066&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430321 482596783 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281068 CCOc1ccc(C)nc1C(=O)N1C2CC(C2)[C@@H](C)C1CNc1nc2ccc(F)cc2s1 |r,wU:17.19,(-1.04,-5,;-2.37,-4.23,;-2.37,-2.69,;-3.71,-1.93,;-5.04,-2.69,;-6.37,-1.93,;-6.37,-.38,;-7.71,.38,;-5.04,.38,;-3.71,-.38,;-2.37,.38,;-1.04,-.38,;-2.37,1.93,;-3.71,2.69,;-3.71,4.23,;-2.37,5,;-2.37,3.47,;-1.04,4.23,;.29,5,;-1.04,2.69,;.29,1.93,;1.63,2.69,;2.96,1.93,;4.37,2.55,;5.4,1.41,;6.94,1.41,;7.71,.07,;6.94,-1.26,;7.71,-2.59,;5.4,-1.26,;4.63,.07,;3.12,.39,)| InChI=1S/C24H27FN4O2S/c1-4-31-20-8-5-13(2)27-22(20)23(30)29-17-9-15(10-17)14(3)19(29)12-26-24-28-18-7-6-16(25)11-21(18)32-24/h5-8,11,14-15,17,19H,4,9-10,12H2,1-3H3,(H,26,28) PETFZHTTWWEOOY-UHFFFAOYSA-N 604066 US11660293, Example 174 Orexin receptor type 2 Homo sapiens 87.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604066&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430321 482596783 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281069 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;8.38,-2.82,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C25H22FN7OS/c1-14-16-9-18(10-16)32(22(14)13-28-25-31-20-4-3-17(26)11-23(20)35-25)24(34)19-8-15(12-27)2-5-21(19)33-29-6-7-30-33/h2-8,11,14,16,18,22H,9-10,13H2,1H3,(H,28,31) MAZDSKJURDSEEG-UHFFFAOYSA-N 604067 US11660293, Example 175::US11660293, Example 177 Orexin/Hypocretin receptor type 1 Homo sapiens 3.89 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604067&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430322 482596784 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281070 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;8.38,-2.82,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C25H22FN7OS/c1-14-16-9-18(10-16)32(22(14)13-28-25-31-20-4-3-17(26)11-23(20)35-25)24(34)19-8-15(12-27)2-5-21(19)33-29-6-7-30-33/h2-8,11,14,16,18,22H,9-10,13H2,1H3,(H,28,31) MAZDSKJURDSEEG-UHFFFAOYSA-N 604067 US11660293, Example 175::US11660293, Example 177 Orexin receptor type 2 Homo sapiens 955 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604067&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430322 482596784 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281071 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;8.38,-2.82,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C25H22FN7OS/c1-14-16-9-18(10-16)32(22(14)13-28-25-31-20-4-3-17(26)11-23(20)35-25)24(34)19-8-15(12-27)2-5-21(19)33-29-6-7-30-33/h2-8,11,14,16,18,22H,9-10,13H2,1H3,(H,28,31) MAZDSKJURDSEEG-UHFFFAOYSA-N 604067 US11660293, Example 175::US11660293, Example 177 Orexin/Hypocretin receptor type 1 Homo sapiens 1.12 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604067&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430322 482596784 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281072 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;8.38,-2.82,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C25H22FN7OS/c1-14-16-9-18(10-16)32(22(14)13-28-25-31-20-4-3-17(26)11-23(20)35-25)24(34)19-8-15(12-27)2-5-21(19)33-29-6-7-30-33/h2-8,11,14,16,18,22H,9-10,13H2,1H3,(H,28,31) MAZDSKJURDSEEG-UHFFFAOYSA-N 604067 US11660293, Example 175::US11660293, Example 177 Orexin receptor type 2 Homo sapiens 347 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604067&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430322 482596784 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281073 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7OS/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) BXYGKHMCWKCMQG-UHFFFAOYSA-N 604069 US11660293, Example 178::US11660293, Example 180 Orexin/Hypocretin receptor type 1 Homo sapiens 3.02 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430323 482596785 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281074 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7OS/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) BXYGKHMCWKCMQG-UHFFFAOYSA-N 604069 US11660293, Example 178::US11660293, Example 180 Orexin receptor type 2 Homo sapiens 2344 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604069&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430323 482596785 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281075 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7OS/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) BXYGKHMCWKCMQG-UHFFFAOYSA-N 604069 US11660293, Example 178::US11660293, Example 180 Orexin/Hypocretin receptor type 1 Homo sapiens 1.66 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430323 482596785 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281076 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7OS/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) BXYGKHMCWKCMQG-UHFFFAOYSA-N 604069 US11660293, Example 178::US11660293, Example 180 Orexin receptor type 2 Homo sapiens 2630 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604069&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430323 482596785 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281077 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-5-18(33-29-7-8-30-33)21(31-13)22(34)32-17-9-15(10-17)14(2)19(32)12-28-20-6-4-16(11-27-20)23(24,25)26/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,27,28) RTDCZMCDRZTDKL-UHFFFAOYSA-N 604071 US11660293, Example 181::US11660293, Example 183 Orexin/Hypocretin receptor type 1 Homo sapiens 8.13 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604071&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430324 482596786 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281078 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-5-18(33-29-7-8-30-33)21(31-13)22(34)32-17-9-15(10-17)14(2)19(32)12-28-20-6-4-16(11-27-20)23(24,25)26/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,27,28) RTDCZMCDRZTDKL-UHFFFAOYSA-N 604071 US11660293, Example 181::US11660293, Example 183 Orexin receptor type 2 Homo sapiens 8128 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604071&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430324 482596786 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281079 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-5-18(33-29-7-8-30-33)21(31-13)22(34)32-17-9-15(10-17)14(2)19(32)12-28-20-6-4-16(11-27-20)23(24,25)26/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,27,28) RTDCZMCDRZTDKL-UHFFFAOYSA-N 604071 US11660293, Example 181::US11660293, Example 183 Orexin/Hypocretin receptor type 1 Homo sapiens 4.90 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604071&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430324 482596786 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281080 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-5-18(33-29-7-8-30-33)21(31-13)22(34)32-17-9-15(10-17)14(2)19(32)12-28-20-6-4-16(11-27-20)23(24,25)26/h3-8,11,14-15,17,19H,9-10,12H2,1-2H3,(H,27,28) RTDCZMCDRZTDKL-UHFFFAOYSA-N 604071 US11660293, Example 181::US11660293, Example 183 Orexin receptor type 2 Homo sapiens 5495 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604071&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430324 482596786 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281081 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H24N8OS/c1-13-5-6-18(31-26-8-9-27-31)20(28-13)22(32)30-16-10-15(11-16)14(2)19(30)12-25-23-29-17-4-3-7-24-21(17)33-23/h3-9,14-16,19H,10-12H2,1-2H3,(H,25,29) SFHUAJBMKRKKSN-UHFFFAOYSA-N 604073 US11660293, Example 184::US11660293, Example 186 Orexin/Hypocretin receptor type 1 Homo sapiens 8.32 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535436 482596787 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281082 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H24N8OS/c1-13-5-6-18(31-26-8-9-27-31)20(28-13)22(32)30-16-10-15(11-16)14(2)19(30)12-25-23-29-17-4-3-7-24-21(17)33-23/h3-9,14-16,19H,10-12H2,1-2H3,(H,25,29) SFHUAJBMKRKKSN-UHFFFAOYSA-N 604073 US11660293, Example 184::US11660293, Example 186 Orexin receptor type 2 Homo sapiens 8511 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604073&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535436 482596787 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281083 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H24N8OS/c1-13-5-6-18(31-26-8-9-27-31)20(28-13)22(32)30-16-10-15(11-16)14(2)19(30)12-25-23-29-17-4-3-7-24-21(17)33-23/h3-9,14-16,19H,10-12H2,1-2H3,(H,25,29) SFHUAJBMKRKKSN-UHFFFAOYSA-N 604073 US11660293, Example 184::US11660293, Example 186 Orexin/Hypocretin receptor type 1 Homo sapiens 3.80 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535436 482596787 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281084 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H24N8OS/c1-13-5-6-18(31-26-8-9-27-31)20(28-13)22(32)30-16-10-15(11-16)14(2)19(30)12-25-23-29-17-4-3-7-24-21(17)33-23/h3-9,14-16,19H,10-12H2,1-2H3,(H,25,29) SFHUAJBMKRKKSN-UHFFFAOYSA-N 604073 US11660293, Example 184::US11660293, Example 186 Orexin receptor type 2 Homo sapiens 4365 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604073 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604073&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535436 482596787 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281085 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;7.34,-2.15,;6,-2.92,;4.67,-2.15,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C25H24FN7O/c1-15-16-10-18(11-16)32(23(15)13-28-24-14-27-20-4-2-3-5-21(20)31-24)25(34)19-12-17(26)6-7-22(19)33-29-8-9-30-33/h2-9,12,14-16,18,23H,10-11,13H2,1H3,(H,28,31) ZWXCLWIEVDDPMT-UHFFFAOYSA-N 604075 US11660293, Example 187::US11660293, Example 189 Orexin/Hypocretin receptor type 1 Homo sapiens 6.46 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604075&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430325 482596788 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281086 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;7.34,-2.15,;6,-2.92,;4.67,-2.15,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C25H24FN7O/c1-15-16-10-18(11-16)32(23(15)13-28-24-14-27-20-4-2-3-5-21(20)31-24)25(34)19-12-17(26)6-7-22(19)33-29-8-9-30-33/h2-9,12,14-16,18,23H,10-11,13H2,1H3,(H,28,31) ZWXCLWIEVDDPMT-UHFFFAOYSA-N 604075 US11660293, Example 187::US11660293, Example 189 Orexin receptor type 2 Homo sapiens 2344 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604075&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430325 482596788 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281087 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;7.34,-2.15,;6,-2.92,;4.67,-2.15,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C25H24FN7O/c1-15-16-10-18(11-16)32(23(15)13-28-24-14-27-20-4-2-3-5-21(20)31-24)25(34)19-12-17(26)6-7-22(19)33-29-8-9-30-33/h2-9,12,14-16,18,23H,10-11,13H2,1H3,(H,28,31) ZWXCLWIEVDDPMT-UHFFFAOYSA-N 604075 US11660293, Example 187::US11660293, Example 189 Orexin/Hypocretin receptor type 1 Homo sapiens 3.09 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604075&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430325 482596788 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281088 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ccccc2n1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;7.34,-2.15,;6,-2.92,;4.67,-2.15,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C25H24FN7O/c1-15-16-10-18(11-16)32(23(15)13-28-24-14-27-20-4-2-3-5-21(20)31-24)25(34)19-12-17(26)6-7-22(19)33-29-8-9-30-33/h2-9,12,14-16,18,23H,10-11,13H2,1H3,(H,28,31) ZWXCLWIEVDDPMT-UHFFFAOYSA-N 604075 US11660293, Example 187::US11660293, Example 189 Orexin receptor type 2 Homo sapiens 1202 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604075 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604075&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430325 482596788 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281089 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H22F4N6O/c1-13-14-8-17(9-14)32(20(13)12-29-21-5-2-15(11-28-21)23(25,26)27)22(34)18-10-16(24)3-4-19(18)33-30-6-7-31-33/h2-7,10-11,13-14,17,20H,8-9,12H2,1H3,(H,28,29) OFDGTCNEGPULOP-UHFFFAOYSA-N 604077 US11660293, Example 190::US11660293, Example 192 Orexin/Hypocretin receptor type 1 Homo sapiens 15.8 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430326 482596789 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281090 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H22F4N6O/c1-13-14-8-17(9-14)32(20(13)12-29-21-5-2-15(11-28-21)23(25,26)27)22(34)18-10-16(24)3-4-19(18)33-30-6-7-31-33/h2-7,10-11,13-14,17,20H,8-9,12H2,1H3,(H,28,29) OFDGTCNEGPULOP-UHFFFAOYSA-N 604077 US11660293, Example 190::US11660293, Example 192 Orexin receptor type 2 Homo sapiens 10471 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604077&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430326 482596789 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281091 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H22F4N6O/c1-13-14-8-17(9-14)32(20(13)12-29-21-5-2-15(11-28-21)23(25,26)27)22(34)18-10-16(24)3-4-19(18)33-30-6-7-31-33/h2-7,10-11,13-14,17,20H,8-9,12H2,1H3,(H,28,29) OFDGTCNEGPULOP-UHFFFAOYSA-N 604077 US11660293, Example 190::US11660293, Example 192 Orexin/Hypocretin receptor type 1 Homo sapiens 7.41 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430326 482596789 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281092 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H22F4N6O/c1-13-14-8-17(9-14)32(20(13)12-29-21-5-2-15(11-28-21)23(25,26)27)22(34)18-10-16(24)3-4-19(18)33-30-6-7-31-33/h2-7,10-11,13-14,17,20H,8-9,12H2,1H3,(H,28,29) OFDGTCNEGPULOP-UHFFFAOYSA-N 604077 US11660293, Example 190::US11660293, Example 192 Orexin receptor type 2 Homo sapiens 6457 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604077 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604077&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430326 482596789 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281093 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-17(33-29-5-6-30-33)19(31-12)20(34)32-16-7-14(8-16)13(2)18(32)11-28-21-26-9-15(10-27-21)22(23,24)25/h3-6,9-10,13-14,16,18H,7-8,11H2,1-2H3,(H,26,27,28) XOKHIOKDAUXJMM-UHFFFAOYSA-N 604079 US11660293, Example 193::US11660293, Example 194 Orexin/Hypocretin receptor type 1 Homo sapiens 26.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604079&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430327 482596790 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281094 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-17(33-29-5-6-30-33)19(31-12)20(34)32-16-7-14(8-16)13(2)18(32)11-28-21-26-9-15(10-27-21)22(23,24)25/h3-6,9-10,13-14,16,18H,7-8,11H2,1-2H3,(H,26,27,28) XOKHIOKDAUXJMM-UHFFFAOYSA-N 604079 US11660293, Example 193::US11660293, Example 194 Orexin receptor type 2 Homo sapiens 22909 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604079&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430327 482596790 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281095 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-17(33-29-5-6-30-33)19(31-12)20(34)32-16-7-14(8-16)13(2)18(32)11-28-21-26-9-15(10-27-21)22(23,24)25/h3-6,9-10,13-14,16,18H,7-8,11H2,1-2H3,(H,26,27,28) XOKHIOKDAUXJMM-UHFFFAOYSA-N 604079 US11660293, Example 193::US11660293, Example 194 Orexin/Hypocretin receptor type 1 Homo sapiens 30.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604079&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430327 482596790 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281096 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-17(33-29-5-6-30-33)19(31-12)20(34)32-16-7-14(8-16)13(2)18(32)11-28-21-26-9-15(10-27-21)22(23,24)25/h3-6,9-10,13-14,16,18H,7-8,11H2,1-2H3,(H,26,27,28) XOKHIOKDAUXJMM-UHFFFAOYSA-N 604079 US11660293, Example 193::US11660293, Example 194 Orexin receptor type 2 Homo sapiens 21878 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604079 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604079&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430327 482596790 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281097 C[C@@H]1C2CC(C2)N(C1CNc1ccc(F)c(C)n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;7.34,2.47,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H26FN7O/c1-13-4-6-19(31-26-8-9-27-31)22(28-13)23(32)30-17-10-16(11-17)14(2)20(30)12-25-21-7-5-18(24)15(3)29-21/h4-9,14,16-17,20H,10-12H2,1-3H3,(H,25,29) FGHFLBHDQRBMPN-UHFFFAOYSA-N 604081 US11660293, Example 196 Orexin/Hypocretin receptor type 1 Homo sapiens 22.4 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604081&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535545 482596791 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281098 C[C@@H]1C2CC(C2)N(C1CNc1ccc(F)c(C)n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;7.34,2.47,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C23H26FN7O/c1-13-4-6-19(31-26-8-9-27-31)22(28-13)23(32)30-17-10-16(11-17)14(2)20(30)12-25-21-7-5-18(24)15(3)29-21/h4-9,14,16-17,20H,10-12H2,1-3H3,(H,25,29) FGHFLBHDQRBMPN-UHFFFAOYSA-N 604081 US11660293, Example 196 Orexin receptor type 2 Homo sapiens 1820 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604081 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604081&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535545 482596791 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281099 C[C@@H]1C2CC(C2)N(C1CNc1cccc(n1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.38,1.72,;4,2.47,;6.72,2.49,;8.05,3.26,;7.49,1.16,;5.95,3.83,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-6-7-17(33-28-8-9-29-33)21(30-13)22(34)32-16-10-15(11-16)14(2)18(32)12-27-20-5-3-4-19(31-20)23(24,25)26/h3-9,14-16,18H,10-12H2,1-2H3,(H,27,31) XIRXYZXSCAKNFI-UHFFFAOYSA-N 604082 US11660293, Example 197 Orexin/Hypocretin receptor type 1 Homo sapiens 102 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604082&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535548 482596792 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281100 C[C@@H]1C2CC(C2)N(C1CNc1cccc(n1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.38,1.72,;4,2.47,;6.72,2.49,;8.05,3.26,;7.49,1.16,;5.95,3.83,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-6-7-17(33-28-8-9-29-33)21(30-13)22(34)32-16-10-15(11-16)14(2)18(32)12-27-20-5-3-4-19(31-20)23(24,25)26/h3-9,14-16,18H,10-12H2,1-2H3,(H,27,31) XIRXYZXSCAKNFI-UHFFFAOYSA-N 604082 US11660293, Example 197 Orexin receptor type 2 Homo sapiens 1738 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604082 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604082&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535548 482596792 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281101 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H25FN8O/c1-14-3-6-21(34-29-7-8-30-34)24(31-14)25(35)33-18-9-16(10-18)15(2)22(33)12-28-23-13-27-20-11-17(26)4-5-19(20)32-23/h3-8,11,13,15-16,18,22H,9-10,12H2,1-2H3,(H,28,32) VLQWZGKNRDOEKJ-UHFFFAOYSA-N 604083 US11660293, Example 198::US11660293, Example 200 Orexin/Hypocretin receptor type 1 Homo sapiens 8.51 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604083&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430328 482596793 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281102 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H25FN8O/c1-14-3-6-21(34-29-7-8-30-34)24(31-14)25(35)33-18-9-16(10-18)15(2)22(33)12-28-23-13-27-20-11-17(26)4-5-19(20)32-23/h3-8,11,13,15-16,18,22H,9-10,12H2,1-2H3,(H,28,32) VLQWZGKNRDOEKJ-UHFFFAOYSA-N 604083 US11660293, Example 198::US11660293, Example 200 Orexin receptor type 2 Homo sapiens 537 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604083&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430328 482596793 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281103 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H25FN8O/c1-14-3-6-21(34-29-7-8-30-34)24(31-14)25(35)33-18-9-16(10-18)15(2)22(33)12-28-23-13-27-20-11-17(26)4-5-19(20)32-23/h3-8,11,13,15-16,18,22H,9-10,12H2,1-2H3,(H,28,32) VLQWZGKNRDOEKJ-UHFFFAOYSA-N 604083 US11660293, Example 198::US11660293, Example 200 Orexin/Hypocretin receptor type 1 Homo sapiens 5.75 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604083&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430328 482596793 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281104 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H25FN8O/c1-14-3-6-21(34-29-7-8-30-34)24(31-14)25(35)33-18-9-16(10-18)15(2)22(33)12-28-23-13-27-20-11-17(26)4-5-19(20)32-23/h3-8,11,13,15-16,18,22H,9-10,12H2,1-2H3,(H,28,32) VLQWZGKNRDOEKJ-UHFFFAOYSA-N 604083 US11660293, Example 198::US11660293, Example 200 Orexin receptor type 2 Homo sapiens 427 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604083 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604083&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430328 482596793 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281105 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)c(F)cc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;8.67,2.47,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H24F2N8O/c1-13-3-4-21(35-30-5-6-31-35)24(32-13)25(36)34-16-7-15(8-16)14(2)22(34)11-29-23-12-28-19-9-17(26)18(27)10-20(19)33-23/h3-6,9-10,12,14-16,22H,7-8,11H2,1-2H3,(H,29,33) AIZIWLKKNSNTLC-UHFFFAOYSA-N 604085 US11660293, Example 201 Orexin/Hypocretin receptor type 1 Homo sapiens 10.7 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604085&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430329 482596794 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281106 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)c(F)cc2n1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;8.67,2.47,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H24F2N8O/c1-13-3-4-21(35-30-5-6-31-35)24(32-13)25(36)34-16-7-15(8-16)14(2)22(34)11-29-23-12-28-19-9-17(26)18(27)10-20(19)33-23/h3-6,9-10,12,14-16,22H,7-8,11H2,1-2H3,(H,29,33) AIZIWLKKNSNTLC-UHFFFAOYSA-N 604085 US11660293, Example 201 Orexin receptor type 2 Homo sapiens 282 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604085 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604085&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430329 482596794 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281107 C[C@@H]1C2CC(C2)N(C1CNc1ccc(F)cc1)C(=O)c1cc(C)ccc1-c1nccs1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C25H26FN3OS/c1-15-3-8-21(24-27-9-10-31-24)22(11-15)25(30)29-20-12-17(13-20)16(2)23(29)14-28-19-6-4-18(26)5-7-19/h3-11,16-17,20,23,28H,12-14H2,1-2H3 PLKSPDHXDVJZOG-UHFFFAOYSA-N 604086 US11660293, Example 202 Orexin/Hypocretin receptor type 1 Homo sapiens 195 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604086&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535443 482596795 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281108 C[C@@H]1C2CC(C2)N(C1CNc1ccc(F)cc1)C(=O)c1cc(C)ccc1-c1nccs1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;4.67,2.47,;6,1.7,;6,.16,;7.34,-.61,;4.67,-.61,;3.33,.16,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-.59,-2.3,;.44,-3.44,;-.33,-4.78,;-1.84,-4.46,)| InChI=1S/C25H26FN3OS/c1-15-3-8-21(24-27-9-10-31-24)22(11-15)25(30)29-20-12-17(13-20)16(2)23(29)14-28-19-6-4-18(26)5-7-19/h3-11,16-17,20,23,28H,12-14H2,1-2H3 PLKSPDHXDVJZOG-UHFFFAOYSA-N 604086 US11660293, Example 202 Orexin receptor type 2 Homo sapiens 955 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604086 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604086&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535443 482596795 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281109 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) ONCMZNWPJLESBJ-UHFFFAOYSA-N 604087 US11660293, Example 203::US11660293, Example 205 Orexin/Hypocretin receptor type 1 Homo sapiens 6.76 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604087&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430330 482596796 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281110 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) ONCMZNWPJLESBJ-UHFFFAOYSA-N 604087 US11660293, Example 203::US11660293, Example 205 Orexin receptor type 2 Homo sapiens 8913 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604087&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430330 482596796 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281111 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) ONCMZNWPJLESBJ-UHFFFAOYSA-N 604087 US11660293, Example 203::US11660293, Example 205 Orexin/Hypocretin receptor type 1 Homo sapiens 2.57 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604087&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430330 482596796 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281112 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) ONCMZNWPJLESBJ-UHFFFAOYSA-N 604087 US11660293, Example 203::US11660293, Example 205 Orexin receptor type 2 Homo sapiens 4571 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604087 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604087&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430330 482596796 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281113 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ncccc2n1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C24H23ClN8O/c1-14-15-9-17(10-15)32(21(14)12-27-22-13-28-23-19(31-22)3-2-6-26-23)24(34)18-11-16(25)4-5-20(18)33-29-7-8-30-33/h2-8,11,13-15,17,21H,9-10,12H2,1H3,(H,27,31) YKQFJSDLTCOGOO-UHFFFAOYSA-N 604089 US11660293, Example 206 Orexin/Hypocretin receptor type 1 Homo sapiens 16.2 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604089&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430331 482596797 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281114 C[C@@H]1C2CC(C2)N(C1CNc1cnc2ncccc2n1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;6.67,-.61,;8,.16,;8,1.7,;6.67,2.47,;5.33,1.7,;4,2.47,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C24H23ClN8O/c1-14-15-9-17(10-15)32(21(14)12-27-22-13-28-23-19(31-22)3-2-6-26-23)24(34)18-11-16(25)4-5-20(18)33-29-7-8-30-33/h2-8,11,13-15,17,21H,9-10,12H2,1H3,(H,27,31) YKQFJSDLTCOGOO-UHFFFAOYSA-N 604089 US11660293, Example 206 Orexin receptor type 2 Homo sapiens 8710 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604089 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604089&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430331 482596797 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281115 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H23ClFN7O/c1-14-15-8-18(9-15)33(25(35)19-10-16(26)2-5-22(19)34-30-6-7-31-34)23(14)12-29-24-13-28-21-11-17(27)3-4-20(21)32-24/h2-7,10-11,13-15,18,23H,8-9,12H2,1H3,(H,29,32) XSAGNRRAVSAHPQ-UHFFFAOYSA-N 604090 US11660293, Example 207::US11660293, Example 209 Orexin/Hypocretin receptor type 1 Homo sapiens 3.47 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604090&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430332 482596798 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281116 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H23ClFN7O/c1-14-15-8-18(9-15)33(25(35)19-10-16(26)2-5-22(19)34-30-6-7-31-34)23(14)12-29-24-13-28-21-11-17(27)3-4-20(21)32-24/h2-7,10-11,13-15,18,23H,8-9,12H2,1H3,(H,29,32) XSAGNRRAVSAHPQ-UHFFFAOYSA-N 604090 US11660293, Example 207::US11660293, Example 209 Orexin receptor type 2 Homo sapiens 363 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604090&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430332 482596798 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281117 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H23ClFN7O/c1-14-15-8-18(9-15)33(25(35)19-10-16(26)2-5-22(19)34-30-6-7-31-34)23(14)12-29-24-13-28-21-11-17(27)3-4-20(21)32-24/h2-7,10-11,13-15,18,23H,8-9,12H2,1H3,(H,29,32) XSAGNRRAVSAHPQ-UHFFFAOYSA-N 604090 US11660293, Example 207::US11660293, Example 209 Orexin/Hypocretin receptor type 1 Homo sapiens 1.82 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604090&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430332 482596798 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281118 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H23ClFN7O/c1-14-15-8-18(9-15)33(25(35)19-10-16(26)2-5-22(19)34-30-6-7-31-34)23(14)12-29-24-13-28-21-11-17(27)3-4-20(21)32-24/h2-7,10-11,13-15,18,23H,8-9,12H2,1H3,(H,29,32) XSAGNRRAVSAHPQ-UHFFFAOYSA-N 604090 US11660293, Example 207::US11660293, Example 209 Orexin receptor type 2 Homo sapiens 158 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604090 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604090&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430332 482596798 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281119 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ccccc1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C25H26F3N5O/c1-15-17-10-19(11-17)33(21(15)13-30-22-9-8-18(12-29-22)25(26,27)28)24(34)23-20(14-32(2)31-23)16-6-4-3-5-7-16/h3-9,12,14-15,17,19,21H,10-11,13H2,1-2H3,(H,29,30) PVUUFIVOJFEQPA-UHFFFAOYSA-N 604092 US11660293, Example 210::US11660293, Example 211 Orexin/Hypocretin receptor type 1 Homo sapiens 2.04 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604092&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430333 482596799 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281120 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ccccc1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C25H26F3N5O/c1-15-17-10-19(11-17)33(21(15)13-30-22-9-8-18(12-29-22)25(26,27)28)24(34)23-20(14-32(2)31-23)16-6-4-3-5-7-16/h3-9,12,14-15,17,19,21H,10-11,13H2,1-2H3,(H,29,30) PVUUFIVOJFEQPA-UHFFFAOYSA-N 604092 US11660293, Example 210::US11660293, Example 211 Orexin receptor type 2 Homo sapiens 1445 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604092&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430333 482596799 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281121 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ccccc1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C25H26F3N5O/c1-15-17-10-19(11-17)33(21(15)13-30-22-9-8-18(12-29-22)25(26,27)28)24(34)23-20(14-32(2)31-23)16-6-4-3-5-7-16/h3-9,12,14-15,17,19,21H,10-11,13H2,1-2H3,(H,29,30) PVUUFIVOJFEQPA-UHFFFAOYSA-N 604092 US11660293, Example 210::US11660293, Example 211 Orexin/Hypocretin receptor type 1 Homo sapiens 1.23 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604092&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430333 482596799 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281122 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ccccc1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C25H26F3N5O/c1-15-17-10-19(11-17)33(21(15)13-30-22-9-8-18(12-29-22)25(26,27)28)24(34)23-20(14-32(2)31-23)16-6-4-3-5-7-16/h3-9,12,14-15,17,19,21H,10-11,13H2,1-2H3,(H,29,30) PVUUFIVOJFEQPA-UHFFFAOYSA-N 604092 US11660293, Example 210::US11660293, Example 211 Orexin receptor type 2 Homo sapiens 562 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604092 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604092&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430333 482596799 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281123 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ncccn1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C23H24F3N7O/c1-13-14-8-16(9-14)33(18(13)11-30-19-5-4-15(10-29-19)23(24,25)26)22(34)20-17(12-32(2)31-20)21-27-6-3-7-28-21/h3-7,10,12-14,16,18H,8-9,11H2,1-2H3,(H,29,30) CWNJZWYXKRZRGD-UHFFFAOYSA-N 604094 US11660293, Example 213::US11660293, Example 215 Orexin/Hypocretin receptor type 1 Homo sapiens 12.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604094&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430334 482596800 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281124 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ncccn1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C23H24F3N7O/c1-13-14-8-16(9-14)33(18(13)11-30-19-5-4-15(10-29-19)23(24,25)26)22(34)20-17(12-32(2)31-20)21-27-6-3-7-28-21/h3-7,10,12-14,16,18H,8-9,11H2,1-2H3,(H,29,30) CWNJZWYXKRZRGD-UHFFFAOYSA-N 604094 US11660293, Example 213::US11660293, Example 215 Orexin receptor type 2 Homo sapiens 40738 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604094&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430334 482596800 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281125 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ncccn1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C23H24F3N7O/c1-13-14-8-16(9-14)33(18(13)11-30-19-5-4-15(10-29-19)23(24,25)26)22(34)20-17(12-32(2)31-20)21-27-6-3-7-28-21/h3-7,10,12-14,16,18H,8-9,11H2,1-2H3,(H,29,30) CWNJZWYXKRZRGD-UHFFFAOYSA-N 604094 US11660293, Example 213::US11660293, Example 215 Orexin/Hypocretin receptor type 1 Homo sapiens 7.08 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604094&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430334 482596800 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281126 C[C@@H]1C2CC(C2)N(C1CNc1ccc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ncccn1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C23H24F3N7O/c1-13-14-8-16(9-14)33(18(13)11-30-19-5-4-15(10-29-19)23(24,25)26)22(34)20-17(12-32(2)31-20)21-27-6-3-7-28-21/h3-7,10,12-14,16,18H,8-9,11H2,1-2H3,(H,29,30) CWNJZWYXKRZRGD-UHFFFAOYSA-N 604094 US11660293, Example 213::US11660293, Example 215 Orexin receptor type 2 Homo sapiens 16218 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604094 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604094&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430334 482596800 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281127 C[C@@H]1C2CC(C2)N(C1CNc1cnc(C)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H26N8O/c1-13-4-5-18(30-26-6-7-27-30)21(28-13)22(31)29-17-8-16(9-17)15(3)19(29)11-25-20-12-23-14(2)10-24-20/h4-7,10,12,15-17,19H,8-9,11H2,1-3H3,(H,24,25) RWTAIGGWMMMNKA-UHFFFAOYSA-N 604096 US11660293, Example 216 Orexin/Hypocretin receptor type 1 Homo sapiens 115 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604096&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430335 482596801 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281128 C[C@@H]1C2CC(C2)N(C1CNc1cnc(C)cn1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6,.16,;7.34,-.61,;6,1.7,;4.67,2.47,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-7.34,.16,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,)| InChI=1S/C22H26N8O/c1-13-4-5-18(30-26-6-7-27-30)21(28-13)22(31)29-17-8-16(9-17)15(3)19(29)11-25-20-12-23-14(2)10-24-20/h4-7,10,12,15-17,19H,8-9,11H2,1-3H3,(H,24,25) RWTAIGGWMMMNKA-UHFFFAOYSA-N 604096 US11660293, Example 216 Orexin receptor type 2 Homo sapiens 23988 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604096 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604096&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430335 482596801 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281129 C[C@@H]1C2CC(C2)N(C1CNc1cncc(n1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,2.47,;8,1.7,;6.67,4.01,;8,3.24,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-28-5-6-29-33)20(30-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-10-18(31-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,31) YGZRZGVMRZPQPJ-UHFFFAOYSA-N 604097 US11660293, Example 217 Orexin/Hypocretin receptor type 1 Homo sapiens 141 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604097&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430336 482596802 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281130 C[C@@H]1C2CC(C2)N(C1CNc1cncc(n1)C(F)(F)F)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,2.47,;8,1.7,;6.67,4.01,;8,3.24,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H23F3N8O/c1-12-3-4-16(33-28-5-6-29-33)20(30-12)21(34)32-15-7-14(8-15)13(2)17(32)9-27-19-11-26-10-18(31-19)22(23,24)25/h3-6,10-11,13-15,17H,7-9H2,1-2H3,(H,27,31) YGZRZGVMRZPQPJ-UHFFFAOYSA-N 604097 US11660293, Example 217 Orexin receptor type 2 Homo sapiens 5129 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604097 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604097&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430336 482596802 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281131 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H24FN7O2/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) XETBBGOCSCXSPO-UHFFFAOYSA-N 604098 US11660293, Example 218::US11660293, Example 219 Orexin/Hypocretin receptor type 1 Homo sapiens 4.68 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604098&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 142536158 482596803 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281132 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H24FN7O2/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) XETBBGOCSCXSPO-UHFFFAOYSA-N 604098 US11660293, Example 218::US11660293, Example 219 Orexin receptor type 2 Homo sapiens 3388 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604098&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 142536158 482596803 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281133 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H24FN7O2/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) XETBBGOCSCXSPO-UHFFFAOYSA-N 604098 US11660293, Example 218::US11660293, Example 219 Orexin/Hypocretin receptor type 1 Homo sapiens 1.95 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604098&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 142536158 482596803 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281134 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccc(F)cc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;7.71,-2.82,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H24FN7O2/c1-13-3-6-19(32-27-7-8-28-32)22(29-13)23(33)31-17-9-15(10-17)14(2)20(31)12-26-24-30-18-5-4-16(25)11-21(18)34-24/h3-8,11,14-15,17,20H,9-10,12H2,1-2H3,(H,26,30) XETBBGOCSCXSPO-UHFFFAOYSA-N 604098 US11660293, Example 218::US11660293, Example 219 Orexin receptor type 2 Homo sapiens 1622 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604098 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604098&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 142536158 482596803 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281135 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) JWTIQXQFNALGKT-UHFFFAOYSA-N 604100 US11660293, Example 221::US11660293, Example 223 Orexin/Hypocretin receptor type 1 Homo sapiens 18.6 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604100&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430337 482596804 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281136 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) JWTIQXQFNALGKT-UHFFFAOYSA-N 604100 US11660293, Example 221::US11660293, Example 223 Orexin receptor type 2 Homo sapiens 11482 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604100&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430337 482596804 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281137 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) JWTIQXQFNALGKT-UHFFFAOYSA-N 604100 US11660293, Example 221::US11660293, Example 223 Orexin/Hypocretin receptor type 1 Homo sapiens 7.41 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604100&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430337 482596804 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281138 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-8-14(23)2-3-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) JWTIQXQFNALGKT-UHFFFAOYSA-N 604100 US11660293, Example 221::US11660293, Example 223 Orexin receptor type 2 Homo sapiens 10471 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604100 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604100&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430337 482596804 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281139 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H23F2N7O/c1-14-15-8-18(9-15)33(25(35)19-10-16(26)3-5-22(19)34-30-6-7-31-34)23(14)12-29-24-13-28-21-11-17(27)2-4-20(21)32-24/h2-7,10-11,13-15,18,23H,8-9,12H2,1H3,(H,29,32) QEYPCCFYSUAXOI-UHFFFAOYSA-N 604102 US11660293, Example 224 Orexin/Hypocretin receptor type 1 Homo sapiens 9.12 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604102&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430338 482596805 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281140 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(-.67,4.78,;-2,4.01,;-3.33,4.78,;-4.67,4.01,;-4.67,2.47,;-3.33,3.24,;-3.33,1.7,;-2,2.47,;-.67,1.7,;.67,2.47,;2,1.7,;2,.16,;3.33,-.61,;4.67,.16,;6,-.61,;7.34,.16,;8.67,-.61,;7.34,1.7,;6,2.47,;4.67,1.7,;3.33,2.47,;-3.33,.16,;-2,-.61,;-4.67,-.61,;-6,.16,;-7.34,-.61,;-8.67,.16,;-7.34,-2.15,;-6,-2.92,;-4.67,-2.15,;-3.33,-2.92,;-3.17,-4.46,;-1.67,-4.78,;-.9,-3.44,;-1.93,-2.3,)| InChI=1S/C25H23F2N7O/c1-14-15-8-18(9-15)33(25(35)19-10-16(26)3-5-22(19)34-30-6-7-31-34)23(14)12-29-24-13-28-21-11-17(27)2-4-20(21)32-24/h2-7,10-11,13-15,18,23H,8-9,12H2,1H3,(H,29,32) QEYPCCFYSUAXOI-UHFFFAOYSA-N 604102 US11660293, Example 224 Orexin receptor type 2 Homo sapiens 646 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604102 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604102&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430338 482596805 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281141 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7O2/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) JJMZXMYATFUCMU-UHFFFAOYSA-N 604103 US11660293, Example 225::US11660293, Example 226::US11660293, Example 227 Orexin/Hypocretin receptor type 1 Homo sapiens 4.79 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604103&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430339 482596806 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281142 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7O2/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) JJMZXMYATFUCMU-UHFFFAOYSA-N 604103 US11660293, Example 225::US11660293, Example 226::US11660293, Example 227 Orexin receptor type 2 Homo sapiens 6026 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604103&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430339 482596806 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281143 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7O2/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) JJMZXMYATFUCMU-UHFFFAOYSA-N 604103 US11660293, Example 225::US11660293, Example 226::US11660293, Example 227 Orexin/Hypocretin receptor type 1 Homo sapiens 3.47 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604103&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430339 482596806 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281144 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7O2/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) JJMZXMYATFUCMU-UHFFFAOYSA-N 604103 US11660293, Example 225::US11660293, Example 226::US11660293, Example 227 Orexin receptor type 2 Homo sapiens 4074 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604103&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430339 482596806 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281145 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7O2/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) JJMZXMYATFUCMU-UHFFFAOYSA-N 604103 US11660293, Example 225::US11660293, Example 226::US11660293, Example 227 Orexin/Hypocretin receptor type 1 Homo sapiens 77.6 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604103&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430339 482596806 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281146 C[C@@H]1C2CC(C2)N(C1CNc1nc2ccccc2o1)C(=O)c1nc(C)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C24H25N7O2/c1-14-7-8-19(31-26-9-10-27-31)22(28-14)23(32)30-17-11-16(12-17)15(2)20(30)13-25-24-29-18-5-3-4-6-21(18)33-24/h3-10,15-17,20H,11-13H2,1-2H3,(H,25,29) JJMZXMYATFUCMU-UHFFFAOYSA-N 604103 US11660293, Example 225::US11660293, Example 226::US11660293, Example 227 Orexin receptor type 2 Homo sapiens 12589 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604103 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604103&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430339 482596806 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281147 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22FN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) HKAGYMNYTHTKJC-UHFFFAOYSA-N 604111 US11660293, Example 228::US11660293, Example 230 Orexin/Hypocretin receptor type 1 Homo sapiens 11.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604111&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430340 482596812 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281148 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22FN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) HKAGYMNYTHTKJC-UHFFFAOYSA-N 604111 US11660293, Example 228::US11660293, Example 230 Orexin receptor type 2 Homo sapiens 9120 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604111&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430340 482596812 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281149 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22FN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) HKAGYMNYTHTKJC-UHFFFAOYSA-N 604111 US11660293, Example 228::US11660293, Example 230 Orexin/Hypocretin receptor type 1 Homo sapiens 3.47 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604111&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430340 482596812 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281150 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22FN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) HKAGYMNYTHTKJC-UHFFFAOYSA-N 604111 US11660293, Example 228::US11660293, Example 230 Orexin receptor type 2 Homo sapiens 4786 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604111 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604111&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430340 482596812 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281151 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C24H22N8OS/c1-14-16-10-17(11-16)31(21(14)13-27-24-30-19-3-2-6-26-22(19)34-24)23(33)18-9-15(12-25)4-5-20(18)32-28-7-8-29-32/h2-9,14,16-17,21H,10-11,13H2,1H3,(H,27,30) IBFMPAYSGLIJHV-UHFFFAOYSA-N 604113 US11660293, Example 231::US11660293, Example 233 Orexin/Hypocretin receptor type 1 Homo sapiens 6.31 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604113&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535453 482596813 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281152 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C24H22N8OS/c1-14-16-10-17(11-16)31(21(14)13-27-24-30-19-3-2-6-26-22(19)34-24)23(33)18-9-15(12-25)4-5-20(18)32-28-7-8-29-32/h2-9,14,16-17,21H,10-11,13H2,1H3,(H,27,30) IBFMPAYSGLIJHV-UHFFFAOYSA-N 604113 US11660293, Example 231::US11660293, Example 233 Orexin receptor type 2 Homo sapiens 6166 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604113&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535453 482596813 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281153 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C24H22N8OS/c1-14-16-10-17(11-16)31(21(14)13-27-24-30-19-3-2-6-26-22(19)34-24)23(33)18-9-15(12-25)4-5-20(18)32-28-7-8-29-32/h2-9,14,16-17,21H,10-11,13H2,1H3,(H,27,30) IBFMPAYSGLIJHV-UHFFFAOYSA-N 604113 US11660293, Example 231::US11660293, Example 233 Orexin/Hypocretin receptor type 1 Homo sapiens 3.89 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604113&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535453 482596813 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281154 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.96,4.78,;-.37,4.01,;-1.71,4.78,;-3.04,4.01,;-3.04,2.47,;-1.71,3.24,;-1.71,1.7,;-.37,2.47,;.96,1.7,;2.29,2.47,;3.63,1.7,;5.03,2.32,;6.07,1.18,;7.61,1.18,;8.38,-.16,;7.61,-1.49,;6.07,-1.49,;5.3,-.16,;3.79,.16,;-1.71,.16,;-.37,-.61,;-3.04,-.61,;-4.37,.16,;-5.71,-.61,;-5.71,-2.15,;-4.37,-2.92,;-3.04,-2.15,;-1.71,-2.92,;-1.55,-4.46,;-.04,-4.78,;.73,-3.44,;-.3,-2.3,;-7.04,.16,;-8.38,.93,)| InChI=1S/C24H22N8OS/c1-14-16-10-17(11-16)31(21(14)13-27-24-30-19-3-2-6-26-22(19)34-24)23(33)18-9-15(12-25)4-5-20(18)32-28-7-8-29-32/h2-9,14,16-17,21H,10-11,13H2,1H3,(H,27,30) IBFMPAYSGLIJHV-UHFFFAOYSA-N 604113 US11660293, Example 231::US11660293, Example 233 Orexin receptor type 2 Homo sapiens 7762 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604113 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604113&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535453 482596813 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281155 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) XQFATZNGJMGSDJ-UHFFFAOYSA-N 604115 US11660293, Example 234::US11660293, Example 236 Orexin/Hypocretin receptor type 1 Homo sapiens 3.55 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604115&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535435 482596814 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281156 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) XQFATZNGJMGSDJ-UHFFFAOYSA-N 604115 US11660293, Example 234::US11660293, Example 236 Orexin receptor type 2 Homo sapiens 3467 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604115&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535435 482596814 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281157 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) XQFATZNGJMGSDJ-UHFFFAOYSA-N 604115 US11660293, Example 234::US11660293, Example 236 Orexin/Hypocretin receptor type 1 Homo sapiens 1.02 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604115&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535435 482596814 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281158 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2s1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7OS/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) XQFATZNGJMGSDJ-UHFFFAOYSA-N 604115 US11660293, Example 234::US11660293, Example 236 Orexin receptor type 2 Homo sapiens 1995 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604115 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604115&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535435 482596814 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281159 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6.05,.13,;6,1.7,;4.67,2.47,;7.38,-.64,;8.72,-1.41,;6.61,-1.98,;8.15,.69,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,;-7.34,.16,;-8.67,.93,)| InChI=1S/C23H21F3N8O/c1-13-15-7-16(8-15)33(19(13)10-29-21-12-28-20(11-30-21)23(24,25)26)22(35)17-6-14(9-27)2-3-18(17)34-31-4-5-32-34/h2-6,11-13,15-16,19H,7-8,10H2,1H3,(H,29,30) HDUARAMMZBSVJV-UHFFFAOYSA-N 604117 US11660293, Example 237 Orexin/Hypocretin receptor type 1 Homo sapiens 46.8 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604117&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430341 482596815 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281160 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(.67,4.78,;-.67,4.01,;-2,4.78,;-3.33,4.01,;-3.33,2.47,;-2,3.24,;-2,1.7,;-.67,2.47,;.67,1.7,;2,2.47,;3.33,1.7,;3.33,.16,;4.67,-.61,;6.05,.13,;6,1.7,;4.67,2.47,;7.38,-.64,;8.72,-1.41,;6.61,-1.98,;8.15,.69,;-2,.16,;-.67,-.61,;-3.33,-.61,;-4.67,.16,;-6,-.61,;-6,-2.15,;-4.67,-2.92,;-3.33,-2.15,;-2,-2.92,;-1.84,-4.46,;-.33,-4.78,;.44,-3.44,;-.59,-2.3,;-7.34,.16,;-8.67,.93,)| InChI=1S/C23H21F3N8O/c1-13-15-7-16(8-15)33(19(13)10-29-21-12-28-20(11-30-21)23(24,25)26)22(35)17-6-14(9-27)2-3-18(17)34-31-4-5-32-34/h2-6,11-13,15-16,19H,7-8,10H2,1H3,(H,29,30) HDUARAMMZBSVJV-UHFFFAOYSA-N 604117 US11660293, Example 237 Orexin receptor type 2 Homo sapiens 15136 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604117 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604117&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430341 482596815 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281161 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(,4.58,;-1.33,3.81,;-2.67,4.58,;-4,3.81,;-4,2.27,;-2.67,3.04,;-2.67,1.5,;-1.33,2.27,;,1.5,;1.33,2.27,;2.67,1.5,;2.67,-.04,;4,-.81,;5.33,-.04,;6.67,-.81,;8,-.04,;9.34,-.81,;8,1.5,;6.67,2.27,;5.33,1.5,;4,2.27,;-2.67,-.04,;-1.33,-.81,;-4,-.81,;-5.33,-.04,;-6.67,-.81,;-6.67,-2.35,;-5.33,-3.12,;-4,-2.35,;-2.67,-3.12,;-2.19,-4.58,;-.65,-4.58,;-.18,-3.12,;-1.42,-2.21,;-8,-.04,;-9.34,.73,)| InChI=1S/C26H23FN8O/c1-15-17-9-19(10-17)34(24(15)13-30-25-14-29-22-11-18(27)3-4-21(22)33-25)26(36)20-8-16(12-28)2-5-23(20)35-31-6-7-32-35/h2-8,11,14-15,17,19,24H,9-10,13H2,1H3,(H,30,33) UUOYRPQQMIDDSR-UHFFFAOYSA-N 604118 US11660293, Example 238 Orexin/Hypocretin receptor type 1 Homo sapiens 10.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604118&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430342 482596816 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281162 C[C@@H]1C2CC(C2)N(C1CNc1cnc2cc(F)ccc2n1)C(=O)c1cc(ccc1-n1nccn1)C#N |r,wU:1.0,(,4.58,;-1.33,3.81,;-2.67,4.58,;-4,3.81,;-4,2.27,;-2.67,3.04,;-2.67,1.5,;-1.33,2.27,;,1.5,;1.33,2.27,;2.67,1.5,;2.67,-.04,;4,-.81,;5.33,-.04,;6.67,-.81,;8,-.04,;9.34,-.81,;8,1.5,;6.67,2.27,;5.33,1.5,;4,2.27,;-2.67,-.04,;-1.33,-.81,;-4,-.81,;-5.33,-.04,;-6.67,-.81,;-6.67,-2.35,;-5.33,-3.12,;-4,-2.35,;-2.67,-3.12,;-2.19,-4.58,;-.65,-4.58,;-.18,-3.12,;-1.42,-2.21,;-8,-.04,;-9.34,.73,)| InChI=1S/C26H23FN8O/c1-15-17-9-19(10-17)34(24(15)13-30-25-14-29-22-11-18(27)3-4-21(22)33-25)26(36)20-8-16(12-28)2-5-23(20)35-31-6-7-32-35/h2-8,11,14-15,17,19,24H,9-10,13H2,1H3,(H,30,33) UUOYRPQQMIDDSR-UHFFFAOYSA-N 604118 US11660293, Example 238 Orexin receptor type 2 Homo sapiens 479 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604118 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604118&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430342 482596816 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281163 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;4,2.47,;5.33,1.7,;5.33,.16,;4,-.61,;2.67,.16,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-16(7-13)32(19(12)11-29-21-27-9-14(10-28-21)22(24,25)26)20(34)17-8-15(23)2-3-18(17)33-30-4-5-31-33/h2-5,8-10,12-13,16,19H,6-7,11H2,1H3,(H,27,28,29) IRLHCQBYCXQBOZ-UHFFFAOYSA-N 604119 US11660293, Example 239::US11660293, Example 241 Orexin/Hypocretin receptor type 1 Homo sapiens 9.12 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604119&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 162611863 482596817 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281164 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;4,2.47,;5.33,1.7,;5.33,.16,;4,-.61,;2.67,.16,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-16(7-13)32(19(12)11-29-21-27-9-14(10-28-21)22(24,25)26)20(34)17-8-15(23)2-3-18(17)33-30-4-5-31-33/h2-5,8-10,12-13,16,19H,6-7,11H2,1H3,(H,27,28,29) IRLHCQBYCXQBOZ-UHFFFAOYSA-N 604119 US11660293, Example 239::US11660293, Example 241 Orexin receptor type 2 Homo sapiens 3090 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604119&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 162611863 482596817 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281165 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;4,2.47,;5.33,1.7,;5.33,.16,;4,-.61,;2.67,.16,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-16(7-13)32(19(12)11-29-21-27-9-14(10-28-21)22(24,25)26)20(34)17-8-15(23)2-3-18(17)33-30-4-5-31-33/h2-5,8-10,12-13,16,19H,6-7,11H2,1H3,(H,27,28,29) IRLHCQBYCXQBOZ-UHFFFAOYSA-N 604119 US11660293, Example 239::US11660293, Example 241 Orexin/Hypocretin receptor type 1 Homo sapiens 5.37 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604119&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 162611863 482596817 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281166 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;4,2.47,;5.33,1.7,;5.33,.16,;4,-.61,;2.67,.16,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-16(7-13)32(19(12)11-29-21-27-9-14(10-28-21)22(24,25)26)20(34)17-8-15(23)2-3-18(17)33-30-4-5-31-33/h2-5,8-10,12-13,16,19H,6-7,11H2,1H3,(H,27,28,29) IRLHCQBYCXQBOZ-UHFFFAOYSA-N 604119 US11660293, Example 239::US11660293, Example 241 Orexin receptor type 2 Homo sapiens 2570 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604119 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604119&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 162611863 482596817 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281167 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2o1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7O2/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) UBJKDORBCILXHJ-UHFFFAOYSA-N 604121 US11660293, Example 242::US11660293, Example 244 Orexin/Hypocretin receptor type 1 Homo sapiens 7.94 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604121&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535556 482596818 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281168 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2o1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7O2/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) UBJKDORBCILXHJ-UHFFFAOYSA-N 604121 US11660293, Example 242::US11660293, Example 244 Orexin receptor type 2 Homo sapiens 7244 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604121&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535556 482596818 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281169 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2o1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7O2/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) UBJKDORBCILXHJ-UHFFFAOYSA-N 604121 US11660293, Example 242::US11660293, Example 244 Orexin/Hypocretin receptor type 1 Homo sapiens 5.62 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604121&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535556 482596818 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281170 C[C@@H]1C2CC(C2)N(C1CNc1nc2cccnc2o1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(.29,4.78,;-1.04,4.01,;-2.37,4.78,;-3.71,4.01,;-3.71,2.47,;-2.37,3.24,;-2.37,1.7,;-1.04,2.47,;.29,1.7,;1.63,2.47,;2.96,1.7,;4.37,2.32,;5.4,1.18,;6.94,1.18,;7.71,-.16,;6.94,-1.49,;5.4,-1.49,;4.63,-.16,;3.12,.16,;-2.37,.16,;-1.04,-.61,;-3.71,-.61,;-5.04,.16,;-6.37,-.61,;-7.71,.16,;-6.37,-2.15,;-5.04,-2.92,;-3.71,-2.15,;-2.37,-2.92,;-2.21,-4.46,;-.71,-4.78,;.06,-3.44,;-.97,-2.3,)| InChI=1S/C23H22ClN7O2/c1-13-14-9-16(10-14)30(20(13)12-26-23-29-18-3-2-6-25-21(18)33-23)22(32)17-11-15(24)4-5-19(17)31-27-7-8-28-31/h2-8,11,13-14,16,20H,9-10,12H2,1H3,(H,26,29) UBJKDORBCILXHJ-UHFFFAOYSA-N 604121 US11660293, Example 242::US11660293, Example 244 Orexin receptor type 2 Homo sapiens 6607 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604121 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604121&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535556 482596818 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281171 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ncccn1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C22H23F3N8O/c1-12-13-6-14(7-13)33(16(12)8-29-18-10-28-17(9-30-18)22(23,24)25)21(34)19-15(11-32(2)31-19)20-26-4-3-5-27-20/h3-5,9-14,16H,6-8H2,1-2H3,(H,29,30) BGFPQGUIERWUCU-UHFFFAOYSA-N 604123 US11660293, Example 245 Orexin/Hypocretin receptor type 1 Homo sapiens 28.2 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604123&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 166003564 482596819 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281172 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nn(C)cc1-c1ncccn1 |r,wU:1.0,(-.01,5.26,;-1.34,4.49,;-2.68,5.26,;-4.01,4.49,;-4.01,2.95,;-2.68,3.72,;-2.68,2.18,;-1.34,2.95,;-.01,2.18,;1.32,2.95,;2.66,2.18,;2.66,.64,;3.99,-.13,;5.32,.64,;5.32,2.18,;3.99,2.95,;6.66,-.13,;7.99,.64,;6.66,-1.67,;7.99,-.9,;-2.68,.64,;-1.34,-.13,;-4.01,-.13,;-5.26,.78,;-6.5,-.13,;-7.99,.27,;-6.03,-1.59,;-4.49,-1.59,;-3.4,-2.68,;-1.91,-2.28,;-.82,-3.37,;-1.22,-4.86,;-2.71,-5.26,;-3.8,-4.17,)| InChI=1S/C22H23F3N8O/c1-12-13-6-14(7-13)33(16(12)8-29-18-10-28-17(9-30-18)22(23,24)25)21(34)19-15(11-32(2)31-19)20-26-4-3-5-27-20/h3-5,9-14,16H,6-8H2,1-2H3,(H,29,30) BGFPQGUIERWUCU-UHFFFAOYSA-N 604123 US11660293, Example 245 Orexin receptor type 2 Homo sapiens 32359 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604123 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604123&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 166003564 482596819 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281173 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1ccc(Cl)cc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-6.67,-2.15,;-8,-2.92,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-3-2-14(23)8-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) RNVBABPZYDUBNY-UHFFFAOYSA-N 604124 US11660293, Example 246 Orexin/Hypocretin receptor type 1 Homo sapiens 26.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604124&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535558 482596820 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281174 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1ccc(Cl)cc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.33,.16,;5.33,1.7,;4,2.47,;6.67,-.61,;8,.16,;6.67,-2.15,;8,-1.38,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-6.67,-2.15,;-8,-2.92,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-3-2-14(23)8-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) RNVBABPZYDUBNY-UHFFFAOYSA-N 604124 US11660293, Example 246 Orexin receptor type 2 Homo sapiens 2455 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604124 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604124&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535558 482596820 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281175 C[C@@H]1C2CC(C2)N(C1CNc1ccc(nn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-8-15(9-13)32(18(12)11-27-20-5-4-19(30-31-20)22(24,25)26)21(34)16-10-14(23)2-3-17(16)33-28-6-7-29-33/h2-7,10,12-13,15,18H,8-9,11H2,1H3,(H,27,31) YSJQMDOLIZZEAI-UHFFFAOYSA-N 604125 US11660293, Example 247 Orexin/Hypocretin receptor type 1 Homo sapiens 182 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604125&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430343 482596821 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281176 C[C@@H]1C2CC(C2)N(C1CNc1ccc(nn1)C(F)(F)F)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21ClF3N7O/c1-12-13-8-15(9-13)32(18(12)11-27-20-5-4-19(30-31-20)22(24,25)26)21(34)16-10-14(23)2-3-17(16)33-28-6-7-29-33/h2-7,10,12-13,15,18H,8-9,11H2,1H3,(H,27,31) YSJQMDOLIZZEAI-UHFFFAOYSA-N 604125 US11660293, Example 247 Orexin receptor type 2 Homo sapiens 13183 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604125 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604125&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430343 482596821 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281177 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,(,5,;-1.33,4.23,;-2.67,5,;-4,4.23,;-4,2.69,;-2.67,3.46,;-2.67,1.92,;-1.33,2.69,;,1.92,;1.33,2.69,;2.67,1.93,;2.67,.38,;4,-.38,;5.38,.36,;5.33,1.93,;4,2.7,;6.72,-.41,;8.05,-1.18,;5.95,-1.75,;7.49,.92,;-2.67,.38,;-1.33,-.39,;-4,-.39,;-5.33,.38,;-6.67,-.39,;-8,.38,;-6.67,-1.93,;-5.33,-2.7,;-4,-1.93,;-2.67,-2.7,;-1.33,-1.92,;,-2.69,;,-4.23,;-1.33,-5,;-2.67,-4.24,)| InChI=1S/C24H24F3N7O/c1-13-4-5-17(22-28-6-3-7-29-22)21(33-13)23(35)34-16-8-15(9-16)14(2)18(34)10-31-20-12-30-19(11-32-20)24(25,26)27/h3-7,11-12,14-16,18H,8-10H2,1-2H3,(H,31,32) HAYOALWMYMMFQF-UHFFFAOYSA-N 604126 US11660293, Example 248 Orexin/Hypocretin receptor type 1 Homo sapiens 17.4 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604126&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535439 482596822 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281178 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,(,5,;-1.33,4.23,;-2.67,5,;-4,4.23,;-4,2.69,;-2.67,3.46,;-2.67,1.92,;-1.33,2.69,;,1.92,;1.33,2.69,;2.67,1.93,;2.67,.38,;4,-.38,;5.38,.36,;5.33,1.93,;4,2.7,;6.72,-.41,;8.05,-1.18,;5.95,-1.75,;7.49,.92,;-2.67,.38,;-1.33,-.39,;-4,-.39,;-5.33,.38,;-6.67,-.39,;-8,.38,;-6.67,-1.93,;-5.33,-2.7,;-4,-1.93,;-2.67,-2.7,;-1.33,-1.92,;,-2.69,;,-4.23,;-1.33,-5,;-2.67,-4.24,)| InChI=1S/C24H24F3N7O/c1-13-4-5-17(22-28-6-3-7-29-22)21(33-13)23(35)34-16-8-15(9-16)14(2)18(34)10-31-20-12-30-19(11-32-20)24(25,26)27/h3-7,11-12,14-16,18H,8-10H2,1-2H3,(H,31,32) HAYOALWMYMMFQF-UHFFFAOYSA-N 604126 US11660293, Example 248 Orexin receptor type 2 Homo sapiens 26303 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604126 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604126&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535439 482596822 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281179 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,(,5.01,;-1.33,4.24,;-2.67,5.01,;-4,4.24,;-4,2.7,;-2.67,3.47,;-2.67,1.93,;-1.33,2.7,;,1.93,;1.33,2.7,;2.67,1.93,;2.67,.39,;4,-.38,;5.38,.36,;5.33,1.93,;4,2.69,;6.72,-.41,;8.05,-1.18,;5.95,-1.75,;7.49,.92,;-2.67,.39,;-1.33,-.38,;-4,-.38,;-5.33,.39,;-6.67,-.38,;-8,.39,;-6.67,-1.92,;-5.33,-2.69,;-4,-1.92,;-2.67,-2.69,;-1.33,-1.93,;,-2.7,;,-4.24,;-1.33,-5.01,;-2.67,-4.23,)| InChI=1S/C24H24F3N7O/c1-13-4-5-17(22-28-6-3-7-29-22)21(33-13)23(35)34-16-8-15(9-16)14(2)18(34)10-31-20-12-30-19(11-32-20)24(25,26)27/h3-7,11-12,14-16,18H,8-10H2,1-2H3,(H,31,32) HAYOALWMYMMFQF-UHFFFAOYSA-N 604127 US11660293, Example 249::US11660293, Example 250 Orexin/Hypocretin receptor type 1 Homo sapiens 7586 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604127&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535439 482596823 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281180 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,(,5.01,;-1.33,4.24,;-2.67,5.01,;-4,4.24,;-4,2.7,;-2.67,3.47,;-2.67,1.93,;-1.33,2.7,;,1.93,;1.33,2.7,;2.67,1.93,;2.67,.39,;4,-.38,;5.38,.36,;5.33,1.93,;4,2.69,;6.72,-.41,;8.05,-1.18,;5.95,-1.75,;7.49,.92,;-2.67,.39,;-1.33,-.38,;-4,-.38,;-5.33,.39,;-6.67,-.38,;-8,.39,;-6.67,-1.92,;-5.33,-2.69,;-4,-1.92,;-2.67,-2.69,;-1.33,-1.93,;,-2.7,;,-4.24,;-1.33,-5.01,;-2.67,-4.23,)| InChI=1S/C24H24F3N7O/c1-13-4-5-17(22-28-6-3-7-29-22)21(33-13)23(35)34-16-8-15(9-16)14(2)18(34)10-31-20-12-30-19(11-32-20)24(25,26)27/h3-7,11-12,14-16,18H,8-10H2,1-2H3,(H,31,32) HAYOALWMYMMFQF-UHFFFAOYSA-N 604127 US11660293, Example 249::US11660293, Example 250 Orexin receptor type 2 Homo sapiens <31623 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604127&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535439 482596823 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281181 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,(,5.01,;-1.33,4.24,;-2.67,5.01,;-4,4.24,;-4,2.7,;-2.67,3.47,;-2.67,1.93,;-1.33,2.7,;,1.93,;1.33,2.7,;2.67,1.93,;2.67,.39,;4,-.38,;5.38,.36,;5.33,1.93,;4,2.69,;6.72,-.41,;8.05,-1.18,;5.95,-1.75,;7.49,.92,;-2.67,.39,;-1.33,-.38,;-4,-.38,;-5.33,.39,;-6.67,-.38,;-8,.39,;-6.67,-1.92,;-5.33,-2.69,;-4,-1.92,;-2.67,-2.69,;-1.33,-1.93,;,-2.7,;,-4.24,;-1.33,-5.01,;-2.67,-4.23,)| InChI=1S/C24H24F3N7O/c1-13-4-5-17(22-28-6-3-7-29-22)21(33-13)23(35)34-16-8-15(9-16)14(2)18(34)10-31-20-12-30-19(11-32-20)24(25,26)27/h3-7,11-12,14-16,18H,8-10H2,1-2H3,(H,31,32) HAYOALWMYMMFQF-UHFFFAOYSA-N 604127 US11660293, Example 249::US11660293, Example 250 Orexin/Hypocretin receptor type 1 Homo sapiens 12.6 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604127&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535439 482596823 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281182 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1nc(C)ccc1-c1ncccn1 |r,wU:1.0,(,5.01,;-1.33,4.24,;-2.67,5.01,;-4,4.24,;-4,2.7,;-2.67,3.47,;-2.67,1.93,;-1.33,2.7,;,1.93,;1.33,2.7,;2.67,1.93,;2.67,.39,;4,-.38,;5.38,.36,;5.33,1.93,;4,2.69,;6.72,-.41,;8.05,-1.18,;5.95,-1.75,;7.49,.92,;-2.67,.39,;-1.33,-.38,;-4,-.38,;-5.33,.39,;-6.67,-.38,;-8,.39,;-6.67,-1.92,;-5.33,-2.69,;-4,-1.92,;-2.67,-2.69,;-1.33,-1.93,;,-2.7,;,-4.24,;-1.33,-5.01,;-2.67,-4.23,)| InChI=1S/C24H24F3N7O/c1-13-4-5-17(22-28-6-3-7-29-22)21(33-13)23(35)34-16-8-15(9-16)14(2)18(34)10-31-20-12-30-19(11-32-20)24(25,26)27/h3-7,11-12,14-16,18H,8-10H2,1-2H3,(H,31,32) HAYOALWMYMMFQF-UHFFFAOYSA-N 604127 US11660293, Example 249::US11660293, Example 250 Orexin receptor type 2 Homo sapiens 14125 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604127 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604127&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535439 482596823 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281183 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-16(7-13)32(19(12)11-29-21-27-9-14(10-28-21)22(24,25)26)20(34)17-8-15(23)2-3-18(17)33-30-4-5-31-33/h2-5,8-10,12-13,16,19H,6-7,11H2,1H3,(H,27,28,29) LABFIQAVGHKVOJ-UHFFFAOYSA-N 604129 US11660293, Example 251 Orexin/Hypocretin receptor type 1 Homo sapiens 22.4 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604129&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535438 482596824 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281184 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C(F)(F)F)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-8,.16,;-6.67,-2.15,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-16(7-13)32(19(12)11-29-21-27-9-14(10-28-21)22(24,25)26)20(34)17-8-15(23)2-3-18(17)33-30-4-5-31-33/h2-5,8-10,12-13,16,19H,6-7,11H2,1H3,(H,27,28,29) LABFIQAVGHKVOJ-UHFFFAOYSA-N 604129 US11660293, Example 251 Orexin receptor type 2 Homo sapiens 20417 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604129 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604129&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535438 482596824 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281185 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1ccc(F)cc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-6.67,-2.15,;-8,-2.92,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-3-2-14(23)8-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) YBTSREHJXOIBQZ-UHFFFAOYSA-N 604130 US11660293, Example 252 Orexin/Hypocretin receptor type 1 Homo sapiens 64.6 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604130&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535463 482596825 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281186 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1ccc(F)cc1-n1nccn1 |r,wU:1.0,(,4.78,;-1.33,4.01,;-2.67,4.78,;-4,4.01,;-4,2.47,;-2.67,3.24,;-2.67,1.7,;-1.33,2.47,;,1.7,;1.33,2.47,;2.67,1.7,;2.67,.16,;4,-.61,;5.38,.13,;5.33,1.7,;4,2.47,;6.72,-.64,;8.05,-1.41,;5.95,-1.98,;7.49,.69,;-2.67,.16,;-1.33,-.61,;-4,-.61,;-5.33,.16,;-6.67,-.61,;-6.67,-2.15,;-8,-2.92,;-5.33,-2.92,;-4,-2.15,;-2.67,-2.92,;-2.51,-4.46,;-1,-4.78,;-.23,-3.44,;-1.26,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-6-15(7-13)32(18(12)9-28-20-11-27-19(10-29-20)22(24,25)26)21(34)16-3-2-14(23)8-17(16)33-30-4-5-31-33/h2-5,8,10-13,15,18H,6-7,9H2,1H3,(H,28,29) YBTSREHJXOIBQZ-UHFFFAOYSA-N 604130 US11660293, Example 252 Orexin receptor type 2 Homo sapiens 11220 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604130 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604130&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535463 482596825 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281187 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1c(F)cccc1-n1nccn1 |r,wU:1.0,(-.77,4.78,;-2.1,4.01,;-3.44,4.78,;-4.77,4.01,;-4.77,2.47,;-3.44,3.24,;-3.44,1.7,;-2.1,2.47,;-.77,1.7,;.56,2.47,;1.9,1.7,;1.9,.16,;3.23,-.61,;4.61,.13,;4.56,1.7,;3.23,2.47,;5.95,-.64,;7.28,-1.41,;5.18,-1.98,;6.72,.69,;-3.44,.16,;-2.1,-.61,;-4.77,-.61,;-6.1,.16,;-6.1,1.7,;-7.44,-.61,;-7.44,-2.15,;-6.1,-2.92,;-4.77,-2.15,;-3.44,-2.92,;-3.28,-4.46,;-1.77,-4.78,;-1,-3.44,;-2.03,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-7-14(8-13)32(17(12)9-28-19-11-27-18(10-29-19)22(24,25)26)21(34)20-15(23)3-2-4-16(20)33-30-5-6-31-33/h2-6,10-14,17H,7-9H2,1H3,(H,28,29) RHQBSMROWWMKTN-UHFFFAOYSA-N 604131 US11660293, Example 253 Orexin/Hypocretin receptor type 1 Homo sapiens 13.2 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604131&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535464 482596826 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281188 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1c(F)cccc1-n1nccn1 |r,wU:1.0,(-.77,4.78,;-2.1,4.01,;-3.44,4.78,;-4.77,4.01,;-4.77,2.47,;-3.44,3.24,;-3.44,1.7,;-2.1,2.47,;-.77,1.7,;.56,2.47,;1.9,1.7,;1.9,.16,;3.23,-.61,;4.61,.13,;4.56,1.7,;3.23,2.47,;5.95,-.64,;7.28,-1.41,;5.18,-1.98,;6.72,.69,;-3.44,.16,;-2.1,-.61,;-4.77,-.61,;-6.1,.16,;-6.1,1.7,;-7.44,-.61,;-7.44,-2.15,;-6.1,-2.92,;-4.77,-2.15,;-3.44,-2.92,;-3.28,-4.46,;-1.77,-4.78,;-1,-3.44,;-2.03,-2.3,)| InChI=1S/C22H21F4N7O/c1-12-13-7-14(8-13)32(17(12)9-28-19-11-27-18(10-29-19)22(24,25)26)21(34)20-15(23)3-2-4-16(20)33-30-5-6-31-33/h2-6,10-14,17H,7-9H2,1H3,(H,28,29) RHQBSMROWWMKTN-UHFFFAOYSA-N 604131 US11660293, Example 253 Orexin receptor type 2 Homo sapiens 10000 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604131 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604131&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535464 482596826 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281189 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.28,.13,;5.23,1.7,;3.9,2.47,;6.61,-.64,;7.95,-1.41,;5.84,-1.98,;7.38,.69,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-4-18(33-30-5-6-31-33)17(7-13)22(34)32-16-8-15(9-16)14(2)19(32)10-28-21-12-27-20(11-29-21)23(24,25)26/h3-7,11-12,14-16,19H,8-10H2,1-2H3,(H,28,29) LBXFAXAKXYQCGD-UHFFFAOYSA-N 604132 US11660293, Example 254::US11660293, Example 256 Orexin/Hypocretin receptor type 1 Homo sapiens 4.27 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604132&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535462 482596827 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281190 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.28,.13,;5.23,1.7,;3.9,2.47,;6.61,-.64,;7.95,-1.41,;5.84,-1.98,;7.38,.69,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-4-18(33-30-5-6-31-33)17(7-13)22(34)32-16-8-15(9-16)14(2)19(32)10-28-21-12-27-20(11-29-21)23(24,25)26/h3-7,11-12,14-16,19H,8-10H2,1-2H3,(H,28,29) LBXFAXAKXYQCGD-UHFFFAOYSA-N 604132 US11660293, Example 254::US11660293, Example 256 Orexin receptor type 2 Homo sapiens 7586 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604132&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535462 482596827 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281191 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.28,.13,;5.23,1.7,;3.9,2.47,;6.61,-.64,;7.95,-1.41,;5.84,-1.98,;7.38,.69,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-4-18(33-30-5-6-31-33)17(7-13)22(34)32-16-8-15(9-16)14(2)19(32)10-28-21-12-27-20(11-29-21)23(24,25)26/h3-7,11-12,14-16,19H,8-10H2,1-2H3,(H,28,29) LBXFAXAKXYQCGD-UHFFFAOYSA-N 604132 US11660293, Example 254::US11660293, Example 256 Orexin/Hypocretin receptor type 1 Homo sapiens 1.78 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604132&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 137535462 482596827 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281192 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.28,.13,;5.23,1.7,;3.9,2.47,;6.61,-.64,;7.95,-1.41,;5.84,-1.98,;7.38,.69,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C23H24F3N7O/c1-13-3-4-18(33-30-5-6-31-33)17(7-13)22(34)32-16-8-15(9-16)14(2)19(32)10-28-21-12-27-20(11-29-21)23(24,25)26/h3-7,11-12,14-16,19H,8-10H2,1-2H3,(H,28,29) LBXFAXAKXYQCGD-UHFFFAOYSA-N 604132 US11660293, Example 254::US11660293, Example 256 Orexin receptor type 2 Homo sapiens 6607 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604132 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604132&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 137535462 482596827 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281193 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C1CC1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.23,.16,;5.23,1.7,;3.9,2.47,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26ClN7O/c1-14-16-8-18(9-16)31(22(14)12-28-23-13-26-20(11-27-23)15-2-3-15)24(33)19-10-17(25)4-5-21(19)32-29-6-7-30-32/h4-7,10-11,13-16,18,22H,2-3,8-9,12H2,1H3,(H,27,28) QNIJPKQSPFLIIY-UHFFFAOYSA-N 604134 US11660293, Example 257 Orexin/Hypocretin receptor type 1 Homo sapiens 26.3 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604134&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430344 482596828 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281194 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C1CC1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.23,.16,;5.23,1.7,;3.9,2.47,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26ClN7O/c1-14-16-8-18(9-16)31(22(14)12-28-23-13-26-20(11-27-23)15-2-3-15)24(33)19-10-17(25)4-5-21(19)32-29-6-7-30-32/h4-7,10-11,13-16,18,22H,2-3,8-9,12H2,1H3,(H,27,28) QNIJPKQSPFLIIY-UHFFFAOYSA-N 604134 US11660293, Example 257 Orexin receptor type 2 Homo sapiens 3890 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604134 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604134&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430344 482596828 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281195 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C1CC1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.23,.16,;5.23,1.7,;3.9,2.47,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26FN7O/c1-14-16-8-18(9-16)31(22(14)12-28-23-13-26-20(11-27-23)15-2-3-15)24(33)19-10-17(25)4-5-21(19)32-29-6-7-30-32/h4-7,10-11,13-16,18,22H,2-3,8-9,12H2,1H3,(H,27,28) LPKAWKUFMACQDU-UHFFFAOYSA-N 604135 US11660293, Example 258 Orexin/Hypocretin receptor type 1 Homo sapiens 85.1 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604135&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430345 482596829 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281196 C[C@@H]1C2CC(C2)N(C1CNc1cnc(cn1)C1CC1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;2.56,.16,;3.9,-.61,;5.23,.16,;5.23,1.7,;3.9,2.47,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26FN7O/c1-14-16-8-18(9-16)31(22(14)12-28-23-13-26-20(11-27-23)15-2-3-15)24(33)19-10-17(25)4-5-21(19)32-29-6-7-30-32/h4-7,10-11,13-16,18,22H,2-3,8-9,12H2,1H3,(H,27,28) LPKAWKUFMACQDU-UHFFFAOYSA-N 604135 US11660293, Example 258 Orexin receptor type 2 Homo sapiens 4467 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604135 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604135&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430345 482596829 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281197 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C1CC1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;3.9,2.47,;5.23,1.7,;5.23,.16,;3.9,-.61,;2.56,.16,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26ClN7O/c1-14-16-8-19(9-16)31(22(14)13-28-24-26-11-17(12-27-24)15-2-3-15)23(33)20-10-18(25)4-5-21(20)32-29-6-7-30-32/h4-7,10-12,14-16,19,22H,2-3,8-9,13H2,1H3,(H,26,27,28) ZDSMCSPGUUNOPP-UHFFFAOYSA-N 604136 US11660293, Example 259 Orexin/Hypocretin receptor type 1 Homo sapiens 21.9 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604136&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430346 482596830 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281198 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C1CC1)C(=O)c1cc(Cl)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;3.9,2.47,;5.23,1.7,;5.23,.16,;3.9,-.61,;2.56,.16,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26ClN7O/c1-14-16-8-19(9-16)31(22(14)13-28-24-26-11-17(12-27-24)15-2-3-15)23(33)20-10-18(25)4-5-21(20)32-29-6-7-30-32/h4-7,10-12,14-16,19,22H,2-3,8-9,13H2,1H3,(H,26,27,28) ZDSMCSPGUUNOPP-UHFFFAOYSA-N 604136 US11660293, Example 259 Orexin receptor type 2 Homo sapiens 4786 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604136 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604136&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430346 482596830 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 1281199 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C1CC1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;3.9,2.47,;5.23,1.7,;5.23,.16,;3.9,-.61,;2.56,.16,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26FN7O/c1-14-16-8-19(9-16)31(22(14)13-28-24-26-11-17(12-27-24)15-2-3-15)23(33)20-10-18(25)4-5-21(20)32-29-6-7-30-32/h4-7,10-12,14-16,19,22H,2-3,8-9,13H2,1H3,(H,26,27,28) DUOMVCMXILLTPI-UHFFFAOYSA-N 604137 US11660293, Example 260 Orexin/Hypocretin receptor type 1 Homo sapiens 35.5 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604137&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 168430347 482596831 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJC,4ZJ8 Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 1281200 C[C@@H]1C2CC(C2)N(C1CNc1ncc(cn1)C1CC1)C(=O)c1cc(F)ccc1-n1nccn1 |r,wU:1.0,(-.1,4.78,;-1.44,4.01,;-2.77,4.78,;-4.1,4.01,;-4.1,2.47,;-2.77,3.24,;-2.77,1.7,;-1.44,2.47,;-.1,1.7,;1.23,2.47,;2.56,1.7,;3.9,2.47,;5.23,1.7,;5.23,.16,;3.9,-.61,;2.56,.16,;6.57,-.61,;7.34,-1.95,;8.11,-.61,;-2.77,.16,;-1.44,-.61,;-4.1,-.61,;-5.44,.16,;-6.77,-.61,;-8.11,.16,;-6.77,-2.15,;-5.44,-2.92,;-4.1,-2.15,;-2.77,-2.92,;-2.61,-4.46,;-1.1,-4.78,;-.33,-3.44,;-1.36,-2.3,)| InChI=1S/C24H26FN7O/c1-14-16-8-19(9-16)31(22(14)13-28-24-26-11-17(12-27-24)15-2-3-15)23(33)20-10-18(25)4-5-21(20)32-29-6-7-30-32/h4-7,10-12,14-16,19,22H,2-3,8-9,13H2,1H3,(H,26,27,28) DUOMVCMXILLTPI-UHFFFAOYSA-N 604137 US11660293, Example 260 Orexin receptor type 2 Homo sapiens 12882 US Patent 10.7270/Q2280CJQ aid1919461 US11660293 Micheli, F; Bertani, B; Gibson, KR; Di Fabio, R; Raveglia, L; Zanaletti, R; Cremonesi, S; Pozzan, A; Semeraro, T; Tarsi, L; Luker, TJ 5/30/2023 7/2/2023 Chronos Therapeutics http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=604137 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=604137&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 168430347 482596831 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WS3,5WQC Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0